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Regulation of steroidogenic enzymes in the rat adrenal gland
Abstract
Functional zonation of the rat adrenal cortex may be defined by the expression of
the mitochondrial enzymes aldosterone synthase (CYP11B2) and 11 (3-hydroxylase
(CYP11B1) that regulate the secretion of the steroids aldosterone in the zona
glomerulosa (ZG) and corticosterone in the zona fasciculata (ZF), respectively.
Synthesis of these steroids is also dependent on steroidogenic acute regulatory (StAR)
protein which limits the transport of cholesterol into the mitochondria. The main aims
of this thesis were to study the distribution and expression of CYP11B2 and
CYP11B1 in the adrenal cortex ofWistar adult female rats, pregnant rats, their fetuses
and offspring, after maternal manipulation of (i) the renin-angiotensin system (RAS)
by changing dietary sodium, and (ii) the hypothalamo-pituitary-adrenal (HPA) axis by
chronic administration of dexamethasone (DEX). Thirdly, an antibody against a
bovine StAR peptide sequence was characterised for future studies on StAR protein
expression in the rat adrenal paradigms. Immunohistochemistiy, immunoblotting and
competitive reverse transcriptase-polymerase chain reaction (cRT-PCR) methods
were developed to examine protein and mRNA expression for CYP11B2 and
CYP11B1. Radioimmunoassays were used for plasma steroid levels.
In the first experimental series, fetal adrenocortical functions were compared at
embryonic day 20 (E20) after feeding high (HS; 3% Na), normal (NS; 0.3%) and low
(LS; 0.03%) sodium diets throughout pregnancy. The effects of dietary sodium on
fetal adrenal histology were compared with those of adult adrenals of non-pregnant
female and pregnant rats. As expected, compared with tissues of rats fed a NS-diet,
LS-diet caused significant increases of ZG width in non-pregnant and pregnant rats
whereas HS-diet markedly reduced ZG width in both non-pregnant and pregnant rats.
Cell hypertrophy was seen in the ZG of the adrenals from both the non-pregnant and
pregnant LS-treated rats. In pregnant rats, the adrenal CYP11B2 level was 2.8-fold
higher in LS-treated rats and 50% lower in HS-treated rats compared with NS-treated
rats. Similarly, levels of CYP11B2 mRNA were significantly increased and
decreased by LS- and HS-treatment, respectively. A HS-diet also significantly
reduced the ZG staining for CYP11B2. There were no effects of sodium diets on
either adrenal CYP11B1 protein or mRNA expression in pregnant rats. In fetal rats,
plasma aldosterone levels were significant increased in the LS- compared to those in
the NS- and the HS-groups (LS; 1005.0 ± 139.6 pmol/L, NS; 436.0 ± 46.4 pmol/L,
HS; 520.9 ± 69.5 pmol/L). The staining intensity of CYP11B2 was markedly
increased (P<0.005) in the LS- compared to the NS- and HS-groups. However, there
were no significant differences of protein or mRNA expression of CYP11B2 among
the groups and no differences of any measured variable between NS- and HS-groups.
Plasma corticosterone levels and the protein and mRNA expression levels of the fetal
adrenal CYP11B1 were not affected by maternal sodium intake. These results
suggest that dietary sodium restriction may activate the RAS to induce the expression
of CYP11B2 in fetal adrenals but that responses of protein and mRNA are muted
compared with changes in maternal adrenal expression. These modest fetal effects
are compatible with published data suggesting that aldosterone biosythesis is
initiated only in the final few days of gestation.
In the second experimental series, chronic daily injections of DEX (100 pg/kg
body weight/day) throughout gestation significantly reduced the protein and mRNA
expression of the CYP11B1 and caused modest increases in CYP11B2 mRNA and
protein in adrenals of DEX-treated pregnant rats. Regulation of protein and mRNA
levels of CYP11B2 and CYP11B1 in these E20 adrenals appeared to be similar to
those in maternal adrenals. These results suggest that DEX readily crosses the
placenta and down-regulates fetal HPA axis activity, and are compatible with
previous in vitro studies demonstrating that fetal adrenal CYP11B1 activity is
regulated from El5. Intrauterine DEX-treated rats exhibited fetal growth retardation
with differential effects on heart, kidney and adrenal weights. Some of these effects
persisted after birth when DEX-treatment had been stopped. Postnatal body weights
continued to be lower at age 7-, 28-day and 4-month-old whereas heart weight was
proportionately greater after DEX-treatment in utero, particularly at days 7 and 28.
In addition to CYP11B1 and CYP11B2, transcripts of CYP11B3 a third gene
encoding an 11 P-hydroxylase enzyme were found in 7- and 28-day-old rat adrenals,
but not in E20, 4-month-old and pregnant rat adrenals. The relative amount of
CYP11B3 mRNA was higher in 28-day-old than in 7-day-old rat adrenals. No
obvious effect of the prenatal DEX-treatment on the amount of the CYP11B3
transcripts was observed. Long-term DEX exposure throughout gestation causes
significant changes of the expression of the CYP11B1 in the adrenals of pregnant
rats. In the adrenals of the 7-, 28-day- and 4-month-old rat offspring, gene and
protein expression of CYP11B2 and CYP11B1 was regulated in a different manner
from those in E20 and pregnant rats. Intrauterine DEX-treatment slightly increased
the CYP11B1 and CYP11B2 mRNA and protein expression, especially in the
4-month-old offspring. The results suggest that maternal DEX-treatment may
programme the physiological state of the adult offspring via changes in the activity
of the HPA axis or possibly the RAS system.
Immunohistochemical studies in adult rat adrenal glands, using a peptide StAR
antibody, showed the distribution of StAR protein in the ZG and ZF with less intense
staining in the zona reticularis (ZR). In addition, intense immunoreactivity was seen
in the adrenal medulla. The specificity of the peptide StAR antibody was examined
by immunoblotting. Consistent with other studies, a 30 kDa band, corresponding to
StAR, was detected mainly in the total protein homogenate of the adrenal and ovary
and the mitochondria of the ZG and ZF. These results suggest that StAR protein may
have some other as yet unidentified functions in the adrenal gland, especially in the
medulla. Alternatively, the adrenal medulla may contain a protein closely related to
StAR, sharing common antigenicity. These preliminary studies emphasise the need
for further studies on the role of StAR (and related) proteins in the adrenal gland and
in the other endocrine organs in different physiological situations.
Chapter 1 Introduction
1.1 The adrenal gland
In mammalian species, the adrenal glands are located above the kidneys. The
adrenal glands develop into two different endocrine tissues, the cortex and the
medulla. These two distinct tissues have different morphologies, functions and
embryological origins.
1.1.1 Morphology and function of the adult rat adrenal gland
The adult rat adrenal glands are encapsulated by fibrous collagen. The adrenal
cortex is divided into three zones, the zona glomerulosa (ZG), the zona fasciculata
(ZF) and the zona reticularis (ZR) (Fig. 1.1). Underneath the capsule, the ZG contains
aggregated rounded cells which secrete mineralocorticoids, aldosterone being the
most potent one. Mineralocorticoids are essential for maintaining the balance ofwater
and electrolytes, and hence for the regulation of blood pressure. About 75% of the
cortex consists of the ZF. The ZF cells form finger-like columns following the
vasculature and synthesise glucocorticoids, principally Cortisol in primates and
corticosterone in rodents. These cells also contain high levels of cholesterol and
cholesterol esters. Glucocorticoids are involved in carbohydrate, protein and fat
metabolism and they also regulate blood pressure by positive modulation of the
noradrenergic pressor response and probably through other, as yet, unidentified
mechanisms. The ZR, which is responsible for adrenal C19 steroid biosynthesis has a
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Fig. 1. 1 Adrenal morphology. Adrenal sections of adult Wistar rats were stained by
haematoxylin. A. Magnification 48X. B. Magnification 480X. C, ZG, ZF, ZR and M




In addition to these zones, a cell layer, described previously as the intermediate or
transitional zone (Deane and Greep, 1946; Nicander, 1952; Cain and Harrison, 1950;
Josimovich et al., 1954), has been reported to exist between the ZG and ZF. Mitani et
al. (1994) confirmed that this Sudan-unstained and tightly packed cell layer
corresponded to the intermediate or transitional zone by using various
immunohistochemical methods. Furthermore, the cells are regarded as inert in relation
to the biosynthesis of aldosterone and corticosterone (Mitani et al. 1994).
The medulla consists of the non-steroidogenic chromaffin cells, which are derived
from neuroectoderm and synthesise norepinephrine or epinephrine. However, small
islands of cortical tissues surrounding the central adrenal vein in the medulla have
been reported. Some chromaffin cells also transverse the adrenal cortex (Bornstein et
al. 1994; Bornstein et al., 1997). The physiological function of these cells, interwoven
in the cortex and medulla is still unclear.
1.1.2 Adrenal embryology and development
The adrenal gland is derived from mesenchymal tissue next to coelomic
epithelium (Fig. 1.2). The adrenal cortex originates from mesodermal tissue and the
medulla is of neuroectodermal origin and migrates from the neural crest into the
adrenal primordium. These two tissues then become encapsulated.
Evidence for visible adrenal differentiation in rats was not seen prior to 11.5 days
of gestation. However, at this stage, adrenal blastema cells, showing small, multiple
nucleoli, were seen beneath the surface of the urogenital ridge. Fetuses in their 14th
day of development had well-developed nests of presumptive adrenocortical cells
distributed along the angle of the dorsal mesentery. Mesenchymal cells started to be
flattening out as capsular tissue along the adrenal. At 15th embryonic day, the nests of
adrenocortical cells were enlarged and more readily distinguishable (Roos, 1967). In
the 16.5 day of fetuses, a narrow layer immediately beneath the capsule consisted of
relatively small, tightly packed cells, which were correspondent to the ZG cells of the
3
adult. At this stage, the adrenal cells appeared virtually fat-free (Josimovich et al.,
1954). The adrenals of mature fetuses (18.5 day) were completely formed with a
distinct capsule and a basophilic ZG. The cells in the inner ZF and ZR were similar,
with swollen cytoplasm and a central nucleus (Roos, 1967). Small lipid droplets
occurred in all of the cortical cells. However, a lipid-free transitional zone became
detectable between the ZG and the ZF (Josimovich et al., 1954).









(schematic cross section of embryo)
Fig. 1. 2 Formation of adrenal gland (Adapted from Mitani et al., 1997).
4
Blood vessels and nerve cells appeared within the developing adrenal during the
15th embryonic day (Roos, 1967). A cluster of prospective medullary cells was able
to be seen outside of the adrenal gland at 16.5 day rat fetus. After that, the medullary
nests migrated toward the centre of the glands and gradually coalesced (Josimovich et
al., 1954, Mitani et al., 1997). The medullary cells enlarged only slightly before birth
(Fig. 1.2). Both hypertrophy and hyperplasia accounted for the further growth after
birth. However, even at 2.5 days after birth, the medullary tissue still occurred in
separate clusters surrounded by strands of cortical cells (Josimovich et al., 1954).
1.1.3 Adrenal zonation
The development of functionally distinct cells in relation to the zonation of the
adrenal cortex has been studied over several decades. A number of theories have been
proposed to account for the observed structure and function of the adrenal cortex.
Cell migration theory
The cell migration theory is also called the escalator theory. Gottschau first
proposed that adrenal cortical cells arose from a common stem cell in and beneath the
capsule or in the subcapsular region, that then migrated centripetally and degenerated
at the border between the ZR and the medulla (reviewed by Long, 1975). This theory
was also supported by studies which showed that the original ZF and ZG cells died
and were absorbed after adrenal cortex enucleation or autotransplantation. However,
the adrenal capsule formed a sphere, within which the glomerulosa developed well
and generated new functional fasciculata cells (Belloni et al., 1991; Vendeira et al.,
1996). More recently, Morley et al. (1996) confirmed that the adrenal parenchyma is
composed of clonally related cords of cells that extend centripetally from the ZG in to
the ZF/R in the adult mouse using a 21-hydroxylase/p-galactosidase transgenic mouse
model (Morley et al., 1996). According to a mitotic study, cell proliferation is greater
in the ZG and ZF related to the higher rate ofmitosis in these zones (Mitchell, 1948).
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In contrast, cell death is indicated by more apoptotic bodies and pyknotic nuclei,
which are more prominent in the ZR than in the other two zones (Wyllie et al, 1973a,
1973b). These observations are consistent with the model proposed by Mitchell who
modified the cell migration theory to propose a non-migrating, self-sustaining ZG and
a second proliferating population of cells in the outer part of the ZF that subsequently
migrated centripetally (Mitchell, 1948).
Zonal theory
The zonal theory originated from the relatively independence of pituitary control
on the ZG cells, while, in contrast, the inner zones (ZF and ZR) relied on the
regulation of pituitary adrenocorticotropic hormone (ACTH) (reviewed by Long,
1975). In addition, each zone in the cortex had its own distinct function and
replenished its own cells, which subsequently died locally.
Transformation field theory
This theory is based on certain histological changes of the ZG cells during various
phases of activity. Continuous stimulation of rat ZG cells in culture with ACTH led to
the loss of mineralocorticoid secretory capacity in favour of glucocorticoids, with a
concomitant histological transformation from a typical glomerulosa to a more
fasciculata-like appearance (reviewed by Estivariz et al. 1992).
However, none of the above theories could explain the adrenal zonation
completely. More recently, Mitani et al. defined a progenitor cell layer in the rat
adrenal cortex between the ZG and ZF, based on functional and morphological
observations (Mitani et al., 1994). This finding was in accordance with the
intermediate or transitional zone previously suggested by others (Deane and Greep,
1946; Nicander, 1952; Cain and Harrison, 1950; Josimovich et al., 1954). As a
consequence of the occurrence of DNA-synthesizing cells present in and around the
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intermediate zone, and the fact that the cells labelled with 5-bromo-2'-deoxyuidine
(BrdU) migrated inward from around this zone in a time-dependent manner, it was
proposed that the intermediate zone is an undifferentiated zone and could potentially
be the stem cell zone of the adrenal cortex (Mitani et al., 1994) (Fig. 1.3).
1.2 Steroidogenesis in the adrenal cortex
Adrenal steroid biosynthesis is the result of sequential hydroxylation,
dehydrogenation and isomerisation reactions that convert cholesterol to the
physiologically active mineralocorticoids, glucocorticoids and adrenal androgens.
The synthesis of the various adrenal hormones involves several proteins and key
enzymes. The steroidogenic pathway and enzymatic steps are shown in Fig. 1.4. The
key enzymes and proteins are discussed in this chapter.
1.2.1 Biosynthesis of steroid hormones
Cholesterol is the precursor for all steroid hormone biosynthesis. In the past, the
conversion of cholesterol to pregnenolone by cytochrome P450 cholesterol side chain
cleavage (CYP11A1) was thought to be the rate-limiting step for steroidogenesis
(reviewed by Hall, 1987; Jefcoate et al., 1992). However, some researchers found that
a protein synthesis inhibitor, cycloheximide retarded steroidogenesis and blunted the
activity and amounts of CYP11A1 in response to acute hormone stimulation (Davis
and Garren, 1968; Privalle et al., 1983). Thereafter, a rapidly synthesised,
cycloheximide-sensitive protein, named steroidogenic acute regulatory (StAR)
protein (Clark et al., 1994), was identified and proposed to act in the translocation of
cholesterol through the aqueous intermembrane mitochondrial space to the inner
mitochondria where CYP11A1 is localised (Cherradi et al., 1997) and where
pregnenolone is synthesised. As pregnenolone is a more hydrophilic metabolite than
cholesterol, it can then be transported to the endoplasmic reticulum, where it is
converted to progesterone by 3p-hydroxysteroid dehydrogenase/A 5-4 isomerase
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space to the inner mitochondria where CYP11A1 is localised (Cherradi et al., 1997)
and where pregnenolone is synthesised. As pregnenolone is a more hydrophilic
metabolite than cholesterol, it can then be transported to the endoplasmic reticulum,
where it is converted to progesterone by 3P-hydroxysteroid dehydrogenase/A 5-4
isomerase (3P-HSD), which is expressed in both the endoplasmic reticulum and in
the mitochondrial compartments (Cherradi et al., 1997) and is also present in all
cortical cells (Ishimura and Fujita, 1997).
Fig. 1. 3 Adrenal zonation. An adrenal section from a sodium-deficient rat for 20
days was stained with the anti-CYPllB2 and the anti-CYPllBl simultaneously. C,
G, ZI and F denote capsule, zona glomerulosa, zona intermediate and zona
fasciculate. Violet and brown colours show the presence ofCYP11B2 and CYP11B1,
respectively (Adapted from Mitani et al., 1994).
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As shown in Fig. 1.4, pregnenolone and progesterone can enter a number of
biosynthetic pathways catalysed by various enzyme cascades. These different
pathways produce a range of steroid hormones with various biological activities.
However, rats have divergent metabolic pathways when compared to other species. It
has been known that the rat adrenal cortex lacks steroid 17a-hydroxylase (CYP17)
whereas the ZF and ZR contain CYP17 in many species, including the human and
bovine species (Bell et al., 1979). Therefore, the progesterone is converted into
deoxycorticosterone (DOC) by cytochrome P450 21-hydroxylase (CYP21) in the rat
adrenal cortex. As a result, the cells in the ZF/R synthesise corticosterone rather than
Cortisol, which is synthesised in humans or other mammalian species, as the major
glucocorticoid. Also, the ZR of the rat adrenal is presumably inert to synthesise C19
steroids (Bell et al., 1979). The nature of the enzyme involved in the final steps of
aldosterone synthesis has only been established relatively recently. The rate-limiting
steps of aldosterone biosynthesis are involved in the conversion of DOC to
aldosterone in the adrenal ZG.
1.2.2 Mineralocorticoids (aldosterone) and glucocorticoids (corticosterone)
biosynthesis
As illustrated in Fig. 1.4, the early steps in steroidogenesis are common to all
cortical zones. In contrast, the late steps in the steroidogenic pathway are zone-
specific. In the rat adrenal ZG, cytochrome P450 aldosterone synthase (CYP11B2)
contains 11 P-hydroxylase, 18-hydroxylase and 18-oxidase activities. The
11 P-hydroxylation of DOC to corticosterone and its subsequent 18-hydroxylation of
corticosterone to 18-hydroxycorticosterone (18-OH-B) and 18-oxidation of
18-OH-DOC to aldosterone are catalysed by CYP11B2. Expression of this enzyme is
limited to the ZG so that it prevents the production of aldosterone in other
































Fig. 1. 4 Principal pathways for adrenal steroid biosynthesis. Pathways which do not
exist in the rat adrenal cortex are bordered by a solid line. StAR protein:
Steroidogenic acute regulatory protein, CYP11A1: Cytochrome P450 cholesterol side
chain cleavage enzyme, CYP17: Cytochrome P450 17a-hydroxylase, 3p-HSD:
3p-Hydroxysteroid dehydrogenase/ A 5-4 isomerase, CYP21: Cytochrome P450
21-hydroxylase, CYP11B1: 11 p-Hydroxylase, CYP11B2: Aldosterone synthase.
(Adapt from Brook, C. & Marshall, N., 1996)
10
On the other hand, corticosterone biosynthesis is completed by cytochrome P450
lip-hydroxylase (CYP11B1). Although CYP11B1 has 18-hydroxylation activity, but
unlike CYP11B2, CYP11B1 is unable to express 18-oxidase. Therefore, CYP11B1
has limited function to convert DOC to corticosterone in the ZF and ZR in rats
(Ogishima et ah, 1992; reviewed by Rainey, 1999).
1.2.2.1 Zone-specific enzymes: CYP11B2 and CYP11B1
Although the functional zonation of the rat adrenal cortex according to the
morphological findings had been established for several decades, the enzymes
responsible for the final steps of aldosterone and corticosterone biosynthesis in rats
were not identified until recent years.
Treatment of rats with low sodium and high potassium diet markedly stimulated
the production of aldosterone in rats (Meuli and Muller, 1983). Later, a protein of
molecular size 49 kilodaltons (kDa) was isolated from ZG mitochondria of rats on a
sodium-restricted and potassium-replete diet (Lauber et al., 1987). Another 51 kDa
protein was identified from the ZF/R mitochondria of rats on normal diet (Ogishima et
al., 1989) or on a sodium-replete and potassium-deficient diet (Lauber et al., 1987).
These findings indicated the existence of two different forms of CYP11B in the rat
adrenal cortex, with only one of them, i.e. the 49 kDa form, being capable of
catalysing the two final steps for aldosterone biosynthesis in situ (Meuli and Muller,
1983; Lauber et al., 1987; Ogishima et al., 1989). Thereafter, several studies led to the
isolation and purification of the 49 kDa protein, named CYP11B2, from the capsular
portion of rat adrenals (Lauber and Muller, 1989; Ogishima et al., 1989). On the other
hand, the 51 kDa protein, named CYP11B1, was found mainly in the decapsulated
portion of the adrenals (Ogishima et al., 1989).
The zonal distribution ofCYP11B2 and CYP11B1 was further confirmed by other
techniques, i.e. immunohistochemistry and in situ hybridisation. CYP11B2 is
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localised strictly in the ZG of the rat adrenal cortex, while CYP11B1 is present in the
ZF and ZR and more abundant in the outer ZF. Also, the zonal distributions are
principally unchanged following treatment with angiotensin II (All) or by sodium
depletion, but the number ofCYP1 lB2-positive cells increase considerably in the ZG
(Ogishima et al., 1992; Ho and Vinson, 1993; Mitani et al., 1994; Wotus et al., 1998;
Mitani et al., 1999).
1.2.2.2 Molecular cloning of CYP11B2 and CYP11B1
Two discrete complementary DNAs (cDNAs), encoding CYP11B2 and CYP11B1,
were cloned and identified from the adrenal capsular tissues of sodium-depleted,
potassium-replete rats and from ACTH-stimulated rats, respectively. The nucleotide
sequences of CYP11B2 cDNA contain a 74 base pairs (bp) 5'-noncoding region, a
1530 bp open reading frame and a 1217 bp 3'-noncoding region. The overall length of
the CYP11B1 nucleotide sequence is 2747 bp with a 1247 bp 3'-noncoding region.
The two proteins are highly homologous in their amino acid sequence with 88%
similarity. Both the deduced amino acid sequences of CYP11B2 and CYP11B1
contain a conserved heme-binding site and steroid binding site (Nonaka et al., 1989;
Matsukawa et al., 1990). Furthermore, expression of the proteins encoded by these
cDNAs in nonsteroidogenic COS-7 cells confirmed the difference in their enzymatic
activities (Matsukawa et al., 1990; Nonaka et al., 1991).
According to the analyses of the 5'-upstream regions, both the CYP11B2 and
CYP11B1 genes contain a common sequence ofTATA box, defining the transcription
initiation site and 4 modified or conserved cAMP response elements (CREs; or cis
elements) which are linked to cAMP / dibutyryl cAMP dependent stimulators (Mukai
et al., 1993; Nomura et al., 1993). In addition, Mukai et al. (1993) also isolated
CYP11B2 and CYP11B1 genomic clones with two additional genes, CYP11B3 and
CYP11B4. Of these, CYP11B3 had the same number of exons and the same location
of introns as those of CYP11B2 and CYP11B1. In the nucleotide sequences, the
homologies between CYP11B2 and CYP11B3 and between CYP11B1 and CYP11B3
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are 89% and 96%, respectively. However, no CYP11B3 gene product including
transcript has been reported (Mukai et al., 1993; Nomura et al., 1993). As CYP11B4
lacks exon 3 and a part of exon 4, it is considered as a pseudogene (Mukai et al.,
1993).
1.2.2.3 Expression of CYP11B2 and CYP11B1 in adrenal glands during
development
According to functional and morphological studies, the rat adrenal gland at 16
days of gestation has a distinct capsule and distinguishable ZG and ZF structures (see
sectionl.1.2). It was also reported that a considerable amount of glucocorticoid was
produced at this stage of gestation (Roos, 1967; Kalavsky, 1971; Milkovic et al., 1973;
Yamamoto et al., 1983; Yamamoto et al., 1986). Fetal adrenal glands were able to
secret some mineralocorticoid at around 18 days of gestation (Milkovic et al., 1976;
Churchill et al., 1981). The discrepancy between the morphological features and the
steroidogenic capacity of adrenal glands was clarified at the molecular level.
The developmental expression of zone specific enzymes has been studied in detail
by immunohistochemistry and in situ hybridisation. Although small clusters of
CYPllB2-positive cells throughout the adrenal were detected at 16 days of gestation
(E16) (Wotus et al. 1998), a clear expression of CYP11B2 and its mRNA was
established between El 8 and E20 (Mitani et al., 1997; Wotus et al. 1998, Mitani et al.,
1999). This implies that aldosterone biosythesis is initiated only in the final few days
of gestation. On the other hand, although the appearance of angiotensin receptor-type
IB (ATib) mRNA was apparent in the outer part of the adrenal (Mitani et al., 1999),
the ATib receptor was thought to be not functionally mature or the concentration of
All in plasma was not sufficient at this stage, resulting in no expression of CYP11B2
until the time around birth (Mitani et al., 1999). A CYP1 lB2-positive layer was
clearly recognized in the outer part of the adrenal gland and showed the number of
functionally active ZG cells which increased one day after birth. The intensity of
CYP11B2 staining then increased afterward with time until adulthood (Mitani et al.,
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1999).
The onset of expression of CYP11B1 was detected throughout the adrenal gland
and intermingled with medullary cells from E16. At the same time, CYP11A1 and
CYP21 were also co-expressed in the inner part of the gland (Mitani et al., 1999). This
suggests that the ZF cells start functioning as early as El6. At E20, CYP11B1 was
more apparent in the ZF than in those of earlier days although the cortical cells
remained mixed together with medullary cells, but most of them were found gathering
at the centre of the gland. Furthermore, a zona intermediate, lacking CYP11B2 and
CYP11B1, was first clearly identified at this stage and thereafter constantly observed
in adult rats (Mitani et al., 1997; Wotus et al. 1998, Mitani et al., 1999).
1.3 Regulations of CYP11 B2/aldosterone and
CYP11B1 /corticosterone biosynthesis
The regulation of steroid biosynthesis in the adrenal cortex is conducted mainly
via the renin-angiotensin system (RAS) and the hypothalamo-pituitary-adrenal (HPA)
axis. The RAS system is primarily involved in the regulation of mineralocorticoid
(aldosterone) synthesis whereas the ITPA axis is associated more with glucocorticoid
synthesis. The nature of the adrenal cortex is to produce aldosterone and
corticosterone distinctly. This mainly relies on the differential expression of
CYP11B2 and CYP11B1.
1.3.1 Regulation of CYP11B2 and aldosterone biosynthesis
1.3.1.1 The renin-angiotensin system (RAS)
The RAS is the principal regulator of the secretion of aldosterone. The classical
circulating RAS is important in the control of salt and water balance and blood
pressure through actions in the kidney (Fig. 1.5).
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Renin, a protease enzyme, is mainly synthesised by the juxtaglomerular cells of
kidney and is responsible for the synthesis of angiotensin I (AI) from renin substrate
(angiotensinogen). Angiotensin II (All) is the effective peptide, which is cleaved from
AI by angiotensin-converting enzyme (ACE). All exerts two major actions, one as a
direct arteriolar vasconstrictor and the other as a stimulus to aldosterone secretion.
These two actions, in concert, maintain the volume and pressure of the arterial
circulation (Fig 1.5). Sodium reabsorption in renal tubules and aldosterone secretion
in the ZG of adrenal cortex are also regulated to some extent by AIL
Local RASs have now been identified in a number of tissues, including the brain,
testes, ovaries and the adrenal gland. In the rat, the adrenal gland has the highest renin
concentration next to the kidney. All of the components of RAS have also been
identified in the adrenal cortex (reviewed by Mulrow, 1999; Lumbers, 1999).
Aguilera et al. (1981) demonstrated the presence of renin enzyme in the outer
zone of adrenal cortex of the rat and noted that All was present in the adrenal as well
as in the plasma of nephrectomised rats, suggesting that the adrenal cortex was the
source of the plasma All (Aguilera et ah, 1981). The presence and concentration of
angiotensin peptides were not eliminated or reduced by nephrectomy. This also
suggested that All is produced locally rather than recycled from the circulation.
All exerts its action on target organs by interacting with a receptor in the plasma
membrane. There are several types ofAll receptors. Angiotensin receptor-type 1 (ATi)
and angiotensin receptor-type 2 (AT2) are the major ones (Murphy et ah, 1991; Sasaki
et al., 1991). The ATi receptor exists as two isoforms, angiotensin receptor-types 1A
(ATia) and IB (AT|B). Most of the known biological actions ofAll are mediated via
the ATi and probably ATia except in the adrenal where control of aldosterone
secretion appears to be mediated via the ATib (Gigante et al., 1997). By in situ
hybridization and by using losartan and PD123319 as specific ligands to displace
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[ I]All from AT, and AT2 receptors, respectively, the adrenal ZG was shown to



























Fig. 1. 5 The renin-angiotensin system. Plus and minus signs indicate stimulation and
inhibition, respectively. Only the major influences on the system are shown. (Adapted
from Felig et al., 1995).
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(Aguilera et al., 1992; Lehoux et al., 1997). However, the mechanisms by which the
adrenal RAS acts on aldosterone remain unclear.
1.3.1.2 Factors regulate CYP11B2 and aldosterone biosynthesis in adult
rat adrenal glands
1.3.1.2.1 Sodium
It is now well established that sodium restriction causes both hypertrophy and
hyperplasia of the ZG and an increase in aldosterone (Pike et al., 1966; Pohanka and
Pike, 1970; McEwan et al., 1999). The increase in basal and All-stimulated
aldosterone output from isolated ZG cells is due to the specific increase ofCYP11B2
mRNA levels and its associated enzyme activities, but not the expression of
CYP11Al mRNA and its enzyme activities (Tremblay et al., 1992; Adler et al., 1993).
Volpe et al. (1997) showed that salt depletion and losartan caused a rise in plasma and
adrenal renin activities and its expression, whereas CYP11B2 mRNA and plasma
aldosterone levels were increased by salt restriction and reduced by losartan in both
intact and nephrectomised rats (Volpe et al., 1997). Lehoux et al. (1994) further
extended these observations to the effective translation ofATi receptor mRNA into
ATi receptor protein and established a correlation between the increased synthesis of
aldosterone and the increased level of ATi receptor in addition to an increased
capacity of adrenal cells to bind All in the ZG of rats after sodium deprivation
(Lehoux et al., 1997).
1.3.1.2.2 Potassium
Potassium supplementation specifically increased CYP11B2 mRNA levels in the
ZG without affecting CYP11B1 expression in the ZF (Tremblay et al., 1992). The
induction of adrenal CYP11B2 expression seen following potassium loading in rats
has been thought to be associated with sodium loss rather than direct effects of
potassium on the ZG. Potassium has been shown to markedly increase plasma
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aldosterone and adrenal renin in rats, whereas plasma renin activity was suppressed
(Nakamaru et al., 1985). In isolated ZG cells, All secretion and renin activity were
also stimulated by potassium loading (Doi et al., 1984; Shier et al., 1989; Yamaguchi
et al., 1990). Numerous studies in isolated ZG cells have demonstrated that potassium
stimulates aldosterone directly in vitro (Miiller, 1987). Captopril inhibited both the
inductions of CYP11B2 mRNA and plasma aldosterone levels in the
potassium-treated rats (Nakamaru et al., 1985; Tremblay et al., 1992). However,
recent studies using mice with targeted deletion of angiotensinogen (Okubo et al.,
1997) or the AT]B receptor (Chen et al., 1997) have demonstrated that potassium itself
can be an alternative potent regulator of adrenal glomerulosa aldosterone production
and increase CYP11B2 expression in the ZG during dietary sodium restriction.
1.3.1.2.3All
Short-term and chronic All administrations induce a significant rise in plasma
aldosterone and cause lipid depletion and hypertrophy of the ZG cells, especially the
hypertrophy of smooth endoplasmic reticulum and mitochondrial compartment where
the steroidogenic enzymes involved in aldosterone synthesis are located (Mazzocchi
et al., 1980). All also stimulates adrenal ZG cell proliferation as well as augmenting
aldosterone synthesis (McEwan et al, 1996; McEwan et al, 1999). Iwai and Inagami
(1992) demonstrated that continuous infusion of All increased the level of ATi
receptor mRNA in the adrenal and suggested that this receptor mRNA level is
dependent on the RAS (Iwai and Inagami, 1992). The effects ofAll can be inhibited
by antagonists to the ATi receptor. Furthermore, blockade of All receptors by the
non-selective antagonist, saralasin, or the AT] selective antagonist, losartan, and ACE
inhibition by captopril reduce aldosterone secretion from in situ perfused adrenals in
rats kept on a sodium-restricted diet (Mazzocchi et al., 2000). Along with these
observations, All receptors exhibit a zonal distribution and suggest a role for All in
the ZG cell-specific expression of CYP11B2 (Donna et al., 1998).
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1.3.1.2.4 ACTH
Short-term or acute administration of ACTH stimulates the early steps in
aldosterone synthesis, i.e. prior to formation of pregnenolone (Lumbers, 1999)
whereas ACTH has inhibitory effects on adrenal expression of CYP11B2 in the
long-term experiments in rats (Mitani et al., 1996; Lumbers, 1999). Sander et al.
(1994) compared the regulation of adrenal steroidogenesis after ACTH injection of
[TGR(mREN2)27] transgene rats, and normotensive SD rats. Both groups of animals
showed no difference in expression ofCYP11A1 and CYP11B1 by ACTH. However,
ACTH treatment rendered CYP11B2 mRNA undetectable and altered the
morphology of adrenal cortex, resulting in a lack ofZG-like cells (Sander et al., 1994).
Suppression of or stimulation ofACTH secretion resulted in an increase or a decrease
in the number of CYP1 lB2-positive cells in ZG, respectively (Mitani et al., 1996).
These results perhaps account for the transient nature ofACTH's stimulatory effect on
aldosterone secretion. However, the physiological relevance and the mechanisms of
the ACTH regulation in aldosterone production and CYP11B2 expression remain
unclear.
1.3.1.2.5 Other factors
Additional regulators have also been proposed to affect aldosterone biosynthesis
and CYP11B2 gene regulation. These factors include atrial natriuretic peptide (ANP),
dopamine, noradrenaline, adrenaline and transcriptional regulation.
ANP is an important vasoactive peptide which has diverse biological actions, such
as diuresis, natriuresis and vasorelaxation. ANP also inhibits the activity of the RAS
through inhibition of renin secretion and blocks the actions of All on aldosterone
secretion in the ZG of the rat adrenal gland (Lumbers, 1999).
Dopamine has been suggested to exert an inhibitory influence on aldosterone
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secretion. Infusion of dopamine into the isolated perfused rat adrenal gland resulted in
a dose-related reduction of aldosterone secretion (Porter et al., 1992). Both
epinephrine and norepinephrine stimulated aldosterone production by cultured
adrenal capsules whereas a (3-adrenergic antagonist, propranolol, inhibited the
epinephrine effect (Pratt et al., 1985).
The molecular mechanisms that specify expression of the two CYP11B2 and
CYP11B1 homologues in different adrenocortical zones remain unknown. However,
the homology of the 0.5 kb 5'-flanking regions of CYP11B2 and CYP11B1 is only
50%. In further upstream regions up to 1.7 kb, the homology is approximately 45%.
These low homologies are suggested to contribute to the differences in gene
regulation of the two genes (Mukai et al. 1993; Nomura et al., 1993).
1.3.1.3 Regulation of CYP11B2 and aldosterone biosynthesis in fetal rat
adrenal glands
During late gestation, fetal adrenal ZG cells can be morphologically identified
(Josimovich et al., 1954; Roos, 1967) and produce amounts of aldosterone that can be
found in the circulation of adrenolectomised mothers (Milkovic et al., 1976; Klepac,
1979; Churchill et al., 1981). Although the ZG cells are presumably able to express
CYP11B2 and its gene transcripts at this stage (Mitani et al., 1997; Wotus et al., 1998),
Mellon et al. (1995) suggested that the CYP11B2 in the fetal adrenal might be
transcriptionally quiescent in vivo to intrauterine treatment (Mellon et al. 1995).
However, hypertension has been reported in the late-gestation of the spontaneously
hypertensive rat fetus and neonate relative to its normotensive genetic control (Mellon
et al., 1995). The discrepancy between the gene regulation of CYP11B2 associated
with aldosterone synthesis and the physiological changes in the rat fetus remains
unclear.
On the other hand, renin is expressed in the kidney of fetal lambs (Iwamoto and
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Rudolph, 1981; Siegel, 1981) and also in the adrenal tissue of the fetal mouse (Zemel
et al., 1989; Jones et al., 1989). The concentration ofAll binding sites continued to
increase from the second half of intrauterine development, reaching more than twice
the levels in the adrenal at 18 and 20 days of gestational age in rat fetuses (Jones et al.,
1989). Feuillan et al. (1993) used subtype-specific All antagonists to show that the
adrenal capsule of rat fetus has both ATi and AT2 receptors whereas the medulla
contains mainly AT2 receptor. Moreover, there was a greater proportion of AT2
receptors in the adrenal capsule of the rat fetus than that has been reported in the adult
(Feuillan et al., 1993). ACE and angiotensinogen have also been found to increase
around the time of birth (Lee et al., 1987). In adult rats, both the systemic and local
RAS have trophic effects on the regulation of aldosterone synthesis in the ZG of the
adrenal gland. This has provoked interest as to whether the fetal and adult rats have a










Fig. 1. 6 Mechanism for the regulation of glucocorticoid / corticosterone secretion in
rats. Solid arrows indicate stimulation; dashed arrows indicate inhibition.
Glucocorticoids are known to inhibit both pituitary ACTH and hypothalamic CRH
secretion. ACTH also exerts a short negative feedback effect on CRH release.
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1.3.2 Regulation of CYP11B1 and corticosterone biosynthesis
1.3.2.1 Hypothalamus-pituitary-adrenal gland (HPA) axis
The key components of the HPA axis include corticotrophin-releasing hormone
(CRH) released from the hypothalamus and ACTH secreted from the anterior pituitaiy.
The control of glucocorticoid synthesis is through a negative feedback regulatory
process, whereby high plasma corticosterone levels inhibit both CRH and ACTH
secretion, via specific glucocorticoid receptors. On the other hand, ACTH also exerts
a short negative feedback effect on CRH release (Fig 1.6).
1.3.2.2 Factors regulate CYP11B1 and corticosterone biosynthesis in
adult rat adrenal glands
1.3.2.2.1 ACTH
CYP11B1 expression in the ZF depends on normal plasma levels ofACTH. It has
been demonstrated that ACTH stimulates corticosterodogenesis. In early studies an
experimental anterior pituitary tumor that stimulated the secretion of ACTH, was
shown to influence the adrenal morphology and also elevate the corticosterone
secretion in rats (Ganten et al., 1974). Injection of high doses of ACTH increased
CYP11B1 mRNA within the initial 24 hours and repeated injections maintained the
elevated expression and increased the number of inner cortical cells expressing
CYP11B1 mRNA (Ho and Vinson, 1993; Sander et al. 1994; Engeland et al., 1997).
ACTH adminstration for 7 days increases corticosterone secretion in vivo and
corticosterone production by adrenal tissue in vitro. The increases of corticosterone
were accompanied by the increased activities of CYP11B1 as well as CYP11A1
(Kramer et al., 1977). Lehoux et al. (1998) reported that both acute and chronic
ACTH treatments provoked changes in plasma corticosterone levels. However, there
was little effect on the expression of CYP11B1 whereas the CYP11A1 mRNA levels
were increased (Lehoux et al. 1998). Sanders et al. (1994) also found that neither
adrenal CYP11B1 nor CYP11A1 mRNA levels were affected by ACTH
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administration by immunocytochemistry (Sanders et al. 1994).
1.3.2.2.2 Glucocorticoids
Treatment with dexamethasone, a synthetic glucocorticoid, markedly decreased
CYP11B1 mRNA levels in the rat adrenal given a normal diet. Normal levels were
then restored by treatment with ACTH (Malee and Mellon, 1991; Oertle and Midler,
1993). However, the dexamethasone-induced virtual disappearance of CYP11B1
mRNA was associated with only minor decreases in CYP11B1 protein levels and also
in the conversion of DOC to corticosterone and 18-OH-DOC by decapsulated
adrenals (Oertle and Midler, 1993). The decreases in the CYP11B1 mRNA apparently
reflected specific feedback inhibition in the glucocorticoid biosynthesis.
1.3.2.2.3 Other factors
Physiological stimuli produced by stress, for instance surgical stress, not only
increased the number of cells expressing CYP11B1 mRNA, but also increased the
amount of mRNA per cell (Engeland et al., 1997). Chronic stress in rats induced by
immobilisation or repleated injection of hypertonic saline has been shown to activate
the HPA axis and thereby to induce an increase in ACTH release accompanied by the
increased plasma corticosterone levels. It also caused an increased thickness of the ZF
and an expansion outward of the area ofCYP11B1 mRNA expression (Aguilera et al.,
1995; Pellegrini et al., 1998).
Adrenergic agonists can induce adrenal P450 gene expression in vitro indicating
the possibility that neurotransmitters released from nerve terminals could act directly
on cortical cells to increase CYP11B1 mRNA levels (Guse-Behling et al., 1992).
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1.3.2.3 Regulation of CYP11B1 and corticosterone biosynthesis in fetal
rat adrenal glands
Fetal steroidogenesis has also been assessed using in vitro and in vivo conversions
of radiolabeled precursors to a variety of products. Steroidogenesis, especially
corticosterone biosynthesis, in fetal adrenal glands is highly active at the end of
gestation (Dupouy et al., 1975; Dalle et ah, 1978). Furthermore, the fetal HPA axis
regulation seems to appear between day 16 and day 18 of gestation along with the
increased CYP11B1 expression and corticosterone biosynthesis (Milkovic et ah, 1976;
Churchill et ah, 1981; Mitani et ah, 1997).
During the period around birth, maternal steroids obviously cross the placental
barrier, thereby modulating the fetal HPA axis (Milkovic et ah, 1973; Dupouy et ah,
1975; Milkovic et ah, 1976). However, whether the expression of CYP11B1 in the
developing adrenals is affected by the maternal treatment and whether the changes of
the gene expression in the development of the adrenal cortex would initiate
programming of adult disease have not been fully elucidated.
1.4 Aims of the thesis
The main aims of this thesis were to study the distribution and expression of
CYP11B2 and CYP11B1 in the adrenal cortex of Wistar adult female rats, pregnant
rats, their fetuses and offspring, after various maternal manipulations.
(i) To investigate the effects of dietary salt treatments throughout
pregnancy on the expression of CYP11B1 and CYP11B2 and their
transcripts in the adrenals of adult female rats, pregnant rats and their
fetuses.
(ii) To investigate the effects of maternal dexamethasone treatment, a
modest dose of glucocorticoid hormone on the expression of CYP11B1




(iii) To investigate the effects of maternal dexamethasone treatment, a
modest dose of glucocorticoid hormone on the expression of CYP11B1
and CYP11B2 and their transcripts in the developing adrenals.
(iv) To characterise a StAR protein antibody raised against a bovine StAR
peptide sequence for further studies on StAR protein expression in the
rat adrenal paradigms.
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Chapter 2 Materials and methods
2.1 General protocols for immunohistochemistry
2.1.1 Tissue preparation
Tissues were fixed in 10% neutral buffered formalin and embedded in paraffin
(Tissue-Tek II embedding wax) within 24-48 hours. Details of paraffin processing
using an automatic tissue processor (Pathology Department, University of Edinburgh,
Western General Hospital, Edinburgh) are summarised in Table 2.1. Microtome
sections (4 pm) were mounted on superfrost plus slides (Merck, Lutterworth, UK)
and were incubated at 40°C overnight to prevent tissue detaching from the slides.
Table 2. 1 Paraffin processing using an automatic tissue processor (overnight
processing)
Steps Solution Concentrations Time Temperature
1 Buffered formalin 10% 45 mins 40°C
2 Buffered formalin 10% 45 mins 40°C
3 Alcohol 70% 45 mins 40°C
4 Alcohol 80% 45 mins 40°C
5 Alcohol 90% 60 mins 40°C
6 Alcohol 95% 60 mins 40°C
7 Alcohol 100% 60 mins 40°C
8 Alcohol 100% 60 mins 40°C
9 Xylene 100% 60 mins 40°C
10 Xylene 100% 60 mins 40°C
11 Wax 60 mins 60°C
12 Wax 60 mins 60°C
13 Wax 90 mins 60°C
14 Wax 90 mins 60°C
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2.1.2 General immunostaining procedures
After deparaffinisation in xylene and graded rehydration in ethanol, sections
were incubated with 3% hydrogen peroxide for 10 minutes to inhibit endogenous
peroxidase activity. Antigen retrieval (Fig. 2.1) methods and avidin and biotin
blocking kits (Vector, Peterborough, UK) may be needed for different antibodies
(Shi et al., 1991; Shi et al., 1997). Each of the blocking solutions was applied for 15
minutes, and slides were rinsed with phosphate buffered saline (PBS, pH 7.4)
between the two blocking solutions. All the slides were treated with 20% normal
serum for 10 minutes to reduce non-specific binding. A two step indirect technique
(Fig. 2.2A) or avidin-biotin complex immunolabelling technique (Fig. 2.2B) was
used to detect antigens. The optimal incubation time and concentration varied
according to different antibodies. 3'-Diaminobenzidine tetrahydrochloride (DAB)
(Dako Ltd., Cambridgeshire, UK) was used as a chromogen substrate to detect the
antigens. The sections were immersed in copper enhancement solution for 5 minutes
and were counterstained with hematoxylin. The brown-coloured deposits were left at
the antigen sites and the nuclei stained blue. Negative control slides were processed
using the same protocol, except that no incubation was carried with the primary
antibody. The slides were examined with a Nikon light microscope.
2.2 General protocols for protein work
2.2.1 Protein extraction
Frozen tissues were homogenised in extraction buffer (Table 2.2). The
homogenate was centrifuged at 4500rpm for lOmin to remove tissue debris. The
supernatant was spin at 12500rpm at 4°C to obtain a mitochondrial pellet. The pellet
was then resuspended in 20-40pl of extraction buffer. Protein concentration was





Fig. 2. 1 Antigen retrieval methods. Formalin fixation may form cross-linking
between epitopes (antigens) and unrelated proteins. Breaking the cross-linking by
various techniques, for example microwave heating or enzyme digestion, can












4. Make Avidin Biotin Peroxidase Complex
or
3. React with Biotinylated Second Antibody
(Biotinylated Goat anti Rabbit IgG)
A









5. React with ABC Complex
6. Histochemical Reaction
for Peroxidase
Fig. 2. 2 Procedures for two-step indirect (A) and avidin-biotin complex




Table 2. 2 Protein extraction buffer (10 ml)
Components Volume Final concentration
1M Tris (pH 7.5) 0.5 ml 50 mM
1M Sucrose 2.5 ml 250 mM
250 mM EDTA 200 pi 5 mM
1 mg/ml Leupeptin 20 pi 2 pg/ml
1 mg/ml Aprotinin 20 pi 2 pg/ml
1 mg/ml Trypsin and antipain 20 pi 2 pg/ml
100 mM PMSF (Phenylmethylsulfonyl
Fluoride)
100 pi 1 mM
dH20 6.64 ml
2.2.2 SDS-polyacrylamide gel electrophoresis
A Bio-Rad mini-gel apparatus (Bio-Rad, North Yorkshire, UK) was used for gel
electrophoresis. CYP11B2 and CYP11B1 proteins were separated in a 10% SDS-
polyacrylamide gel. The gradients of the 10% separating gel (Table 2.3) and 4%
stacking gel (Table 2.4) were prepared first. Samples (20-30 pg) were diluted at least
1:4 with sample buffer (Table 2.5), and then heated at 95°C for 5 minutes prior to
loading onto the gel. The condition used for separating CYP11B2 and CYP11B1
proteins was running the gel at constant voltage, 150V in lx running buffer (Table
2.6) for 3-4 hours.
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Table 2. 3 Separating gel, 10% gel in 0.375 M Tris, pH8.8 (10 ml)
Components Volume
1.5 M Tris-HCl (pH 8.8) 2.5 ml
10% SDS 0.1 ml
Acrylamide/Bis-acrylamide (30%/0.8% w/v) 3.3 ml
Ammonium persulfate 0.05 ml
TEMED 0.005 ml
Distilled water 4.05 ml
Table 2. 4 Stacking gel, 4% gel in 0.125M Tris, pH6.8 (5 ml)
Components Volume
1.5 M Tris-HCl (pH 6.8) 1.25 ml
10% SDS 0.05 ml
Acrylamide/Bis-acrylamide (30%/0.8% w/v) 0.67 ml
Ammonium persulfate 0.015 ml
TEMED 0.025 ml
Distilled water 3.3 ml
Table 2. 5 Sample loading buffer
Components Volume
0.5M Tris-HCl 1.0 ml
Glycerol 0.8 ml
10% SDS 1.6 ml
P-Mercaptoethanol 0.4 ml
Bromophenol blue 0.2 g
dH20 4.0 ml
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Table 2. 6 Running buffer, pH8.3 (5x)
Components Weight / Volume
Tris Base 15 g
Glycine 72 g
SDS 5 g
dH20 Add to 1 litre
2.2.3 Western blotting
A normal SDS protein gel was run on a small BioRad protein gel system. Then
the gel was soaked in lx transfer buffer (0.025 M Tris-HCl, 0.192 M glycine) for ten
minutes to leach out the SDS in the gel. At the same time a nitrocellulose membrane
(Amersham Pharmacia Biotech, Buckinghamshire, UK.) as well as two sheets of
3MM papers were presoaked in the transfer buffer.
Proteins from the gel were transfered to the nitrocellulose membrane using Bio¬
Rad transfer apparatus in the same transfer buffer at 250 mA for two hours. After
transfer, the membrane was washed with water and then blocked with blocking
buffer (5 % non-fat dry milk, Bio-Rad, North Yorkshire, UK) in TBS (50 mM Tris-
HCl pH7.4, 150 mM NaCl) overnight in order to block any non-specific sites on the
membrane. Monoclonal CYP11B2 (1:100) or CYP11B1 (1:3500) antibody was
incubated for 2 hours and then the membrane was washed three times in TBS/0.5%
Tween 20, 15 minutes for each wash. The CYP11B2 and CYP11B1 antibodies were
raised in mice, as described by Tarn (1988), with the peptide
KVRQNARGSLTMDVQQ or KNVYRELAEGRQQS, respectively. (Generously
provided by Dr. Celso E. Gomez-Sanchez, Department of Internal Medicine,
University of Missouri-Columbia and the Harry S. Truman Memorial Veterans
Hospital.)
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Sheep anti-mouse-HRP conjugated secondary antibody (1:2000) (Amersham
Pharmacia Biotech, Buckinghamshire, UK.) was incubated for 1 hour, then the
membrane was washed three times in TBS, 15 minutes for each wash. ECL reagent
(Amersham Pharmacia Biotech, Buckinghamshire, UK.) was applied to detect the
signal. The X-OMAT film was exposed to the membrane from 30 min to 1 hour for
the CYP11B2 antibody and for 2-5 min for the CYP11B1 antibody.
2.3 General protocols for RNA work
2.3.1 RNA extraction
Total RNA from frozen tissues was extracted by Rneasy Mini Kits (QIAGEN,
UK). Samples were homogenised in 350 pi of GITC-containing buffer. After
removing tissue debris by 3 min maximunm speed of centrifugation, a further 350pl
of 70% ethanol was added into the lysate mixture. The lysate was centrifuged in a
collection tube at 8000x g for 15 sec. Then, 700pl of washing buffer (buffer RW1)
was applied on to the Rneasy column and centrifuged for 15 sec at 8000x g. The
column was washed twice by adding 500pl ofRPE buffer and was centrifuged at full
speed. The total RNA was eluted by 25 pi ofRnase-free water.
2.3.2 Competitive reverse transcription-polymerase chain reaction (cRT-
PCR) amplif ication
2.3.2.1 Reverse transcription
Three hundred nanograms and 5 nanograms ofRNA templates were used in the
analyses of CYP11B2 mRNA and CYP11B1 mRNA, respectively. RNA template
was reverse transcribed into complementary DNA (cDNA) using Gene Amp kit (PE
Biosystems, Cheshire, UK.). Templates were hybridised at 25°C for 10 min. Reverse
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transcription was performed at 42°C for 12 min. The composition of a 20 pi RT
reaction mixture are listed in the Table 2.7.
2.3.2.2 PCR amplification
The composition of a 30 pi PCR reaction mixture are listed in the Table 2.8.
The cDNAs of CYP11B2 and CYP11B1 were amplified through 28 cycles. The
amplification programmes are listed below.
PCR amplification programme:
Step 1. Denature: 95°C for 10 minutes
Step 2. Denature: 95°C for 45 seconds
Step 3. Annealing: 51°C for 45 seconds
Step 4. Extension: 72°C for 45 seconds
Step 5. Repeat step 2-step 4 for 27 cycles.
2.3.2.3 Primers
CYP11B2 primers
The CYP11B2 primers amplified a 297 bp fragment corresponding to the
sequence 657-954 of CYP11B2 (Oaks and Raff, 1995). This fragment includes
sequence from exon 3 to exon 5 and cross two introns. The sequences of sense and
antisense of CYP11B2 were as described (Fig 2.3).
Forward 5' ACCATGGATGTCCAGCAA 3'
Reverse 5' GAGAGCTGCCGAGTCTGA 3'
34
Table 2. 7 RT mixture (20 ju.1)
Components Volume (pi) Final concentration
lOx RT PCR buffer 2 lx
MgCl2 (25 mM) 2 2.5 mM
dNTP blend (Deoxyribonucleotide
triphosphates) (10 mM)
2 1 mM (250 pM of each dNTP)
DTT (100 mM) (Dithiothreitol) 2 10 mM
Random Hexamers (50 pM) 0.5 1.25 pM
MultiScribellvl Reverse Transcriptase
(50 Units/pl)
0.3 15 Units/20 pi
Rnase inhibitor (20 Units/pl) 0.5 10 Units/20 pi
RNA template 1 Various*
Rnase-free water 9.7 -
*300ng and 5 ng of RNA templates were used in t le analyses of CYP11B2 mRNA
and CYP11B1 mRNA, respectively.
Table 2. 8 PCR mixture (30 pi)
Components Volume (pi) Final concentration
lOx RT PCR buffer 3 lx
MgCl2 (25 mM) 2 1.67 mM
dNTP blend (Deoxyribonucleotide
triphosphates) (10 mM)
2 0.67 mM (167.5 pM of each
dNTP)
AmpliTaq Gold DNA Polymerase 0.5 2.5 Units/30 pi
Primers (upstream) 1 10 pmole/30 pi
Primers (downstream) 1 10 pmole/30 pi
Rnase-free water 19.5 -
Non-homologous DNA competitor 1 Various*
*See serial dilution table in Fig. 2.1.
35
CYP11B1 primers
The CYP11B1 primers amplified a 312 bp fragment corresponding to the
sequence 528-840 of CYP11B1 (Oaks and Raff, 1995). This fragment includes
sequence from exon 3 to exon 5 and cross two introns. The sequences of sense and
antisense of CYP11B1 were as described (Fig. 2.4).
Forward 5' GCTGGAGAATGTTCATGG 3'
Reverse 5' CTCTGCCAGTTCGCGATA 3'
2.3.2.4 Competitors
Non-homologous competitors (generously provided by Sue Lloyd-MacGlip,
Molecular Medicine Centre, Western General Hospital, Edinburgh) were synthesised
by amplifying onion fragment from onion alliinase gene with the combination of
CYP11B2 or CYP11B1 primers and primers, which were specific to onion fragment.
The cRT-PCR protocol is schemed in Fig. 2.5. The sense and antisense sequences of
both CYP11B2 and CYP11B1 competitors were as followed.
CYP11B2 competitor
Forward 5' ACCATGGATGTCCAGCAAGTTGCTCATGCCCC 3'
Reverse 5' GAGAGCTGCCGAGTCTGACGTAATCCGCTGCA 3'
CYP11B1 competitor
Forward 5' GCTGGAGAATGTTCATGGGTTGCTCATGCCCC 3'
Reverse 5' CTCTGCCAGTTCGCGATACGTAATCCGCTGCA 3'
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2.3.2.5 Quantitative PCR
Serial dilutions of PCR competitors (see Fig. 2.5) were added to PCR
amplification reactions containing constant amounts of the experimental RNA/
cDNA samples. The PCR competitor and target templates thus competed for the
same primers in the same reaction. By knowing the amount ofPCR competitor added
to the reactions, the amount of target template, i.e. the initial mRNA levels can be
determined.
2.4 Statistical analyses
Data were analysed by one-way or two-way ANOVA analyses, followed by




ATGGCTCTCA GGGTGACAGC AGATGTGTGG CTGGCAAGAC CCTGGCAGTG
CCTGCACAGG ACGAGGGCAC TGGGCACTAC GGCAACACTG GCCCCTAAGA
CACTGAAGCC CTTTGAAGCC ATACCACAAT ACTCCAGGAA CAAGTGGCTG
AAGATGATAC AGATCCTGAG GGAGCAGGGC CAAGAGAACC TACACCTGGA
GATGCACCAG GCCTTCCAGG AGCTGGGGCC CATTTTCAGG CACAGTGCAG
GGGGAGCACA GATTGTGTCT GTGATGCTGC CTGAGGACGC TGAGAAGCTG
CACCAGGTGG AGAGTATCCT CCCGCGTCGG ATGCACCTGG AGCCGTGGGT
GGCCCACAGG GAACTCCGTG GCCTGAGACG TGGTGTGTTC TTGCTAAATG
GGGCTGAATG GCGCTTCAAC CGACTGAAAC TGAACCCAAA CGTGCTGTCA
CCAAAAGCTG TTCAAAATTT TGTCCCCATG GTGGACGAGG TAGCAAGGGA
CTTCTTGGAG GCCCTGAAAA AGAAGGTGCG TCAGAATGCT CGAGGGAGCC
►
TXACCATGGA TGTCCAGCAA AGTCTCTTCA ACTACACTAT AGAAGCCAGC
AACTTTGCAC TTTTTGGAGA GAGGCTGGGC CTCCTTGGTC ATGACCTGAA
CCCTGGTAGC CTGAAGTTCA TCCATGCCCT ACATTCAATG TTCAAGTCCA
CCACACAGCT CCTGTTCTTA CCCAGAAGCT TGACTCGCTG GACAAGCACC
CAGGTGTGGA AAGAACATTT TGATGCCTGG GATGTCATCT CTGAGTATGC
CAACAGATGT ATCTGGAAGG TGCACCAGGA AC TCAGACTC GGCAGCTCTC
4 AGTCTGAG CCGTCGAGAG
AGACCTACAG TGGCATTGTG GCAGCACTAA TAACTCAGGG AGCTTTACCT
CTGGACGCCA TCAAAGCCAA CTCTATGGAG CTCACTGCTG GGAGCGTTGA
CACGACAGCA ATCCCCTTGG TAATGACACT TTTTGAGCTG GCTCGGAACC
CAGATGTTCA GCAGGCCCTG CGGCAGGAGA CCCTGGCAGC TGAGGCCAGC
ATCGCTGCTA ATCCCCAGAA GGCCATGTCA GACCTGCCCT TGCTGCGGGC
TGCCCTTAAA GAGACCTTGA GACTCTACCC TGTTGGTGGC TTTTTGGAGA
GAATCCTAAA CTCAGACCTG GTGCTTCAGA ACTATCATGT CCCTGCTGGG
ACGTTGGTCC TACTTTATCT GTACTCCATG GGCCGAAACC CTGCAGTGTT
CCCAAGACCT GAGCGCTATA TGCCTCAGCG CTGGCTGGAG AGGAAAAGGA
GTTTCCAGCA TCTGGCCTTC GGCTTTGGGG TGCGCCAGTG CCTGGGGCGG
CGCCTGGCAG AGGTGGAGAT GCTGCTCCTG CTTCACCATA TGCTGAAAAC
CTTCCAGGTG GAGACACTGA GACAAGAGGA TGTGCAGATG GCCTATCGCT
TTGTTTTGAT GCCCAGCTCT AGTCCTGTCC TCACTTTCCG GCCCATCAGC
TAG




ATGGCTCTCA GGGTGACAGC AGATGTGTGG CTGGCAAGAC CCTGGCAGTG
CCTGCACAGG ACGAGGGCAC TGGGCACTAC GGCAAAAGTG GCCCCCAAGA
CACTGAAGCC CTTTGAAGCC ATACCACAAT ACTCCAGGAA CAAGTGGCTG
AAGATGATAC AGATCCTGAG AGAGCAGGGC CAAGAGAACC TACACCTGGA
GATGCACCAG GCCTTCCAAG AGCTGGGGCC CATTTTCAGG CACAGTGCAG
GGGGAGCACA GATTGTGTCT GTGATGCTGC CTGAGGACGC TGAGAAGCTG
CACCAGGTGG AGAGTATCCT CCCGCATCGG ATGCCCCTGG AGCCGTGGGT
GGCCCACAGA GAACTCCGTG GCCTGAGACG TGGTGTGTTC TTGCTAAATG
GGGCAGACTG GCGCTTCAAC CGACTGCAGC TGAATCCAAA TATGCTGTCA
CCAAAAGCCA TTCAATCTTT TGTCCCCTTT GTGGATGTGG TAGCAAGGGA
CTTTGTGGAA AACCTGAAGA AGAGAATGCT GGAGAATGTT CATGGAAGCA
TGTCTATAAA CATTCAGTCC AATATGTTCA ACTATACCAT GGAAGCCAGC
CATTTTGTTA TTTCCGGAGA GCGTCTGGGC CTCACAGGCC ATGACCTGAA
ACCTGAGAGC GTGACATTCA CTCATGCTCT GCACTCAATG TTCAAGTCCA
CCACACAGCT CATGTTCTTA CCCAAGAGCT TGACTCGTTG GACAAGCACC
CGGGTGTGGA AAGAACACTT TGATTCCTGG GATATCATCT CTGAGTATGT
CACAAAATGT ATCAAGAATG TG TA TCGCGA ACTGGCAGAG GGTCGCCAAC
M ATAGCGCT TGACCGTCTC
AGTCCTGGAG TGTCATATCC GAGATGGTAG CACAGAGTAC TCTGTCAATG
GATGCCATCC ATGCCAACTC AATGGAACTT ATTGCTGGAA GTGTTGACAC
GACAGCAATC TCCTTGGTAA TGACCCTTTT TGAGCTGGCT CGGAACCCAG
ATGTTCAGCA GGCCCTGCGG CAGGAGAGCC TAGCAGCTGA GGCCAGCATC
GTTGCTAATC CCCAGAAGGC CATGTCAGAC CTGCCCTTGC TGCGGGCTGC
CCTTAAAGAG ACCTTGAGGC TCTACCCTGT TGGTAGCTTT GTAGAGAGAA
TCGTACACTC AGACCTGGTG CTTCAGAACT ATCATGTCCC TGCTGGGACA
TTCGTCATAA TTTATCTGTA CTCCATGGGC CGAAACCCTG CAGTGTTCCC
AAGGCCTGAG CGCTACATGC CTCAGCGCTG GCTGGAGAGG AAAAGGAGTT
TCCAGCATCT GGCCTTCGGC TTTGGGGTGC GCCAGTGCCT GGGGCGGCGC
CTGGCAGAGG TGGAGATGCT GCTCCTGCTT CACCATATGC TGAAAACCTT
CCAAGTGGAG ACACTGAGAC AAGAGGATAT GCAGATGGTT TTTCGCTTTC
TTTTGATGCC CAGCTCTAGT CCTTTCCTTA CTTTCCGGCC TGTGAGCTAG




Prepare Target Sequences & Reverse Transcription
Isolate RNA from tissue samples
i
RT reaction: ^ynthesise lst-strand cDNA (20 pi)
Conduct Competitive PCR
Make serial dilutions of PCR Competitor







Competitor 1 3.16 x 10"12 l.Ox 10""
Competitor 2 3.16 x 10"13 3.16 x 10"12
Competitor 3 1.0 x 10"13 l.Ox 10"12
Competitor 4 3.16 x 10"14 l.Ox 10"13
Add 1 pi of each PCR Competitor dilution to 1 st-strand
cDNA samples (20 pi)
Add 29 pi of PCR reaction buffer to each sample
i
Perform PCR^total volume: (50 pi))
Electrophorese products (12.5 pi) on an agarose gel (2%)
i
Analvse above data
Fig. 2. 5 Outline for competitive RT-PCR protocols.
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2.5 The methods for salt diet experiment
2.5.1 Animals handling
Animal handling and sample collections followed standards conforming to "The
Principles of Animal Care"(NIH publication No. 85-23, revised 1985) and Home
Office regulations in the U.K. Female Wistar/Han rats of the same age and weight
were maintained in a 12-hour light/dark cycle and controlled temperature with
sexually mature males and had free access to normal rat chow and deionized water.
After the detection of a vaginal plug, indicating that mating had taken place, females
were housed individually in breeding cages. Female rats were divided into three
groups and were fed high (3%, HS), normal (0.3%, NS) or low (0.03%, LS) sodium
diets (Appendix I) throughout pregnancy. Another three groups of non-pregnant
female rats were also fed the same diets for 20 days.
2.5.2 Sample collection
In the first experiment, non-pregnant and pregnant rats were euthanised after 20
days of diet. The weights of the heart, kidneys and adrenal glands were recorded. The
adrenal glands were immersed in 10% neutral-buffered formalin and embedded in
paraffin within 24 hours.
In the second experiment, pregnant rats were sacrificed at day 20 of gestation.
The adrenal glands were removed from pregnant rats and their offspring. Adrenal
glands were frozen at -80°C. Frozen samples were used for Western blotting and
competitive RT-PCR analysis. The weights of the heart, kidneys and adrenal glands
were also recorded. The excised adrenals were bisected and decapsulated by the
method of Giroud et al. (1956). Capsular (zona glomerulosa) and decapsulated (zona
fasciculate, zona reticularis and medulla) portions of the adrenal glands were
immediately frozen and stored at -80°C.
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2.5.3 Immunohistochemistry
The conditions for the antibodies used in the experiments are summarised in
Table 2.9. Negative control slides were processed using the same protocols, except
that no incubation was carried with the primary antibody. The 3(3-HSD antibody was
raised in rabbit against human placenta 3P-HSD (Doody et al., 1990). The details of
the immunostaining methods employed are described in Section 2.1.2.
Table 2. 9 Conditions for the antibodies used for immunostaining.
Antibody\Conditions AR method/Time1 1° /Time2 2° /Time3 StreptABC/Time4
CYP11B2 Microwave (20min) 1:50/1 hr 1:800/1 hr 30min
CYP11B1 Microwave (20min) 1:100/1 hr 1:400/1 hr 30min
3P-HSD Trypsin (30min) 1:400/30min l:400/30min 30min
(1° /Time": primary antibody dilution and incubation time.)
(2° /Time3: secondary antibody dilution and incubation time.)
(StreptABC/Time4: streptavidine-biotin complex method and incubation time.)
2.5.3.1 Scoring for immunostaining results
Slide labels were masked and coded to obtain objectivity in the readings. The
score for the immunostaining was defined from 0 (no staining) to 9 (strong staining
for throughout ZG or ZF). Score from 0 to 3 represents weak staining. Score from 4
to 6 stands for medium staining. Strong positive staining was scored from 7 to 9. All
slides were examined carefully. The negative control slides showed no staining at all.
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2.5.3.2 Measurement of ZG zona width and cell size in the ZG and the ZF
To identify ZG and ZF cells, sections were stained with hematoxylin and eosin.
The width of the ZG was measured at a magnification of x400. The average width of
ZG was determined by 8 counts from each adrenal section (2 counts per subfield for
each of 4 subfields). A group of ZG and ZF cells was counted at a magnification of
xlOO (10 counts per subfield for each of 4 subfields) by computer-assisted grain
counting using an image analysis system (MCID 4.0 software package).
2.5.4 Radioimmunoassays
2.5.4.1 Aldosterone
Plasma aldosterone levels were measured (in cooperation with Dr. Christopher
Kenyon) using Coat-A-Count® Aldosterone kit (Diagnostic Products Corporation,
Los Angeles, USA). According to the manufacturers' instruction, aldosterone-
specific antibody immobilised to the wall of a polypropylene tube. Plasma samples
were added into the tubes prepared. I25I-labeled aldosterone (1.0 ml) was added to
each tube and mixed briefly and gently. Labeled aldosterone was incubated for 3
hours at 37°C with plasma samples. All visible moisture was removed after
incubation. Samples and standards were counted for 1 minute in an LKB Wallac
Microbeta counter after the tubes were drained for 2 or 3 minutes. The percent cross
reactivity of corticosterone in the aldosterone assay was 0.002%. The intraassay
variation was 3.2%.
2.5.4.2 Corticosterone
Plasma samples were diluted tenfold with borate buffer (0.133 M boric acid,
67.5mM NaOH - HC1, pFl 7.4 containing 0.5% bovine serum albumin, 1% methanol
and 0.1% ethylene glycol) (in cooperation with Dr. Christopher Kenyon). After
heating samples at 80°C for thirty minutes to denature corticosterone binding
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globulin, aliquots (25pi) of diluted plasma were incubated with rabbit antibody
(Amersham Pharmacia Biotech, Buckinghamshire, UK.)to corticosterone (final
dilution 1:40,000), 3H-corticosterone (specific activity 80Ci/mmol; final
concentration 1.5nM, Amersham Pharmacia Biotech, Buckinghamshire, UK.) and
anti- rabbit scintillation proximity assay reagent (25pi diluted suspension) were
mixed in a final volume of lOOpl borate buffer. After incubation overnight at room
temperature, samples and standards were counted in an LKB Wallac Microbeta
counter. Intra and inter assay variations were 9.4 and 9.2% respectively. Compared
with corticosterone (100%), cross reactivities for progesterone, deoxycorticosterone
and Cortisol are 7.7, 6.5 and 5.3 % respectively.
2.5.5 Western blotting and cRT-PCR
The protocols for western blotting and cRT-PCR were described in section 2.2
and 2.3. Twenty micrograms and thirty micrograms of protein samples extracted
from adult and fetal adrenals, respectively, were used for western blotting analyses.
Three hundred nanograms and 5 nanograms of RNA templates were used for
CYP11B2 and CYP11B1, respectively.
2.6 The methods for dexamethasone experiments in fetal and
pregnant rat adrenal glands
2.6.1 Animal handling
Animal handling and sample collections followed standards conforming to "The
Principles of Animal Care"(NIH publication No. 85-23, revised 1985) and Home
Office regulations in the U.K. Female Wistar/Han rats of the same age and weight
were maintained in a 12-hour light/dark cycle and controlled temperature with




After the detection of a vaginal plug, indicating that mating had taken place, females
were housed individually in breeding cages. Female rats were divided into two
groups. The experimental group was injected subcutaneously with 100 pg/kg body
weight/day dexamethasone in 0.1 ml 4% ethanol-saline throughout pregnancy (20
days of gestation). The control group was treated with saline (called saline-treated or
DEX-treated in the following sections).
2.6.2 Sample collection
Pregnant rats were euthanised at 20 days of gestation. The adrenal glands were
removed from pregnant rats and their offspring and trimmed of fat. A fetal adrenal
gland, from two pups of each pregnant rat was immersed in 10% neutral buffered
formalin and embedded in paraffin within 24 hours. Other fetal adrenal glands were
frozen at -80°C. Frozen samples were used for western blotting and competitive RT-
PCR analysis of gene expression. The weights of the heart, kidneys and adrenal
glands were also recorded.
2.6.3 Immunohistochemistry
2.6.3.1 Serial staining for CYP11B2, CYP11B1, 3p-HSD and
chromogranin A
Serial sections of the adrenal glands were taken. These sections then were
stained consecutively with antibodies specific for CYP11B2, CYP11B1, 3P-E1SD
and chromogranin A (generously provided by Dr. David Apps, Department of
Biomedical Sciences and Clinical Laboratory, University of Edinburgh, UK).
Negative control slides were processed using the same protocols, except that no
incubation was carried with the primary antibody. The conditions for the antibodies
used are summarised in Table 2.10. The details of the immunostaining methods
employed are described in Section 2.1.
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Table 2. 10 Conditions for the antibodies used for immunostaining.
Antibody/Conditions AR method/Time1 1° /Time2 2° /Time3 StreptABC/Time4
CYP11B2 Microwave (20min) 1:200/ON° 1:400/1 hr 3Omin
CYP11B1 Microwave (20min) 1:200/ON 1:400/1 hr 3Omin
3P-HSD Trypsin (30min) 1:400/30min 1:400/3Omin 3Omin
Chromogranin A Microwave (20min) 1:25/1 hr 1:25/1 hr -
(AR method/Time : antigen retrieval method and time.)
(1° /Time : primary antibody dilution and incubation time.)
(2° /Time : secondary antibody dilution and incubation time.)
(StreptABC/Time4: streptavidin-biotin complex method and incubation time.)
(ON5: overnight incubation.)
2.6.3.2 Scoring for CYP11B2 and CYP11B1 immunostaining
Slide labels were masked and coded to obtain objectivity in the readings.
CYP11B2 and CYP11B1 staining methods are summarised in Table 2.10. The
scoring for the immunostaining was defined over the range zero (no staining) to 9
(strong staining throughout the ZG or ZF). All slides were examined carefully. The
negative control slide had to exhibit no staining at all.
2.6.3.3 Measurement of cell size in the ZF and medulla
To identify ZF cells and medullary cells, two consecutive sections were stained
with antibodies for CYP11B1 and chromogranin A, respectively. A group of ZF or
medullary cells was measured at a magnification of x400. The average cell size was
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determined by 20 counts from each adrenal section by computer using an image
analysis system (MCID 4.0 software package), which identified individual cell nuclei.
2.6.4 Western blotting and cRT-PCR
The protocols for western blotting and cRT-PCR were described in section 2.2
and 2.3. Twenty micrograms and thirty micrograms of protein samples extracted
from adult and fetal adrenals, respectively, were used for western blotting analyses.
Three hundred nanograms and 5 nanograms of RNA templates were used for
CYP11B2 and CYP11B1, respectively. In order to obtain a visible signal for
CYP11B1 transcripts from the dexamethasone-treated pregnant rat adrenals, it was
necessary to increase the amount of the RNA template to 150 nanograms.
2.7 The methods for dexamethasone experiments in postnatal rat
adrenal glands
Animal handling and sample collections followed standards conforming to "The
Principles of Animal Care"(NIH publication No. 85-23, revised 1985) and Home
Office regulations in the U.K. Sample collections were also made as for the previous
experiments (see Chapter 4). Female rats were divided into two groups. The
experimental group was injected subcutaneously with 100 pg/kg body weight/day
dexamethasone in 0.1 ml 4% ethanol-saline or vehicle (saline) throughout pregnancy.
No further treatment was given to mothers or pups after delivery. Male offspring
(called saline-treated or DEX-treated in the following sections) were kept until they
were 7-day, 28-day or 4-month-old. The protocols for serial staining, scoring and
western blotting and cRT-PCR were described in Section 2.6.
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2.7.1 Detection of CYP11B3 mRNA transcripts
CYP11B1 primers also amplified CYP11B3 mRNA transcripts. The RT-PCR
method was described in section 2.6. Ten nanograms of RNA templates were
amplified by CYP11B1 primers. Then, the RT-PCR products (15 pi) of CYP11B1
were digested using Smal enzyme (0.1%) at room temperature for an hour. The
digestion buffer is summarised in Table 2.11. CYP11B3 transcripts are resistant to
enzyme digestion whereas CYP11B1 transcripts are digested into smaller fragments.
The relative amount of CYP11B3 transcripts to the total amount of CYP11B1
transcripts from 1% agarose gels was computed.
Table 2. 11 Digestion buffer (15 pi)
Components Volume (pi)
PCR product 10
lOx Buffer J 1.5
BSA 0.15
dH20 2.35
Sma I enzyme 1
2.8 The methods for characterisation of StAR protein
Adult Wistar rats were killed by cervical dislocation. Adrenal tissues and testis
were fixed in 10% neutral buffered formalin and embedded in paraffin for
immunostaining uses. Microtome sections (5 pm) were mounted. In addition,
adrenals from adult male CD mice were also collected. Samples, including heart,




The immunostaining for StAR protein was carried out using a similar protocol
to that described in Chapter 2, but instead of using enzyme digestion, slides were
heated with citrate buffer (0.01 M, pH 6.0) in the microwave oven using the
intermittent heating method of two 10-minute cycles. Then, slides were incubated
with normal donkey serum (Scottish Antibody Production Unit, Lanarkshire, UK) for
10 minutes.
Immunostaining was performed using a sheep antibody against a sequence of
purified bovine StAR protein (AMQRALGILKDQEGWKKESRQANGDEV),
diluted 1 in 100 in PBS buffer. Horse-radish-peroxidase (HRP) conjugated secondary
antibody (Binding Site company, Birmingham, UK) (1 in 200 dilution) was used for
StAR protein localisation. The immunostaining procedures for 3P-HSD and
chromogranin A were described in Section 2.5.3.
2.8.2 Protein extraction and Western blotting
Whole or dissected tissues were homogenized at 4 °C in 5mM Tris-HCl buffer,
pH7.4, containing 275mM sucrose. The homogenate was centrifuged at 680 x g for
10 minutes to remove debris. The supernant was centrifuged at 10,000 x g for 10
minutes to obtain the mitochondria pellet. Further centrifugation of the supernant at
105,000 x g for lhour yielded the microsomal pellet. Both of the pellets were washed
with the same buffer. Protein concentration of each sample was determined by
Bradford method.
Proteins were analyzed on SDS-polyacrylamide mini-gel. Primary antibodies,
StAR and 3|3-HSD (1 in 10,000 and 1 in 5,000 diluted with 3% non-fat milk in PBS),
and HRP-conjugated secondary antibodies, donkey-anti-sheep and anti-rabbit (1 in
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100,000 and 1 in 50,000 dilution) were incubated. Proteins were detected by
chemiluminescence (Pierce).
2.8.4 Reverse transcription-PCR amplif ication
RNA template was reverse transcribed into complementary DNA (cDNA) using
Gene Amp kit (PE Biosystems, Cheshire, UK.). Template (10 ng) was hybridised at
25°C for 10 min. Reverse transcription was performed at 42°C for 12 min.
The 494 bp rat StAR cDNA was amplified using primers corresponding to
nucleotide sequence from 321 bp to 815 bp. The PCR protocol comprised 1 min of





Chapter 3 Effects of dietary sodium chloride on
steroidogenic enzymes in pregnant and fetal rat adrenal
glands
3.1 Introduction
Changes of dietary sodium chloride (salt) intake during pregnancy can exert
profound effects on the structure (Pike et al., 1966; Pohanka and Pike, 1970;
Smiciklas et al., 1971) and function (Khokhar and Pike, 1973) of the maternal adrenal
cortex. It is also known to affect the expression of genes involved in steroidogenesis,
especially the CYP11B2 gene that encodes aldosterone synthase (Brochu et al., 1998;
Malee and Mellon, 1991). Peak aldosterone secretory activity with adrenal
hypertrophy and hyperplasia was observed at day 18 of pregnancy in rats fed a low
sodium diet. Depletion of renin secretory granules in the renal juxtaglomerular cells is
indicative of maximal activation of the renin-angiotensin system (Pike et al., 1966;
Khokhar and Pike, 1973). Clearly, the maternal renin-angiotensin system is vital in
regulating sodium homeostasis during pregnancy. However, in adrenalectomised rats,
pregnancy proceeds normally and sodium continues to be retained. Plasma
concentrations of aldosterone were only partly reduced after adrenalectomy whereas
plasma values were negligible in a non-pregnant adrenalectomised control group
(Churchill et al., 1981). This disparity of the effects of adrenalectomy might indicate
an alternative fetal source of aldosterone.
In the fetal rat, adrenal development starts from around day 12 of gestation (El2)
and its embryogenesis is completed by E16 (Josimovich et al., 1954; Roos, 1967).
Although the zona glomerulosa (ZG) cells can be identified morphologically as early
as El8, Mitani et al., reported that CYP11B2 remained undetectable until E20;
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11 P-hydroxylase, encoded by CYP11B1 gene, was seen from El8 in Sprague-Dawley
rats (Mitani et al., 1997). Later, Wotus et al. (1998) found both CYP11B2 mRNA and
protein expression at El 8 and El9 and were able to show production of aldosterone
by fetal adrenal tissue. They also described two distinct phases of ZG development.
Firstly, the appearance of small clusters of CYPllB2-positive cells throughout the
adrenal at El6. Then, secondly, cell differentiation and a change in the distribution of
CYP11B2 expressing cells, which were localised exclusively in a sub-capsular region
of the adrenal gland at El 8 and El 9.
It would appear therefore that the period around birth is a critical stage in the
development of the rat adrenal gland in terms ofboth cell proliferation (Josimovich et
al., 1954; Roos, 1967) as well as differentiation with the expression ofCYP11B2 and
CYP11B1, which are responsible for mineralocorticoid and glucocorticoid
biosynthesis, respectively (Mitani et al., 1997; Wotus et al., 1998). On the basis of
those studies, the primary focus of this chapter was to investigate whether dietary salt
intake, a major factor regulating aldosterone synthesis in adults, has any influence on
fetal adrenal function. Two experiments were carried out. In the first experiment,
effects of dietary salt were compared with a particular emphasis on adrenal histology
in non-pregnant female and pregnant rats and in fetal rats. In the second experiment,
molecular techniques were used to investigate expression of CYP11B genes in
maternal and fetal adrenal glands. Adrenal cortical functions at E20 and in maternal
adrenal glands were compared after feeding high (3%), normal (0.25%) and low
(0.03%) sodium diets throughout pregnancy. Immunohistochemical, Western blotting
and competitive RT-PCR methods were used to examine adrenal gland morphology




3.2.1 Characterisation of antibodies
The specificities of the CYP11B2, CYP11B1 and 3P-HSD antibodies were
confirmed by immunohistochemistry (Fig. 3.1) and Western blotting (Fig. 3.2) in rat
adrenal sections and protein extracts.
CYP11B2 was localised in the ZG (Fig.3.1A) exclusively whereas CYP11B1 was
stained intensely in the ZF (Fig.3.IB). 3P-HSD was found in all cortical zones (Fig.
3.1C). There was no staining detected in the capsule or the medulla by CYP11B2,
CYP11B1 and 3P-HSD antibodies, except that some cortical cells were positively
stained in the medulla by CYP11B1 and 3P-HSD antibodies.
CYP11B2 and CYP11B1 recognized protein bands in mitochondrial pellets of the
rat adrenal capsules and inner cortex with molecular sizes of-48 kDa (Fig. 3.2A) and
~49 kDa (Fig. 3.2 B), respectively. After the membrane was incubated overnight with
CYP11B2 antibody at 1 in 100 dilution, and the CYP11B1 antibody was applied for
an hour at 1 in 3500 dilution on the next day, a doublet, which indicated a separation
of CYP11B2 and CYP11B1, was seen in mitochondrial fractions from the low salt
adrenal (Fig. 3.2C). The capsular fraction of the adrenal also showed a different size
of band compared to the decapsulated adrenal cortex (Fig. 3.2C). Compared to the
adult adrenals, fetal adrenal glands showed a very weak expression of CYP11B2 (Fig.
3.2D) and relatively high expression of CYP11B1 (Fig. 3.2E).
3.2.2 Organ weights and adrenal morphology changes in non-pregnant and
pregnant rats
In non-pregnant rats, there were no significant differences in body weights, heart
weights and adrenal weights among the three groups treated with various salt
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Table 3.1 Body weights and organ weights (mean ± S.E.) of non-pregnant female







Body weight (g) 271.419.2 265.318.5 263.5112.9
Heart weight (g) 0.9110.06 0.9110.03 0.8510.02
Heart wt / Body wt % 0.3410.01 0.3410.01 0.3210.01
Kidney weight (g) 1.04i0.05b 0.84i0.03a 0.87i0.04a
Kidney wt / Body wt % 0.3810.01b 0.3110.02a 0.33+0.01a
Adrenal weight (mg) 50.6412.94 45.5011.83 48.0012.50
Adrenal weight / Body wt % 0.01910.002 0.01710.001 0.01810.001
n represents the number of the animals tested.
Data were analysed by Tukey's test. Values with the different superscripts are
significantly different (P<0.05).
Table 3. 2 Body weights and organ weights (mean ± S.E.) of pregnant rats







Body weight (g) 320.9111.3 315.6116.0 315.0117.5
Heart weight (g) 0.9010.03 0.9110.04 0.9510.07
Heart wt / Body wt % 0.2810.01 0.2910.01 0.3010.01
Kidney weight (g) 0.8710.02" 0.7410.043 0.7610.04ab
Kidney wt / Body wt % 0.2710.01b 0.2410.0a 0.24i0.01a
Adrenal weight (mg) 49.8311.94 43.0012.99 45.4213.72
Adrenal weight / Body wt % 0.01610.001 0.01410.001 0.01510.001
n represents the number of the animals tested.
Data were analysed by Tukey's test. Values with the different superscripts are
significantly different (P<0.05).
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levels in their diets (Table 3.1). However, kidney weight was significantly increased
by high salt dietary treatment compared to normal- and low-salt dietary treatments
(P<0.05).
Similar results were observed in pregnant rats (Table 3.2). The body weights,
heart weights and adrenal weights remained unchanged in pregnant rats. The relative
kidney weight was elevated in high-salt-treated rats compared to normal rats.
However, the increase was less in pregnant rats than in non-pregnant rats.
Salt treatment had a profound effect on the zonal width of the ZG. In both the
non-pregnant (Fig. 3.3A) and the pregnant (Fig. 3.3B) rats, the greatest ZG width was
revealed in the low-salt-treated rats. Low salt diet caused a 5.1% increase in the ZG
width in non-pregnant rats and a 25.2% increase in pregnant rats compared to the rats
treated with normal-salt diet. In contrast, high salt diet markedly decreased the ZG
width in non-pregnant rats (26.7%) and in pregnant rats (27.3%) compared to the
corresponding rats given normal salt diet.
Low-salt-diet-treated rats also showed a greater cell size of the ZG than those
from high- or normal-salt-treated rats in both the non-pregnant (Fig. 3.3C) and
pregnant (Fig. 3.3D) rats. Neither pregnancy nor various salt diets affected the ZF cell
size. In addition, a coarsely vacuolar appearance was seen in the ZG in the
low-salt-treated pregnant rats (Fig. 3.8C arrows), but not in the other animal group
(Fig. 3.6A-C and 3.8A-B).
3.2.3 Expression of steroidogenic enzymes in non-pregnant and pregnant
rat adrenal glands
3.2.3.1 Immunostaining results for 3(3-HSD
In adult rats, 3p-HSD was expressed in all three cortical zones. The staining
pattern and intensity for 3P-HSD were not affected by dietary salt (Fig. 3.4A-F), but
pregnant rat adrenals had significantly higher 3P-HSD expression (P<0.05) than
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non-pregnant rat adrenal glands in the ZG (Fig. 3.5A) and the ZF (Fig. 3.5B).
3.2.3.2 Immunostaining results for CYP11B2 and CYP11B1
A few cells were weakly stained in the adrenal ZG of the high salt intake rats (Fig.
3.6A and Fig. 3.8A). Most, but not all, ZG cells showed medium staining in the
normal (Fig. 3.6B and Fig. 3.8B) and nearly all cells showed intense staining in the
low salt groups (Fig. 3.6C and Fig. 3.8C). In adult adrenal glands isolated from
non-pregnant and pregnant rats, a high salt diet significantly reduced (P<0.002) the
ZG staining for CYP11B2 compared to adrenals from normal or low salt diet groups
(Fig. 3.7A and Fig.3.9A).
CYP11B1 was stained throughout the ZF and ZR. The most intense staining was
shown in the outer region of the ZF and the staining became weak in the ZR. There
were no significant differences in the intensity of staining for CYP11B1 between
non-pregnant and pregnant rats (Fig. 3.7B and Fig.3.9B). The staining ofCYP11B1 in
the ZF also showed no difference among the three dietary groups in non-pregnant (Fig.
3.6D-F and Fig. 3.7B) or pregnant rats (Fig. 3.8D-F and Fig.3.9B).
3.2.3.3 Western blotting results for CYP11B2 and CYP11B1
The expression of CYP11B2 was 5.8-fold and 2.8-fold higher in the adrenals of
the low-salt-treated pregnant rats compared to the expression in the adrenals of the
high- and normal-salt-treated rats (Fig. 3.1OA and B).
The various salt treatments during pregnancy had no effect on the expression
levels of CYP11B1 in pregnant rat adrenal glands (Fig. 3.IOC and D).
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3.2.3.4 Gene expression of CYP11B2 and CYP11B1
The abundances of CYP11B2 (Fig. 3.11A) and CYP11B1 (Fig. 3.1 IB) mRNA
transcripts were determined by a competitive RT-PCR (c-RT-PCR) method. The
CYP11B2 primers amplified a 297 bp fragment of the CYP11B2 mRNA. The
CYP11B1 primers amplified a 312 bp fragment of the CYP11B1 mRNA.
Amplification of the competitors using CYP11B2 and CYP11B1 primers showed no
cross reaction between these two primers (Fig. 3.11C).
The levels of CYP11B2 mRNA (Fig. 3.12A) in pregnant rat adrenal glands were
significantly elevated (5.4-fold) by low salt treatment compared with values from the
normal sodium group (22.76 ± 7.68 attomole/pg RNA vs 4.15 ± 0.81 attomole/pg
RNA). However, the expression of CYP11B2 mRNA in the adrenal glands of the high
salt treated pregnant rats was reduced to barely detectable levels (<0.42 attomole/pg
RNA). Even when the amounts of templates were increased to lpg, CYP11B2 mRNA
was often not measureable.
On the other hand, there was no effect on the expression of the adrenal CYP11B1
mRNA (Fig. 3.12B) in pregnant rats on the various dietary salt regimes.
3.2.4 Organ weights in fetal rats
Body weights of fetal rats were not affected by maternal sodium intake (Table 3.3).
When organ weights expressed per 100 g body weight were compared, there was no
difference observed in the relative heart weights of the fetal rats and no effects of low
salt intake on kidney and relative adrenal weights. In contrast, the relative kidney and
adrenal weights were significantly reduced by high salt diet (P<0.05). The decrease in
fetal kidney weights contrasts with the effects on maternal kidney weights (Table 3.1
and 3.2). Various salt diets also had no apparent effect on the litter size and sex of the
fetuses (Data not shown).
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3.2.5 Plasma aldosterone and corticosterone levels in fetal rats
Plasma aldosterone and corticosterone levels were measured by
radioimmunoassay kits according to the manufacturers' instruction (see Chapter 2).
(Data were provided by Dr. Christopher Kenyon.) There was a 2.3-fold increase in
plasma aldosterone levels of fetal rats given a low salt diet throughout pregnancy
compared to the fetal rats given a normal salt diet (1005.0 ± 139.6 pmole/L vs 436.0 ±
46.4 pmole/L) (Fig. 3.13A). In contrast, there was no effect on the plasma aldosterone
levels by high sodium diet (520.9 ± 69.5 pmole/L).
There was no obvious effect on the plasma corticosterone levels after various
dietary sodium treatments throughout pregnancy, except modestly reduced levels in
the high sodium group (High salt, 1.89 x 105 ± 1.70 x 104 pmole/L; normal salt, 2.26 x
105 ± 1.25 x 104 pmole/L; low salt, 2.18 x 105 ± 1.64 x 104 pmole/L) (Fig. 3.13B).
Table 3. 3 Body weights and organ weights (mean ± S.E.) of E20 rats prenatally







Body weight (g) 3.96310.037 4.08110.049 3.97610.035
Heart weight (mg) 20.0210.27" 21.1 li0.29a 20.6810.28""
Heart wt / Body wt % 0.50610.005 0.52010.007 0.52510.008
Kidney weight (mg) 16.2410.17" 17.8910.30" 17.4510.17"
Kidney wt / Body wt % 0.41110.003" 0.43810.004" 0.44110.004"
Adrenal weight (mg) 1.3710.02" 1.5110.03" 1.4210.03"
Adrenal weight / Body wt % 0.034810.001" 0.03710.001" 0.03610.00""
n represent the number of dam animals studied




3.2.6 Steroidogenic enzyme expression in fetal rat adrenal glands
3.2.6.1 Immunostaining results for 3p-HSD
The staining pattern for 3(3-HSD in the fetal adrenals was similar to that in adult
adrenals (Fig. 3.14A-C). However, the ZG showed weak staining for 3|3-HSD in the
fetal adrenals (Fig. 3.15A). The staining was mainly seen in the inner regions of
cortex and was not affected by various maternal dietary salt intakes (Fig. 3.14A-C and
Fig. 3.15B).
3.2.6.2 Immunostaining results for CYP11B2 and CYP11B1
The staining for CYP11B2 in fetal adrenal ZG was much weaker than in adult
adrenals. In fetal adrenal glands, the ZG cells with closely packed nuclei were able to
be distinguished from the ZF cells. However, only some of the cells in the outer
region of the ZG were positive for CYP11B2 (Fig. 3.16A-C). CYP11B2 was nearly
undetectable in the fetal adrenals of the high salt group. The staining intensity of
CYP11B2 was significantly increased (P<0.005) in the low salt group compared with
the normal and high salt groups (Fig. 3.17A).
The CYP11B1 staining found in the inner regions of fetal adrenal glands appeared
to increase progressively from the high salt group to the normal salt to the low salt
group although the differences were not significant (Fig. 3.16D-F and Fig. 3.17B).
3.2.6.3 Western blotting results for CYP11B2 and CYP11B1
The levels of adrenal CYP11B2 and CYP11B1 in fetal rats were analysed by
immunoblotting. The expression levels of CYP11B2 were not detected in the fetal
adrenal protein extracts as clearly as in the maternal adrenal extracts. This was
confirmed using the CYP11B2 activity assay.
There were no obvious changes of the expression levels for either CYP11B2 (Fig.
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3.18A and B) or CYP11B1 (Fig. 3.18C and D) among the groups treated with various
dietary salt regimens by image analysis of the SDS-PAGE gel results. However,
CYP11B2 did appear to be greater in adrenal tissues from both high and low sodium
groups compared with normal diet group.
3.2.6.4 Gene expression of CYP11B2 and CYP11B1
The mRNA transcripts for CYP11B2 (Fig. 3.19A) in the adrenals ofE20 rats were
not changed by dietary treatments. The mRNA concentrations of CYP11B2 were
lower in fetal adrenals of the normal and low salt groups than in their maternal
adrenals (Fig. 3.12A). However, the mRNA expression ofCYP11B2 was much higher
in the fetal adrenals of the high salt group compared to that in the maternal adrenals
(Fetal adrenal, 2.18+0.81 attomole/pg RNA; maternal adrenal, <0.42 attomole/pg
RNA).
Dietary treatments had no effect on the mRNA transcripts of the CYP11B1 (Fig.
3.19B) in the adrenals of E20 rats. In addition, the transcript levels of CYP11B1 in
fetal adrenals were similar to those in the maternal adrenals (Fig. 3.12B).
3.3 Discussion
Previous studies have shown that a salt-restricted diet induces hypertrophy and
hyperplasia of the ZG of the adrenal cortex in both non-pregnant and pregnant rats
(Pohanka and Pike, 1970). Ultrastructural changes including electron-dense
inclusions in the mitochondria of the ZG cells, autophagic vacuoles and large
cytoplasmic vacuoles reveal evidence of cellular degradation when rats receive either
a low salt diet or have the stress of pregnancy. The combination of sodium restriction
and pregnancy also results in the exhaustion of the ZG cells and the depletion of lipid
droplets in the cells (Pohanka and Pike, 1970; Smiciklas et al., 1971). In this study, we
also demonstrated that the low salt diet gives rise to hypertrophy of the ZG cells and
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the expansion of ZG width. However, the adrenal glands of non-pregnant rats had no
noticeable morphological differences from those of pregnant rats with the exception
of the coarsely vacuolar appearance seen in the ZG in the low-salt-treated pregnant
rats which is in agreement with a previous study (Pike and Gursky, 1970).
Body weights and organ weights were not changed in either non-pregnant or
pregnant rats given a low salt diet. In this study, the low sodium level (0.03% of
sodium or equal to 0.07% of sodium chloride) may be not as extreme as in some
earlier experiments (0.03% of sodium chloride). Therefore, the low sodium diet does
not affect maternal growth, litter size and pup weights. In contrast, renal growth was
observed in high-salt-treated rats. Recently, Ying et al. (1998) demonstrated that a
high level of dietary sodium caused renal growth in rats as a result of the modulation
of transforming growth factor-fl expression.
Elevated plasma aldosterone is proposed to be associated with increased plasma
volume and sodium retention in rats during pregnancy (Schneider and Mulrow, 1973;
Garland et al. 1987; Brochu et al., 1996). As a result, changes of adrenal
steroidogenesis may play a key role in pregnant rats. Recently, Brochu et al. (1997)
demonstrated that the augmented activity and mRNA levels of CYP11B2 in the ZG
are responsible for the elevated plasma aldosterone levels during pregnancy. However,
few comparisons of steroidogenic enzyme expression have been made between
pregnant and non-pregnant rats. In this study, no significant differences of the staining
intensity of CYP11B2 and CYP11B1 were observed between pregnant and
non-pregnant rats. In both pregnant and non-pregnant rat adrenal glands, dietary
sodium restriction caused an increase in CYP11B2 and had no effect on CYP11B1
assessed by immunohistochemistiy. According to reports ofothers (Malee and Mellon,
1991; Brochu et al., 1998), CYP11B2 gene transcripts are regulated in the adrenals of
the pregnant rats in a similar fashion to that in the non-pregnant rat adrenal although
they have demonstrated a greater response to low salt treatment in pregnant adrenal
glands when compared to non-pregnant adrenal glands.
On the contrary, a high salt diet appears to regulate the expression of CYP11B2 in
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the opposite way. The expression of CYP11B2 mRNA in the adrenal glands of the
high salt treated pregnant rats was dramatically reduced to barely detectable levels.
The protein expression of CYP11B2 only reached half the expression level of the
CYP11B2 in normal salt group. The expression of CYP11B2 was 5.8-fold lower in
the adrenals of the high salt treated pregnant rats compared to the expression in the
adrenals of the low salt treated rats. On the other hand, there was no effect on the
expression of the adrenal CYP11B1 mRNA in the various dietary salt regimes in
pregnant rats. This suggests that there is a profound effect on the expression of
CYP11B2 and the corresponding gene, CYP11B2, in rats fed with high salt diet
throughout pregnancy.
On the other hand, the staining pattern and intensity for 3P-HSD were not affected
by dietary salt. However, the staining of 3P-HSD in both the ZG and the ZF cells was
more intense in the pregnant rat adrenals than in the non-pregnant rat adrenals.
Because 3P-HSD converts pregnenolone into progesterone, this implies that the
progesterone synthesis is elevated during pregnancy. Progesterone is a vital hormone
to maintain pregnancy. Whether the elevation of 3P-HSD is to sustain the pregnancy
or to provide more substrates for adrenal steroidogenesis requires further
investigation.
In fetal rat adrenals, it was expected that various dietary salt treatments in
maternal rats might affect the regulation of aldosterone synthesis in a similar manner
to that seen in adult rat adrenals. Low salt diet increases the plasma aldosterone levels
and CYP11B2 expression levels compared to the normal salt diet in fetal rats similar
to that observed in pregnant rats. However, competitive RT-PCR results did not show
the same response to the dietary treatment. There are several possible explanations.
Firstly, levels ofCYP11B2 transcripts in fetal adrenals are relatively low compared to
that observed in the adult adrenals though low salt diet amplifies the expression level
in the fetal adrenal. Secondly, the results indicate that the diets may have no effect on
CYP11B2 gene expression. This is in agreement with a previous study (Mellon et al.,
1995), which suggested that the fetal adrenal might be transcriptionally quiescent in
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vivo to dietary treatments. Thirdly, the elevated plasma aldosterone may be
contributed from extra-adrenal sources. Although there is no direct evidence showing
that maternal aldosterone can cross placenta, it has been shown that fetal injection of
labelled progesterone produced small quantities of labelled aldosterone in the
circulation of acutely adrenolectomised mothers (Milkovic et al., 1976; Klepac, 1979).
Churchill et al. (1981) also demonstrated that significant levels of aldosterone were
found in the blood of adrenalectomised pregnant rats whereas no dectectable
aldosterone was present in the non-pregnant adrenalectomised female rats.
Aldosterone can also be produced locally in the rat brain (Gomez-Sanchez et al., 1997;
MacKenzie et al., 2000), heart (Silvestre et al., 1998) and blood vessels tissues
(Takeda et al., 1996) through local RAS systems. Whether these tissues in fetal rats
are capable of steroid production needs additional investigations. Furthermore, the
elevated plasma aldosterone level may indicate an increased stability of aldosterone or
a decreased metabolism of aldosterone. These possibilities cannot be excluded at
present.
Especially noteworthy is that high salt diet may have different regulation of
CYP11B2 and its gene in fetal rat adrenals. The levels of CYP11B2 mRNA
transcripts were much higher in the fetal adrenals of the high salt group compared to
the expression of CYP11B2 gene transcripts in the maternal adrenals that were
markedly suppressed by high salt diet. CYP11B2 also appeared to be greater in
adrenal tissues in the high sodium group compared with the normal diet group.
Moreover, plasma aldosterone levels in fetal rats were maintained to similar levels as
in fetal rats following maternal normal salt treatment. Consistent with previous results
(Khokhar and Pike, 1973; Churchill et al., 1981; Wotus et al., 1998), the data provide
direct evidence that CYP11B2 and its transcripts start to function in E20 fetal adrenal
glands and are able to produce aldosterone. In addition, high salt diet may be not
sufficient to suppress aldosterone secretion or CYP11B2 gene expression in fetal rat
adrenals.
63
Furthermore, maternal dietary treatments had no effects on the plasma
corticosterone levels and the expression of CYP11B1 and the corresponding
CYP11B1 transcripts in the adrenals of E20 rats. However, it is of interest that the
fetal adrenals have similar expression levels of CYP11B1 and its transcripts to the
maternal adrenals. The present findings clearly support early studies (Dupouy et al.,
1975; Dalle et al., 1978) that steroidogenesis, especially corticosterone biosynthesis,
in fetal adrenal glands is highly active at the end of gestation.
The staining of 3P-HSD in fetal adrenal gland was not affected by the various
maternal dietary salt intakes. The localisation was mainly in the inner cortex,
including the ZF and the ZR with similar staining intensity. The ZG only showed very
weak staining. The data are consistent with previous studies, which suggest that the
low expression of 3p-HSD in the ZG of the fetal adrenal may be related to the low
plasma aldosterone (Pignatelli et al., 1998) and angiotensin II (Dupont et al., 1991)
levels in the newborn or fetal rats.
In conclusion, this is the first attempt to investigate the effects of high (3%),
normal (0.3%) and low (0.03%) dietary sodium content on CYP11B2, CYP11B1 and
3P-HSD expression in adrenal glands obtained from pregnant rats and their 20-day
old fetuses using various techniques. The results suggest that dietary sodium
restriction may activate the RAS system that induces the expression of CYP11B2 in
fetal adrenal glands. Whether the control is exerted by changes ofmaternal or the fetal
RAS system is not clear although others have demonstrated that renin is expressed in
the kidney of fetal lambs (Iwamoto and Rudolph, 1981; Siegel, 1981) and also in the
adrenal tissue of the fetal mouse (Zemel et al., 1989; Jones et al., 1990). Whether the
development of the fetal and pregnant rat adrenal gland are subject to the same
regulatory processes as the normal adult female adrenal gland requires further
investigation. The possible role of the local RAS systems in pregnant and fetal rat
adrenals will be discussed in a later chapter.
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Fig. 3.1 Localisation of CYP11B2 (A), CYP11B1 (B) and 3p-HSD (C) antibodies in
rat adrenal gland by immunohistochemical staining. The brown colour shows the
positive staining. Nuclei (blue colour) were stained by haematoxylin. A, CYP11B2
monoclonal antibody localised in the ZG, exclusively (magnification, x400). B,
CYP11B1 monoclonal antibody localised in the ZF (magnification, xlOO). C, 3P-HSD
polyclonal antibody localised in all adrenal cortex (magnification, xlOO). Cap, ZG and
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Fig. 3.2 Characterisation of CYP11B2 and CYP11B1 antibodies. A, CYP11B2
monoclonal antibody optimisation with various amounts of mitochondrial protein
from adrenal capsules. B, CYP11B1 monoclonal antibody optimisation with
various amounts of mitochondrial protein from decapsulated adrenal cortex . C, A
membrane was incubated with both CYP11B2 and CYP11B1 antibodies.
Mitochondrial pellets of adrenal samples were extracted from different salt treated
pregnant rats. Mitochondrial pellets of the decapsulated or capsule portions and the
liver were extracted from normal rats. D, Mitochondrial pellets from the adult
adrenal capsules, whole adrenals, fetal adrenals and the liver were incubated with
the CYP11B2 monoclonal antibody. E, Reblot of membrane shown in D with
CYP11B1 monoclonal antibody. Each mitochondrial extract consisted of 20 pg
protein/lane.
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ZG width ofnon-pregnant rat adrenals
80 i
(n=6) (n=4) (n=6)
ZGwidth ofpregnant rat adrenals
(n=3) (n=7) (n=5)
Cell size of ZG in non-pregnant rat adrenals
High Normal Low
(n=3) (n=6) (n=5)
Fig. 3.3 Zonal widths (A and B) and cell size (C and D) of the zona glomerulosa in rat
adrenal glands obtained from non-pregnant (A and C) and pregnant (B and D) rats
treated with various salt diets for 20 days and throughout pregnancy, respectively.
Zonal widths and cell size were measured at magnification of x400 and xlOO,
respectively. Values are mean ± S.E. n represents the number of the animals tested.
Data were analysed by the Tukey's test. * P<0.05 compared to normal-salt-diet group.
# PO.05 compared to low-salt-diet group.
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Fig. 3.4 Immunostaining results for 3P-HSD in rat adrenal glands obtained from non¬
pregnant (A-C) or pregnant (D-F) rats treated with various salt diets for 20 days or
throughout pregnancy, respectively. A and D, Adrenal sections from rats fed a high
salt diet. B and E, Adrenal sections from rats fed a normal salt diet. C and F, Adrenal
sections from rats fed a low salt diet. ZG, ZF, ZR and M denote zona glomerulosa,
zona fasciculata, zona reticularis and medulla, respectively. Magnification, x40.
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A. Immunostaining results for 3P-HSD in the ZG of adrenals in rats treated




















(Various salt diets: P>0.05;
Non-pregnant vs. pregnant: P<0.05)
B. Immunostaining results for 3P-HSD in the ZF of adrenals in rats treated






(Various salt diets: P>0.05;
Non-pregnant vs. pregnant: P<0.05)
Fig. 3.5 Immunostaining results for 3P-HSD in rat adrenal glands obtained from non¬
pregnant (NP) or pregnant (P) rats treated with various salt diets for 20 days or
throughout pregnancy, respectively. ZG and ZF denote adrenal zona glomerulosa and
zona fasciculata, respectively. Values are mean ± S.E. n represents the number of
animals studied. Data were analysed by two-way ANOVA and the Tukey's test.
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Fig. 3.6 Immunostaining results for CYP11B2 (A-C) and CYP11B1 (D-F) in rat
adrenal glands obtained from non-pregnant rats treated with various salt diets for 20
days. A and D, Adrenal sections from rats fed a high salt diet. B and E, Adrenal
sections from rats fed a normal salt diet. C and F, Adrenal sections from rats fed a
low salt diet. Cap, ZG and ZF denote adrenal capsule, zona glomerulosa and zona
fasciculata, respectively. A-C, Magnification, x400. D-F, Magnification, xlOO. Arrow
head shows weak CYP11B2 staining in high-salt-treated adrenal section.
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A. Immunostaining results for CYP11B2 in the ZG of the adrenals
in non-pregnant rats treated with various salt diets
Immunostaining results for CYP11B1 in the ZF of the adrenals




Fig. 3.7 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) in rat adrenal
glands obtained from non-pregnant rats treated with various salt diets for 20 days.
ZG and ZF denote adrenal zona glomerulosa and zona fasciculata, respectively.
Values are mean ± S.E. n represents the number of animals tested. Data were
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Fig. 3.8 Immunostaining results for CYP11B2 (A-C) and CYP11B1 (D-F) in rat
adrenal glands obtained from pregnant rats treated with various salt diets for 20 days.
A and D, Adrenal sections from rats fed a high-salt-diet. B and E, Adrenal sections
from rats fed a normal-salt-diet. C and F, Adrenal sections from rats fed a low-salt-
diet. Cap, ZG and ZF denote adrenal capsule, zona glomerulosa and zona fasciculata,
respectively. A-C, Magnification, x400. D-F, Magnification, xlOO. Arrows show
coarsely vacuolars in low salt pregnant adrenal section.
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A Imniunotaining results for CYP11B2 in the ZG of the adrenals






















Immunostaining results for CYP11B1 in the ZF of the adrenals




Fig. 3.9 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) in rat adrenal
glands obtained from pregnant rats treated with various salt diets for 20 days. In Fig.
(A), data were analysed by Tucky's test. * P<0.002 compared to normal-salt-diet
and low-salt-diet groups. Values are mean ± S.E. n represents the number of
animals tested. In Fig (B), data are expressed as mean ± S.E. except that the data in
high-salt-diet group (n=2) represent the range of the two determinations. ZG and ZF






































Fig. 3.10 Western blotting results for CYP11B2 (A and B) and CYP11B1 (C and D) of
adrenal glands in pregnant rats treated with various salt diets throughout pregnancy. A
and C, 10% SDS-PAGE gel results. B and D, Relative intensity of the proteins
quantified from the gels. Values are mean ± S.E. n represents the number of animals
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Fig. 3.11 Expression of CYP11B2 (A) and CYP11B1 (B) mRNA using competitive
RT-PCR in rat adrenal glands obtained from pregnant rats. There was no cross reaction
between CYP11B2 and CYP11B1 primers (C). Three hundred nanograms and 5















Fig. 3.12 Expression of CYP11B2 (A) and CYP11B1 (B) mRNA using competitive
RT-PCR in rat adrenal glands obtained from pregnant rats treated with various salt
diets throughout pregnancy. Three hundred nanograms and 5 nanograms of RNA
templates (300ng and 5ng) were used for CYP11B2 and CYP11B1, respectively.
Values are mean ± S.E. n represents the number of animals tested. Data were analysed
by Tukey's test. * P<0.01 compared to normal-salt-diet group. # P<0.05 compared to
low-salt-diet group.
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A. Plasma aldosterone levels in fetal rats following maternal












B. Plasma corticosterone levels in fetal rats prenatal treated with






















Fig. 3.13 Plasma aldosterone (A) and corticosterone (B) levels in rats at E20 stage
following maternal treatment with various salt diets throughout pregnancy. Values
are mean ± S.E. n represents the number of animals tested. Data were analysed by
Tukey's test. * P<0.05 compared to normal-salt-diet and high-salt-diet groups.
77
Fig. 3.14 Immunostaining results for 3P-HSD at E20 stage in rat adrenal glands
following maternal treatment with various salt diets throughout pregnancy. A, An
adrenal section from a E20 rat following maternal treatment with high-salt-diet
throughout pregnancy. B, An adrenal section from a E20 rat following maternal
treatment with normal salt diet throughout pregnancy. C, An adrenal section from a
E20 rat following maternal treatment with low salt diet throughout pregnancy. ZG, ZF
and M denote zona glomerulosa, zona fasciculata and medulla, respectively. A-C,
Magnification, xlOO.
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A. Immunostaining results for 3P-HSD in the ZG of the adrenals in fetal rats





B. Immunostaining results for 3P-HSD in the ZF of the adrenals in fetal rats
following maternal treatment with various salt diets throughout pregnancy
n=15 n=23 n=19
(P>0.05)
Fig. 3.15 Immunostaining results for 3p-HSD at E20 stage rat adrenal glands following
maternal treatment with various salt diets throughout pregnancy. A, Immunostaining
results for 3P-HSD in the ZG of the adrenal gland. B, Immunostaining results for 3p-
HSD in the ZF of the adrenal gland. ZG and ZF denote zona glomerulosa and zona
fasciculata, respectively. Values are mean ± S.E. n represents the number of animals
tested. Data were analysed by Tukey's test.
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Fig. 3.16 Immunostaining results for CYP11B2 (A-C) and CYP11B1 (D-F) ofadrenal
glands in E20 rats following maternal treatment with various salt diets throughout
pregnancy. A and D, Adrenal sections from E20 rats following maternal treatment
with high salt diet throughout pregnancy. B and E, Adrenal sections from E20 rats
following maternal treatment with normal-salt-diet throughout pregnancy. C and F,
Adrenal sections from E20 rats following maternal treatment with low-salt-diet
throughout pregnancy. Cap, ZG and ZF denote adrenal capsule, zona glomerulosa
and zona fasciculata, respectively. A-C, Magnification, x400. D-F, Magnification,
xlOO.
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A. Immunostaining results for CYP11B2 in the ZG ofthe adrenals in fetal rats
following maternal treatment with various salt diets throughout pregnancy
B. Immunostaining results for CYP11B1 in the ZF ofthe adrenals in fetal rats









Fig. 3.17 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) of adrenal
glands in E20 rats following maternal treatment with various salt diets throughout
pregnancy. ZG and ZF denote adrenal zona glomerulosa and zona fasciculata,
respectively. Values are mean ± S.E. n represents the number of animals tested.






Fig. 3.18 Western blot results for CYP11B2 (A and B) and CYP11B1 (C and D) in
adrenal glands at E20 rats following maternal treatment with various salt diets
throughout pregnancy. A and C, 10% SDS-PAGE gel results. B and D, Relative
intensity of the proteins quantified from the gels. Values are mean ± S.E. n represents






Fig. 3.19 Expression of CYP11B2 (A) and CYP11B1 (B) mRNA using competitive
RT-PCR at E20 stage rat adrenal glands following maternal treatment with various salt
diets throughout pregnancy. Three hundred nanograms and 5 nanograms of RNA
templates (300ng and 5ng) were used for CYP11B2 and CYP11B1, respectively.
Values are mean ± S.E. n represents the number of animals tested. Data were analysed
by Tukey's test.
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Chapter 4 Effects of dexamethasone on steroidogenic
enzyme expression in fetal and pregnant rat adrenal
glands
4.1 Introduction
The control of the fetal hypothalamo-pituitary-adrenal (HPA) axis has been the
subject of intense investigation. The factors influencing the differentiation and
secretory activity of the fetal adrenal glands have been studied using various
experimental approaches. It has been postulated that maternal adrenocorticosteroids
cross the placenta in the prenatal period to regulate ACTH secretion by the fetal
hypophysis (Paul and D'Angelo, 1972). Treatments designed to prevent or diminish
maternal glucocorticoid hormone synthesis; such as adrenalectomy (D'Angelo et al.,
1973; Machin et al., 1995) or hypophysectomy (Paul and D'Angelo, 1972) have the
effect of promoting fetal adrenal steroid synthesis. In contrast, stimulation of
endogenous maternal corticosterone synthesis by implantation of ACTH-secreting-
tumour cells (Milkovic et al., 1968; Milkovic et al., 1973) or injection with synthetic
glucocorticoid hormones (Klepac and Milkovic, 1979) has the opposite effect causing
the suppression of fetal adrenal growth and steroidogenesis.
Alteration of fetal steroidogenesis manifested by maternal treatments has been
studied morphologically and functionally. Pregnant rats implanted with transplantable
ACTH-secreting-tumour cells had high levels of plasma ACTH, which gave rise to a
suppressed fetal adrenal size. The cells in the inner cortical zones remained small
without signs of secretory activity and characteristic adrenocortical arrangement
(Milkovic and Domac, 1973). Conversely, adrenals of fetuses injected with ACTH or
from adrenalectomised mothers showed more abundant larger cortical cells full of
lipid droplets with abundant mitochondria and smooth endoplasmic reticulum
compared to those fetal adrenals from the control pregnant rats (Yamamoto et al.,
1986; Machin et al., 1995). Fetal steroidogenesis has also been assessed by
monitoring in vitro and in vivo conversion of radiolabeled precursors to a variety of
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products. In the adrenals of rat fetuses from dexamethasone treated adrenalectomised
mothers and from the ACTH-tumour-bearing mothers, the conversion of
14C-progesterone to deoxycorticosterone (DOC), corticosterone,
18-hydroxy-11-deoxycorticosterone (18-OH-DOC) was inhibited during the final
days of intrauterine development. However, the production of
18-hydroxy-corticosterone (18-OH-B) and aldosterone was not affected (Klepac,
1976; Klepac et ah, 1977; Klepac et ah, 1978; Klepac, 1981). On the other hand,
fetuses injected with metopirone, an inhibitor of 11(3- and 18-steroid hydroxylases,
resulted in a decrease in the synthesis of corticosterone, 18-OH-DOC and 18-OH-B in
fetal adrenals (Klepac et ah, 1975). Administration of ACTH directly to fetuses
through the uterine wall increased the conversion of progesterone to the
above-mentioned steroids (IClcpac and Milkovic, 1975; Sugihara et ah, 1982).
As described in the introduction and Chapter 3, the adrenal zonal specific cells are
possibly identifiable between day 16 and day 20 of gestation. Studies of the ontogeny
of corticosterone biosynthesis indicated that production of corticosterone begins
around embryonic day 16 and the fetal adrenals become sensitive to ACTH
stimulation around that time (Roos, 1967; Kalavsky, 1971; Milkovic et ah, 1973;
Yamamoto et ah, 1983; Yamamoto et ah, 1986). On the basis of these studies, the fetal
HPA axis regulation seems to appear between day 16 and day 18 of gestation.
Aldosterone synthesis and the development of the ZG is a little later, but is clearly
seen from day 18 onwards (Milkovic et ah, 1976; Churchill et ah, 1981), though
Mitani et ah (1997) reported that CYP11B2 remained undetectable
immunohistochemically until E20 (Mitani et ah, 1997).
During the developing stages of fetal steroidogenesis, maternal steroids cross the
placental barrier, thereby modulating the fetal HPA axis. It is also apparent that the
process is bi-directional. In pregnant adrenalectomised rats, the maternal plasma
corticosterone level can be maintained as high as that observed in intact pregnant rats
after 18 days of gestation (Dupouy et ah, 1975). Significant levels of maternal
hormone and radioactive products have been identified in the maternal circulation
after adrenalectomy following fetal injection of radiolabeled steroid precursors
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(Milkovic et al., 1973; Milkovic et al., 1976). Moreover, it was confirmed that the
increase in maternal plasma corticosterone concentration was inhibited 2 hours later
in adrenalectomised mothers whose fetuses were injected with metopirone
immediately after the operation (Milkovic et al., 1975).
It is also clear that, as with adult adrenals, fetal steroids in the adrenal cortex
influence the development of chromaffin cells. Chromaffin cells are seen between
embryonic day 17 and day 18 by immunohistochemical methods (Josimovich et al.,
1954; Roffi, 1968) and assays of adrenal catecholamine contents (Seidl and Unsicker,
1989; Kennedy and Ziegler, 2000). These developments suggest that fetal
catecholamine secretion or the related enzyme activity may be intimately linked to
fetal adrenocortical activity. Therefore, treatments designed to influence fetal
steroidogenesis may also affect fetal chromaffin tissues. In the present study, we have
investigated the effects of maternal dexamethasone treatment. The main aim of this
study was firstly to examine whether a long-term, modest dose of glucocorticoid
hormone would have effects similar to those achieved with short-term (less than 7
days) and higher dose treatment reported in previous studies. A second aim was to
assess whether the expression of CYP11B1 and CYP11B2 transcripts in the
developing adrenals was affected by the maternal treatment. A third aim was to
investigate whether dexamethasone treatment induced changes in the development of
the adrenal cortex and medulla that may initiate programming of adult onset disease
(see Chapter 5).
4.2 Results
4.2.1 Effects of maternal dexamethasone treatment on adrenal
morphology changes and the steroidogenic enzymes in fetal rats
4.2.1.1 Organ weights
Fetal rats treated with dexamethasone throughout gestation (called DEX-treated in
the following sections) exhibited growth retardation (Table 4.1). The body weights
were significantly reduced by DEX-treatment compared to the control animals.
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DEX-treated fetal rats also had lower organ weights and relative organ weights,
except for the relative heart weights, compared to the saline-treated fetuses (called
saline-treated in the following sections) (P<0.05).
Table 4. 1 Body weights and organ weights (mean ± S.E.) ofE20 rats following
prenatal treatment with saline or dexamethasone throughout pregnancy
Saline (n=3) Dexamethasone (n=4)
Body weight (g) 3.715+0.049' 3.49410.085'*
Heart weight (mg) 25.14±0.55 22.8110.65*
Heart wt / Body wt % 0.67710.012 0.65810.014
Kidney weight (mg) 14.3710.37 12.5710.48*
Kidney wt / Body wt % 0.38610.008 0.35710.007*
Adrenal weight (mg) 1.0610.05 (n=2) 0.83+0.04 (n=2)
n represents the number of pregnant rats tested.
'The number of fetuses in saline and dexamethasone groups is between 48 and 51.
Data were analysed by Student's t-test.
*: Significantly different from saline group (P<0.05).
4.2.1.2 Adrenal cell size
There was no difference in fetal adrenal ZF cell size between the two experimental
groups (Fig. 4.1 A). In contrast, the size of the chromaffin cells was significantly
increased in DEX-treated fetal adrenals compared to the saline-treated adrenals at a
magnification of x400 (89.06 pm2 vs. 75.62 pm2; P<0.05) (Fig. 4.IB). There was a
17.8% increase of the medullary cell size.
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4.2.1.3 Serial adrenal sections stained by various antibodies
To investigate further the morphological changes, serial sections of adrenal glands
were stained by antibodies, which recognise specific zonal markers of the adrenal
cortex or medulla. The brown staining achieved with the CYP11B2 antibody was seen
in the ZG with low staining intensity of the saline-treated fetal adrenal (Fig. 4.2A), but
clear staining was exhibited under the capsule of DEX-treated fetal adrenals (Fig.
4.2E). Most cells were positive for CYP11B1, except for those in the outer ZG and
chromaffin-positive cells. The saline-treated adrenals showed weak staining between
the edge of the ZG and the ZF with increasing intensity towards the inner cortex (Fig.
4.2B), while the DEX-treated adrenal showed homogeneous staining for CYP11B1
(Fig. 4.2F). 3(3-HSD was localised in all cortical cells and the non-steroidogenic cells,
which localised in the central area of the adrenal, exhibited clear negative staining
(Fig. 4.2D and FI). Chromogranin A antibody was used as a specific marker for
medullary cells (Fig. 4.2C and G). Comparing the serial staining results, the most
obvious difference between the saline- and DEX-treated adrenals was the area in the
centre of the gland. DEX-treated adrenals showed a broad area of medullary cells. In
contrast, saline-treated adrenals showed a few scattered medullary cells. Different
staining intensities for each antibody between the control group (Fig 4.2 A-D) and
experimental group (Fig. 4.2 E-H) are discussed in a later section (Section 4.3.1.4).
4.2.1.4 Immunostaining results
DEX-treated fetuses appeared to show higher relative adrenal staining intensity
for CYP11B2 compared to those of saline-treated animals (Fig. 4.3 A). In contrast, the
staining intensity for CYP11B1 was slightly reduced in the DEX-treated group
compared to the control group (Fig. 4.3 B). Neither of the differences, however,
reached statistical significance.
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4.2.1.5 Western blotting results
Due to the low protein levels of the CYP11B2 and the low sensitivity of the
antibody, it was difficult to observe clear 48 kDa bands in fetal adrenal samples (Fig.
4.4A). In contrast, CYP11B1 was highly expressed at this stage (Fig. 4.4C).
According to the Western blotting results, no changes in CYP11B2 or CYP11B1 were
seen when the prenatal treated saline and DEX groups were compared (Fig. 4.4B and
D).
4.2.1.6 Gene expression for CYP11B2 and CYP11B1
The abundance of CYP11B2 transcripts appeared to be elevated in DEX-treated
fetal adrenals compared to the saline-treated adrenals (Fig. 4.5A). There was, however,
a lack of statistically significant differences. DEX-treatment throughout pregnancy
markedly reduced the level of CYP11B1 transcripts in fetal adrenals (Fig. 4.5B).
4.2.2 Effects of dexamethasone on the CYP11B enzymes in pregnant rats
4.2.2.1 Immunostaining results
In pregnant rats, the staining intensity for CYP11B2 was not affected by DEX-
treatment (Fig. 4.6A, Fig 4.7 A and C). On the other hand, the staining ofCYP11B1 in
ZF was markedly reduced in the DEX-treated pregnant rats (Fig. 4.6B, Fig. 4.7 B and
D). The maternal adrenal micrographs for CYP11B2 and CYP11B1 staining were
shown in Fig. 4.7.
4.2.2.2 Western blotting results
Maternal DEX-treatment led to a marked increase (2.8- fold) in the relative
abundance of CYP11B2 in the adrenals of the pregnant rats compared to the saline
controls (Fig. 4.8A and B). In contrast, the expression for CYP11B1 in pregnant rat
adrenals was suppressed to a level of 42% by DEX-treatment compared to the saline
treatment (Fig. 4.8C and D).
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4.2.2.3 Gene expression of CYP11B2 and CYP11B1
The expression of the CYP11B2 transcripts appeared to be modestly increased in
the adrenals of the DEX-treated pregnant rats compared to the saline controls (Fig.
4.9A). Contrasting with the pattern observed in CYP11B2 transcripts, maternal
DEX-treatment caused a dramatic reduction in CYP11B1 expression (Fig. 4.9B) since
similar CYP11B1 transcript levels were seen with 150 nanograms of RNA templates
from adrenal samples of the DEX-treated rats when compared to 5 nanograms of
RNA template in control adrenal samples.
4.3 Discussion
Numerous studies have indicated that prenatal exposure to glucocorticoids causes
intrauterine growth retardation in humans and animals (Paul and D'Angelo, 1972;
D'Angelo et al., 1973; Klepac and Milkovic, 1979; Reinisch et ah, 1978;
Benediktsson et al., 1993). Dexamethasone, an effective synthetic glucocorticoid, has
been used in the clinical treatment of glucocorticoid excess for years. The most
profound effects ofDEX adminstration during gestation are low birth weights and low
adrenal weights with the subsequent development of hypertension and insulin
resistance in the adult offspring (see Chapter 5). In this study, a slight decrease in
heart weight and markedly reduced birth, kidney and adrenal weights were observed
in fetal rats exposed to DEX in utero. This study, in agreement with previous studies,
shows the signs of the intrauterine growth retardation produced by the administration
ofDEX.
A high dose of DEX-treatment (0.3 mg/kg body weight/day) to pregnant rats
during the last 5 days of gestation resulted in atrophic changes, including the
reduction of cell volume and cell number, in the adrenal cortex of the fetal rats
(Hristic et al., 1997). In our study, no difference in cell size was observed in ZF cells
of the adrenal glands from the control and maternal DEX-treated fetal rats. This is
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likely to be due to the modest DEX dosing treatment (100 gig/kg body weight/day)
was applied in the present study. Also, it may be as a result of the inhibition of fetal
ACTH secretion by DEX, which could result in the suppression of steroid output and
cell proliferation rather than affecting the adrenocortical cell size. However, the cell
number or proliferation activity of the adrenal cortex was not examined. In this study,
the protein levels of CYP11B1 in fetal adrenals detected by immunostaining and
Western blotting appeared to be slightly reduced by the maternal DEX-treatment
compared to the control rats. More obviously, the level of the CYP11B1 mRNA in the
adrenals of DEX-treated fetal rats was lowered to 50% of the expression level in the
saline-treated fetal rat adrenals (P<0.05). Although the plasma corticosterone levels
were not measured in this study, the present data are suggestive that the corticosterone
production could potentially be inhibited in the adrenals of fetal rats treated in utero
with DEX throughout gestation.
In the present study, there were no apparent effects on the protein and gene
expression of CYP11B2 in fetal adrenals following prenatal DEX-treatment although
the immunostaining and cRT-PCR results showed a tendency for CYP11B2
expression to be higher in DEX-treated fetal adrenals. According to the
morphological studies, Hristic et al. (1997) reported both the volume and the number
of ZG cells were markedly reduced in the adrenals of rats with prenatal
dexamethasone treatment. Others failed to demonstrate the morphological changes in
the ZG either in the adrenals of fetuses from ACTH-tumour-bearing (Milkovic and
Domac, 1973) or adrenalectomised-treated (Machin et al., 1995) mothers. However,
Sugihara et al. (1977) showed that both the ZG and ZF cells of fetal adrenals became
remarkably hyperaemic to exogenous ACTH injection (Sugihara et al., 1977).
On the other hand, it is worthy of note that the changes of CYP11B2 and
CYP11B1 and their transcripts in fetal adrenals were in a similar fashion to those
observed in the pregnant mothers with the exception of the more profound effects
seen in the DEX-treated mothers. These results are inconsistent with previous studies.
DEX reduced markedly the amount of CYP11B1 mRNA without affecting CYP11B2
mRNA levels in normal, non-pregnant rats, however, there was little effect on the
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abundance of the CYP11B2 and CYP11B1 mRNA in the fetal adrenals (Malee and
Mellon, 1991). Consequently, it was suggested that fetal adrenal CYP11B2 and
CYP11B1 might be transcriptionally quiescent in vivo to the maternal dexamethasone
treatment although changes in plasma and adrenal corticosterone levels were clearly
observed in fetal rats following prenatal treatment with dexamethasone (20 pg/daily)
for one week (Malee and Mellon, 1991; Mellon et ah, 1995). The divergent results for
the protein and gene expression of the CYP11B2 and CYP11B1 may result from the
various doses and the duration of the dexamethasone treatment used in the different
studies. In the present study, pregnant rats were injected with a modest dose of
dexamethasone (100 pg/kg body weight/day) throughout pregnancy compared with
20 pg/daily injection for a week in the study ofMalee and Mellon (1991) or 0.3 mg/kg
body weight/day during last 5 days of gestation in Hristic's experiments (Hristic et al.
1997).
It is also interesting that the expression of the CYP11B2 protein and gene
transcripts showed great responses to dexamethasone in pregnant rat adrenal glands.
One possible explanation may be the increased relative amounts of CYP11B2 due to
the atrophy of the adrenal gland in DEX-treated rats compared to the saline-treated
animals. Alternatively, exogenous dexamethasone may modulate angiotensin II
receptors in the ZG of the adrenal gland. Recently, it has been demonstrated that
glucocorticoid receptors and angiotensin II type I receptor (ATI) expression, but not
angiotensin II type II receptor (AT2), were elevated in sheep and rat adrenal glands
exposed to maternal malnutrition during pregnancy (Bertram et al., 2001; Whorwood
et al., 2001). It has also been demonstrated in vascular smooth muscle cells that
dexamethasone induces expression of the ATI receptor gene and results in an increase
in the number of the ATI receptors (Sato et al., 1994). This may give rise to the
increase of CYP11B2 expression. Furthermore, in the present study, the pregnant rats
were treated with dexamethasone or saline throughout gestation. It has been known
that the last few days of gestation may be a crucial window for fetal development.
However, a modest dose of dexamethasone with long-term treatment may exert more
profound effects via alterations of the glucocorticoid and/or mineralocorticoid
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receptor gene expression.
It is remarkable that the medullary cell size was significantly increased in
DEX-treated fetal adrenal glands. In addition, the maternal DEX-treated adrenals
showed a more extensive array ofmedullary cells, which was confirmed by the serial
staining for chromogranin A and 3(3-HSD, compared to the saline-treated fetal
adrenals. When pregnant rats were given a single injection of dexamethasone (1.5
mg/kg body weight) on day 16 of gestation, the medullary volume and the number of
chromaffin cells were significantly reduced in the fetal adrenals. However, during the
second neonatal week, the mitotic index of chromaffin cells reached higher values in
comparison to control animals (Manojlivic et ah, 1998). It has been reported that
glucocorticoid receptors appear in chromaffin tissue on day 17 of gestation and the
activity of fetal phenylethanolamine N-methyltransferase (PNMT) enzyme required
to convert noradrenaline into adrenaline in chromaffin cells also starts to be initiated
at this stage. Therefore, it is possible that glucocorticoids are essential to trigger the
differentiation of sympathoadrenal precursors in endocrine chromaffin cells (Seidl
and Unsicker, 1989; Kennedy and Ziegler, 2000). Lack of glucocorticoid receptors in
the adrenal medulla impairs the development of chromaffin cells in fetal adrenal
glands (Cole et al., 1995) with loss of PNMT gene expression (Cole et ah, 1995;
Finotto et ah, 1999). On the other hand, chronic dexamethasone exposure of rat
fetuses enhances both PNMT activity and adrenaline contents in the fetal adrenal,
heart and head tissues in the later stage of gestation (Kennedy and Ziegler, 2000).
However, injection ofACTH in fetuses did not result in an increase of fetal medullary
PNMT activity despite leading to fetal adrenal hypertrophy and increases in fetal
plasma and adrenal corticosterone concentrations. This suggests that corticosterone
may be essential in maintaining the activity of PNMT, but that increases in
corticosterone do not necessarily result in an increase in PNMT (Milkovic et ah,
1974). It is interesting therefore that, in the present experiments, a greater cell size and
a more extensive area of the adrenal medulla was seen in fetal rats prenatally exposed
to dexamethasone. This perhaps resulted from the modification of the differentiation
of the medullary cells, especially the PNMT-containing cells associated with
adrenaline secretion.
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In conclusion, long-term dexamethasone exposure throughout gestation causes
significant changes in the expression of CYP11B1 in the adrenals of pregnant rats.
Modest increases of CYP11B2 mRNA expression and significantly increased levels
ofCYP11B2 are also shown in pregnant rat adrenal glands. In the adrenals of the fetal
rats prenatally treated with dexamethasone throughout gestation, gene and protein
expression for CYP11B2 and CYP11B1 appeared to be regulated in a similar fashion
to those in the maternal adrenals. In addition, the morphology of the fetal adrenal
medulla is also affected by chronic DEX-treatment in utero. Whether these changes in
the fetal adrenals are sustained and programmed in the same way in later postnatal and
adult life will merit further investigation.
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Cell size ofmedulla in fetal adrenals
SE20 DE20
(P<0.05; n=6)
Fig. 4.1 Cell size of zona fasciculata (ZF)(A) and medulla (B) in the adrenals of
prenatal saline (SE20)- or dexamethasone (DE20)-treated 20-day rat embryos.
Values are mean±S.E. n represents the number of the animal tested. Data were
analysed by the Student's t-test. *P<0.05
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Fig. 4.2 Serial staining of various antibodies in the adrenals of prenatal saline- (A-D)
or dexamethasone- (E-H) treated 20-day rat embryos. A and E; CYP11B2, B and F;
CYP11B1, C and G; Chromogranin A, D and H; 3 P-E1SD. ZG, ZF and M denote zona
glomerulosa, zona fasciculata and medulla, respectively. Magnification: 50X.
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Fig. 4.3 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) in the adrenals of
prenatal saline (SE20)- or dexamethasone (DE20)- treated 20-day rat embryos. Values














































Fig. 4.4 Western blotting results for CYP11B2 (A and B) and CYP11B1 (C and D)
staining in the adrenals of prenatal saline (SE20-X)- or dexamethasone (DE20-X)-
treated 20-day rat embryos. A and C, 10% SDS-PAGE gel results. B and D, Relative
intensity of the proteins quantified from the gels. Values are the range of the two
determinations, n represents the number of animals tested. X represents an individual













Fig. 4.5 Transcript levels of CYP11B2 (A) and CYP11B1 (B) using cRT-PCR in the
adrenals of prenatal saline (SE20)- or dexamethasone (DE20)-treated 20-day rat
embryos, n represents the number of animals tested. Data are expressed as mean±S.E.
in the dexamethasone-treated groups and the data in saline-treated groups (n=2)
represent the range of the two determinations.
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Fig. 4.6 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) in the adrenals of
pregnant rats treated with saline (SP) or dexamethasone (DP) throughout the gestation.
Values are mean±S.E. n represents the number of animals tested. Data were analysed











Fig. 4.7 Immunostaining for CYP11B2 (A and C) and CYP11B1 (B and D) in rat
adrenal glands obtained from pregnant rats treated with saline (A and B) or
dexamethasone C and D) throughout pregnancy. ZG and ZF denote zona
glomerulosa and zona fasciculata, respectively. Magnification: 100X.
101




























Fig. 4.8 Western blotting results for CYP11B2 (A and B) and CYP11B1 (C and D) in
the adrenals of pregnant rats treated with saline (SP) or dexamethasone (DP)
throughout the gestation. A and C, 10% SDS-PAGE gel results. B and D, Relative
intensity of the proteins quantified from the gels, n represents the number of animals
tested. Data are expressed as mean±S.E. in the dexamethasone-treated groups and the

















Fig. 4.9 Transcript levels of the CYP11B2 (A) and CYP11B1 (B) using cRT-PCR in
the adrenals of pregnant rats treated with saline (SP) or dexamethasone (DP)
throughout the gestation, n represents the number of animals tested. Data are expressed
as mean±S.E. in the dexamethasone-treated groups and the data in saline-treated
groups (n=2) represent the range of the two determinations.
103
Chapter 5 Effects of dexamethasone treatment on adrenal
morphology and CYP11B enzyme expression in the
postnatal rat offspring
5.1 Introduction
It has been extensively reported that birth weight is related to the nature of the
intrauterine environment. Epidemiological studies have suggested that low birth
weight is strongly associated with the incidences of ischaemic heart disease (Barker et
ah, 1989), hypertension (Barker et al., 1990), cardiovascular (Barker, et al., 1993a)
and metabolic disorders (Barker, et al., 1993b), and, for instance syndrome X, a
combination ofnon-insulin-dependent diabetes, hypertension and hyperlipidaemia, in
the adult. Clinical and experimental investigations have identified a number of factors
that cause intrauterine growth retardation, including undernutrition (Barker et al.,
1993c), stress and glucocorticoid exposure (Levitt et al., 1996; Welberg et al., 2001).
The adaptation to such intrauterine environments in fetuses may change the
concentrations of fetal and placental hormones and result in persistent changes of the
physiological function and disease in adult life (Barker et al., 1993b; Clark, 1998).
In rodents, many studies are demonstrative that offspring exposed to synthetic
glucocorticoids during gestation show reduced birth weight (Blackburn et al., 1965;
Reinisch et al., 1978; Benediktsson et al., 1993) which may also lead to increased
blood pressure in the later adult life after the last exposure to glucocorticoid in utero
(Benediktsson et al., 1993; Levitt et al., 1996). It has been suggested that fetal growth
is directly correlated with the activity of the placental 11 P-hydroxysteroid
dehydrogenase (11P-OHSD2), which converts excess maternal active corticosterone
to inactive 11 -dehydrocorticosterone and protects the fetus from exposure to the
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excess glucocorticoids in utero. In contrast, there is an inverse correlation between
11P-OHSD2 activity and placenta weight in fetus with dexamethasone treatment
throughout pregnancy (Benediktsson et ah, 1993). The disproportion between birth
weight and placenta size of the fetus has been linked with high blood pressure in adult
life in humans (Barker et ah, 1990). It has also been found that dexamethasone
treatment during the last week of pregnancy diminishes the expression levels of the
glucocorticoid and mineralocorticoid receptors in specific brain areas, e.g.
hippocampus in the adult offspring in the rat. This may account for the high blood
pressure in the adult offspring after intrauterine dexamethasone treatment (Levitt et al.,
1996).
Treatment of pregnant rats with glucocorticoid hormone or by feeding a low
protein diet has life long effects on the offspring (Benediktsson et al., 1993;
Langley-Evans et al., 1996). The programmed effects of both these treatments are
associated with dysregulation of the HPA axis (Langley-Evans et al., 1996; Levitt et
al., 1996). More recently, Lindsay et al. observed increased plasma aldosterone
concentrations in adult rats previously exposed to dexamethasone in utero. In addition,
chronic and acute effects of angiotensin II (All) elevated the blood pressure response
more in the dexamethasone-treated group than in the control group (Lindsay et al.,
unpublished data). The results suggested that prenatal exposure to dexamethasone
might have a programming effect on hypertension in later adult life mediated by
modification of the renin-angiotensin system. In view of these observations and of the
effects described in Chapter 4 of maternal dexamethasone on fetal adrenal
development, it is possible that programmed dysregulation of the HPA axis in the
adult offspring is due to abnormal growth and differentiation of the adrenal gland at a
critical stage of fetal adrenal development. The hypothesis that effects of prenatal
dexamethasone on fetal adrenal function persist into adulthood has been tested in the
present chapter.
The protocol for these studies was similar to that described in the previous chapter
except that tissues erere sampled at various intervals after birth when dexamethasone
treatment has stopped. As before, adrenal expression of CYP11B2 and CYP11B1
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proteins and mRNA transcripts were measured by western blotting and competitive
RT-PCR. Preliminary adrenal morphologies from saline and dexamethasone-treated
rats were examined using various immunostaining techniques. Samples were obtained
from adult rats as well as from neonates. Measurements of enzyme expression in
neonatal samples is complicated by the presence of CYP11B3. As indicated in the
Introduction (Chapter 1), CYP11B3 is one of two other genes located adjacent to the
CYP11B2 and CYP11B1 locus on rat chromosome 7. It is highly homologous with
CYP11B1 and has similar biological and immunological properties which make it
difficult to identify. A method for distinguishing CYP11B1 and CYP11B3 mRNA
transcripts is described that confirmed which CYP11B3 is not expressed in adult
adrenal glands.
5.2 Results
5.2.1 Effects of dexamethasone on body weights and organ weights
DEX-treatment throughout gestation resulted in a trend for lower body weights
and organ weights in the offspring at 7 days, but without any significant differences
compared to the 7-day-old control rats (Table 5.1). However, the prenatally
DEX-treated offspring had a higher relative heart weight when compared to the
control rats (P<0.05).
DEX-exposure during pregnancy also caused growth retardation, including lower
body weights and organ weights, in 28-day-old offspring (P<0.05) (Table 5.2).
However, the relative organ weights were significantly increased in the offspring with
DEX-treatment in utero compared to the control 28-day-old offspring (P<0.05).
In 4-month-old offspring, prenatal DEX-treated rats showed a trend for lower
body weights and organ weights compared to the saline-treated control rats though the
differences did not reach statistically significant levels (Table 5.3).
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Table 5. 1 Body weights and organ weights (mean ± S.E.) of 7-day old rats following
prenatal treatment with saline or dexamethasone throughout pregnancy
Saline (n=3) Dexamethasone (n=4)
Body weight (g) 14.5+0.6 13.0±1.0*
Heart weight (mg) 105±3 101+5
Heart wt / Body wt % 0.74+0.02 0.80+0.03*
Kidney weight (mg) 90.9+3.7 82.6+5.3
Kidney wt / Body wt % 0.64±0.02 0.65+0.01
Adrenal weight (mg) 2.68+0.28 2.12+0.24
Adrenal wt (mg) / Body wt % 19.5+2.5 16.0+1.0
Data were analysed by the Student's t-test.
*: Significantly different from saline group (P<0.05).
n represents the number of dam animals
Table 5. 2 Body weights and organ weights (mean ± S.E.) of 28-day old rats following
prenatal treatment with saline or dexamethasone throughout pregnancy
Saline (n=3) Dexamethasone (n=4)
Body weight (g) 110.8+4.9 77.8+4.2*
Heart weight (mg) 569.1+21.9 468.9+18.3*
Heart wt / Body wt % 0.52+0.02 0.59+0.02*
Kidney weight (mg) 577.8+23.2 445.1+19.5*
Kidney wt / Body wt % 0.52+0.01 0.56+0.01*
Adrenal weight (mg) 16.97+1.04 14.29+1.23
Adrenal wt (mg) / Body wt % 15.5+0.9 18.6+0.7*
Data were analysed by the Student's t-test.
*: Significantly different from saline group (P<0.05).
n represents the number of dam animals
107
Table 5. 3 Body weights and organ weights (mean ± S.E.) of 4-month-old rats





Body wt. (g) 557±22 513+25
Heart wt. (g) 1.70±0.09 1.48+0.08
Heart wt/ Body wt % 0.31±0.02 0.29+0.02
Kidney wt. (g) 1.71±0.05 1.52+0.05
Kidney wt/ Body wt % 0.31+0.01 0.30+0.01
Adrenal wt. (mg) 39.3±2.1 33.0+3.1
Adrenal wt. (mg) / Body wt % 7.20±0.63 6.58+0.90
Data were analysed by the Student's t-test.
n numbers represent the number of dam animals treated and examined,
m numbers represent the number of offspring examined.
5.2.2 Immunostaining results
DEX-treatment increased the relative staining intensity for CYP11B2 in adrenals
of 7-day-old offspring compared with the age-matched control rats (Fig. 5.1A). There
was no effect on the adrenal staining intensity for CYP11B1 in the DEX-treated group
compared to the control group (Fig. 5.IB).
No obvious effects on the adrenal staining intensity for CYP11B2 (Fig. 5.2A) and
CYP11B1 (Fig. 5.2B) were found in 28-day-old offspring following prenatal
treatment with DEX compared to the saline group.
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5.2.3 Western blotting results
Prenatal saline- or DEX-treatment had no significant effect on the protein
expression of CYP11B2 (Fig. 5.3A and B) and CYP11B1 (Fig. 5.3C and D) in
7-day-old rat adrenal glands although DEX-treatment tended to reduce (by 20% and
30%) in the enzyme expression of CYP11B2 and CYP1 IB 1, respectively.
There was an apparent 20% reduction in the mean enzyme expression of adrenal
CYP11B2 (Fig. 5.4A and B) in the 28-day-old offspring with DEX-treatment in utero
compared to the control saline-treated offspring. Flowever, the difference was not
significant. Prenatal saline- or DEX-treatment had similar expression levels of adrenal
CYP11B1 (Fig. 5.4C and D). It is worthy of note that there was an unknown band
observed in some adrenal extracts which showed a similar molecular weight to
CYP11B1 when the membrane was reapplied with the CYP11B1 antibody after
stripping off the original CYP11B2 signal (Fig. 5.4C).
There was a 2.1-fold increase in the enzyme expression of adrenal CYP11B2
(Fig. 5.5A and B) in the 4-month-old offspring with DEX-treatment in utero
compared to the control offspring. However, the difference was of borderline
significance (P=0.052). DEX-treatment in utero also resulted in an apparent increase
(20%) in the expression of adrenal CYP11B1 (Fig. 5.5C and D).
5.2.4 Gene expression for CYP11B2 and CYP11B1
The abundance of the adrenal CYP11B2 gene transcripts appeared to be slightly
elevated in prenatally DEX-treated adrenals compared to the saline-treated adrenals in
the 7-day-old rats (DEX, 18.61 ± 0.46 attomole/pg vs. saline, 10.92 ± 6.06
attomole/pg) (Fig. 5.6A). On the other hand, DEX-treatment throughout pregnancy
did not alter the expression of CYP11B1 gene in adrenals of the 7-day-old offspring
(DEX, 327.6 ± 39.2 attomole/pg vs. saline, 280.5 ± 90.1 attomole/pg) (Fig. 5.6B).
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In adrenals of the 28-day-old rat offspring, prenatal DEX-treatment did not affect
the expression of adrenal CYP11B2 gene transcripts (DEX, 14.0+ 1.7 attomole/pg vs.
saline, 15.0 ± 2.9xl0"13 attomole/pg; P>0.5) (Fig. 5.10A). The expression levels of
adrenal CYP11B1 gene transcripts were apparently 1.6-fold higher in prenatally
DEX-treated adrenals than in the saline-treated adrenals (DEX, 2.1 ± 0.2 fmole/pg vs.
saline, 1.3 ± 0.3 fmole/pg) (Fig. 5.10B). However, there was no significant difference
(P>0.1).
The abundance of adrenal CYP11B2 gene transcripts appeared to be elevated
(1.4-fold) in the adrenals of the 4-month-old offspring with DEX-treatment
throughout pregnancy compared to the adrenals in the saline group (DEX, 3.11 ± 0.65
attomole/pg vs. saline, 2.20 ± 0.84 attomole/pg) (Fig. 5.13A) though there was no
significant difference. Intrauterine DEX-treatment throughout pregnancy also resulted
in a higher expression of CYP11B1 gene in adrenals of the 4-month-old offspring
compared to the saline control animals (DEX, 0.92 ± 0.48 fmole/pg vs. saline, 0.25 ±
0.16 fmole/pg) (Fig. 5.13B). However, the difference was not significant because of
the large variation within the experimental groups.
5.2.5 Detection of gene expression for CYP11B3
According to previous unpublished data (Communicated by Dr. C.J. Kenyon),
CYP11B1 primers used in this experiment could amplify both CYP11B1 and
CYP11B3 gene transcripts. However, when the RT-PCR products were digested with
Smal and were separated by 1% agarose gel electrophoresis, CYP11B1 gene
transcripts were digested into a 220 bp and a 92 bp fragments. In contrast, the
RT-PCR products of CYP11B3 gene transcripts were protected from Smal digestion.
To determine whether the CYP11B3 gene was expressed in various rat adrenal
specimens, RNA templates of adrenals from rats at different stages of development
were amplified using CYP11B1 primers. Adrenal RNA templates were amplified
from pregnant rats, E20 embryos, 7-day, 28-day and 4-month-old rats. In 7-day and
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28-day-old rat adrenals, both CYP11B1 and CYP11B3 gene transcripts were detected.
However, the adrenals of E20 embryos appeared to lack CYP11B3 gene transcripts
(Fig. 5.7A). Neither saline nor DEX-treated pregnant rats and their 4-month-old
offspring beared CYP11B3 gene transcripts (Fig. 5.7B and C).
To investigate if saline- or DEX-treatment throughout pregnancy would affect the
expression levels of CYP11B3 in 7- and 28-day-old rat offspring, the relative
intensities of the CYP11B3 bands, which were protected from the Smal digestion,
were quantified by AIDA software. The signals were calculated as the percentage of
the total expression levels which were amplified by the CYP11B1 primers. In
prenatally saline- and DEX-treated adrenals of the 7-day-old rats, CYP11B3
expression levels were only 10% and 7.5% of the total CYP11B1 expression levels,
respectively (Fig. 5.8A and B). There was no correlation between CYP11B1 or
CYP11B3 and total CYP11B1/CYP11B3 gene transcripts.
The abundance of the CYP11B3 gene was slightly reduced in prenatally DEX-
treated adrenals compared to the saline-treated adrenals in the 7-day-old rats (DEX,
24.2 ± 2.9 attomole/pg vs. saline, 29.2 ± 9.4 attomole/pg) (Fig. 5.9A). Taking into
consideration the co-expression of CYP11B3 and CYP11B1 gene transcripts
amplified by CYP11B1 primers, the actual expression levels of CYP11B1 gene in the
saline-treated adrenals were 251.3 ± 80.8 attomole/pg and the levels in the
DEX-treated adrenals were 303.4 ± 36.3 attomole/pg (Fig. 5.9B) whereas the total
expression levels of CYP11B1 were 280.5 ± 90.1 attomole/pg (saline) and 327.6 ±
39.2 attomole/pg (DEX), respectively (Fig. 5.6B).
The expression levels of total CYP11B1, including the expression of CYP11B1
and CYP11B3, contained 20% and 38% of CYP11B3 in prenatally saline- and
DEX-treated adrenals of the 28-day-old rat offspring, respectively (Fig. 5.11A and B).
The abundance of the CYP11B3 gene was moderately increased in prenatally
DEX-treated adrenals compared to the saline-treated adrenals in the 28-day-old rats
(DEX, 0.79 ± 0.11 fmole/pg vs. saline, 0.31 ± 0.21 fmole/pg; P>0.05) (Fig. 5.12A).
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The actual expression levels of CYP11B1 gene in the saline-treated adrenals were
0.96+ 0.06 fmole/pg and the levels in the DEX-treated adrenals were 1.29 ± 0.15
fmole/pg (P>0.05) (Fig. 5.12B) whereas the total expression levels of CYP11B1 were
1.3 ± 0.3 fmole/pg (saline) and 2.1 ± 0.2 fmole/pg (DEX) (Fig. 5.10B).
5.2.6 Effects of dexamethasone on morphological changes using serial
staining by various antibodies
To assess the morphological changes of the adrenal gland, serial sections of
adrenal glands were stained using various antibodies, which recognise specific cells
of the adrenal cortex or medulla. The CYP11B2 staining was restricted to the ZG
whereas CYP11B1 was detected in the ZF and the ZR (Fig. 5.14 and 5.15, A and E).
3p-HSD was localised over the entire cortex (Fig. 5.14 and 5.15D and El). Some
3P-HSD-positive cells were scattered in the medulla in both the saline and
DEX-treated adrenals (Fig. 5.15D and H). Medullary cells could be distinguished by
chromogranin A antibody (Fig. 5.14 and 5.15 C and F).
In the adrenal of the 7-day-old offspring, clear brown positive staining for
CYP11B2 was shown under the capsule in the adrenals from the DEX-treated group
(Fig. 5.14E) whereas low staining intensity was detected in control animals (Fig.
5.14A). On the other hand, the adrenal in the saline-treated rat showed weak staining
for the CYP11B1 (Fig. 5.14B), while the DEX-treated adrenal showed intense
staining between the edge of the ZG and the ZF with decreasing intensity towards the
inner cortex (Fig. 5.14F). Comparison of the adrenal morphology and serial staining
results in this preliminary study, showed that the most obvious difference between the
saline- and DEX-treated adrenals of the 7-day-old offspring was in the central area of
the adrenal gland. DEX-treated adrenals had a broad area of medullary cells and had
more medullary cells, which were heavily stained by chromogranin A. In contrast,
most medullary cells in the control adrenal showed weak chromagranin A staining
(Fig. 5.14 C and F).
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The positive staining for CYP11B2 was also clearly shown beneath the capsule
and restricted to the ZG (Fig. 5.15A and E) and the staining of CYP11B1 was intense
in the adrenals of the 28-day-old offspring (Fig. 5.15B and F). In addition, some
adrenal cortical cells were also stained in the medulla in contact with chromaffin cells
forming islets in the adrenals from both saline- and DEX-treated rats (Fig. 5.15B and
F).
When the cortical areas of adrenal glands were carefully examined, a group of
cells was seen apparently cortical cells, because they were positive for 3P-HSD
staining (Fig. 5.16D). However, they were negative for CYP11B2, CYP11B1 and
chromogranin A staining, respectively (Fig. 5.16A-C). Comparison of the adrenal
cortical cell morphology in the 28-day-old rats treated with DEX in utero and in the
saline-treated control rats, the adrenal sections ofprenatally saline-treated rats showed
homogenous staining for CYP11B1 in the ZF whereas the ZG was easily
distinguished by negative staining (Fig. 5.17A). On the other hand, unusual zonation
between the ZG and the ZF was observed in all adrenal sections from the prenatally
DEX-treated rats (Fig. 5.17B-F). In these adrenal sections, CYP11B2 staining was
still restricted to the ZG region, which was about 3 to 5 layers of cells. CYP11B1 was
located in most of the cortical area. However, a broad area that was negative for both
CYP11B2 and CYP11B1 was also observed in these sections (Fig. 5.17B-F).
To further investigate the morphological changes of the prenatally DEX-treated
adrenal in the 28-day-old rat offspring, more serial sections of one adrenal gland
randomly selected from each group were stained to examine the morphological
differences. Several features were observed in the earlier sections of the DEX-treated
adrenal gland in the 28-day-old rat offspring. Firstly, the medulla had an eccentric
morphology (Fig. 5.16E-H). An irregular border between the medulla and the ZR was
found unexpectedly in the adrenal from one of the DEX-treated offspring (Fig. 5.15F).
Secondly, the medullary cells invaded the cortex. Rays of chromaffin tissue traversed
the entire adrenal cortex. Thirdly, chromaffin cells were protruding into the ZG, often
in subcapsularly (Fig. 5.16G). This was further confirmed by chromogranin A
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staining (Fig. 5.15G) which identified the medullary cells. In contrast, few medullary
cells occasionally showed in the ZR of adrenal sections of the 28-day-old
saline-treated rats (Fig. 5.15C). In addition, cortical cells were also found
intermingled with medullary cells (Fig. 5.16F and H).
5.3 Discussion
A wide range of studies, including the data presented in Chapter 4, have
demonstrated that glucocorticoid treatment during pregnancy can lead to intrauterine
growth retardation in man and experimental animals (Blackburn et al., 1965; Reinisch
et al., 1978; Benediktsson et al., 1993; Levitt et al., 1996). Moreover, the impaired
growth and development have been associated with increased risks for the later
development of clinical diseases (Barker et al., 1989; Barker et al., 1990; Barker, et al.,
1993a; Barker, et al., 1993b). In the present experiments, we tested the hypothesis that
DEX exposure in utero may contribute to the postnatal growth failure and the changes
of the expression levels of steroidogenic enzymes and their gene transcripts. The body
weights and organ weights continued to be lower in prenatally DEX-treated rat
offspring than in saline-treated rat offspring at the neonatal and adult stages. This
observation is consistent with other animal studies which showed experimentally
induced intrauterine growth retardation due to malnutrition (Langley and Jackson,
1994), stress (Pellegrini et al., 1998) or prenatal DEX exposure (Levitt et al., 1996;
Welberg et al., 2001) resulting in postnatal growth failure without any signs of
catch-up growth, and especially lighter body weight compared to control animals. It
was reported recently that maternal DEX treatment regulated the HPA axis in a
sex-specific manner in adult offspring of guinea pigs (Liu et al., 2001). The authors
suggested that the increase in adrenal-to-body weight in the adult female offspring
with antenatal DEX treatment was likely to be due to the increased cortical mass
accompanied by the increased plasma Cortisol levels, which indicated an increase in
the HPA axis activity. In contrast, male adult offspring with intrauterine DEX
treatment showed no significant changes of adrenal weight, however, marked
reduction of the brain weight and the decrease ofplasma Cortisol levels were observed
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(Liu et al., 2001). In the present study, it is possible that the lower adrenal weight of
male adult offspring (4-month-old) with intrauterine DEX treatment results from the
altered feedback regulation of the HPA axis.
Another interesting observation relates to the morphological changes deeper
within the adrenal gland, especially in the adrenal medulla. Adrenals from the
7-day-old offspring with maternal DEX treatment throughout pregnancy had a broad
area ofmedullary cells. More profound effects were found in the 28-day-old rats with
the same prenatal treatment. Chromaffin tissues traversed the adrenal cortex and also
protruded into the subcapsular areas. Although considerable research has been
devoted to the effects of glucocorticoids on the enzyme activity in the adrenal medulla
(Cole et al., 1995; Finotto et al., 1999; Kennedy and Ziegler, 2000), rather less
attention has been paid to the morphological changes in the adrenal medulla. Some
studies demonstrated that chromaffin tissues were also interspersed with cortical cells
in normal rats, but less intensely than appeared in the present studies(Gallo-Payet et
al., 1987; Bornstein et al., 1991; Bomstein and Ehrhart-Bornstein, 1992; Bornstein et
al., 1994). Gallo-Payet et al. described that rays of chromaffin tissues were seen over
four or five consecutive 5-pm sections in the rat adrenal gland (Gallo-Payet et al.,
1987). However, the cord-like structure of the adrenal medulla from the 28-day-old
offspring exposed to DEX throughout gestation was observed over 30 consecutive
4-pm sections whereas no particular feature was seen in the adrenal from the control
rat. Such marked morphological changes of the adrenal medulla in neonatal and
postnatal rat offspring exposed to intrauterine DEX was somewhat unexpected.
Although there is no direct evidence to explain why the DEX exposure in utero leads
to the morphological changes of the medulla at the postnatal stages in rats, it is likely
to assume that the glucocorticoids may trigger the differentiation of sympathoadrenal
precursors to endocrine chromaffin cells (Seidl and Unsicker, 1989) or that the
phenomenon resulted from the direct effect of prolonged DEX treatment on adrenal
tissues (Klepac, 1976; Barlow et al., 1979; Huss et al., 1996). Lack of glucocorticoid
receptors (GR) in the adrenal medulla in GR-deficient mice impairs the development
of chromoaffin cells in the adrenal glands, especially the loss of the expression of the
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phenylethanolamine N-methyltransferase (PNMT) gene in chromaffin cells (Finotto
et al., 1999). Whether the regulation of the glucocorticoid receptor expression in the
medulla is altered by prolonged intrauterine DEX treatment remains to be determined.
In addition, scattered cortical cells, identified by 3P-HSD staining, were also
found in the adrenal medulla of rats exposed to maternal saline and DEX treatments.
This observation is consistent with other studies in mammals (Gallo-Payet et al., 1987;
Bornstein et al., 1991; Bornstein and Ehrhart-Bornstein, 1992; Bornstein et al., 1994).
The close arrangement of cortical and medullary cells is suggestive that functionally
relevant intra-adrenal paracrine factors interact between these two distinct endocrine
tissues.
Administration of ACTH or dexamethasone to rats can restore the activity of the
PNMT enzyme that converts noradrenaline into adrenaline in the chromaffin cell, and
the effect is diminished by hypophysectomy (Wurtman and Axelrod, 1966; Roffi,
1968). Also, catecholamines and other medullary products may also exert a regulatory
effect on aldosterone secretion (De Lean et al., 1984; Racz et al., 1984; Pratt et al.,
1985). Taken together, the morphological changes of the adrenal medulla may affect
the paracrine regulation of the cortex mediated by chromaffin cells. Moreover, an
ultrastructural study clearly demonstrated an exocytotic process from a chromaffin
cell to a neighbouring cortical cell (Bornstein and Ehrhart-Bornstein, 1992).
Another prominent effect of the prenatal DEX exposure on adrenal morphology
of the 28-day-old rats was the surface area of the adrenal cortex. A group of cells
appeared to be cortical cells and this was confirmed by 3J3-HSD staining. However,
these cells were lacking in CYP11B2 and CYP11B1 expression. The features of these
cells are similar to the stem cells that were identified by Mitani et al. (1994). These
authors reported a cell layer located between the ZG and the ZF without CYP11B2
and CYP11B1. These cells were capable ofproliferation and migration into the ZF. In
addition, the cell number of the unstained cells was rapidly decreased when the rats
were given a low sodium diet. It is likely that prenatal DEX exposure may affect the
116
proliferation of the stem cells and result in the change of the progenitor cell zone of
the adrenal cortex.
CYP11B3 has been cloned from a rat genomic library (Mukai et ah, 1993).
Expression of the CYP11B3 gene could result in the formation of CYP11B3 mRNA
encoding a protein of 498 amino acids. CYP11B3 closely resembles CYP11B1 in
nucleotide (96% identical) and amino acid (94% identical) sequences. However, it
was first reported that the CYP11B3 mRNA could not be detected in the adrenal even
by the RT-PCR (Nomura et al., 1993). Later, others found that CYP11B3 mRNA was
expressed in various rat brain tissues and in neonatal (Zhou et al., 1995) and early
postnatal (8-32 days old) rat adrenal glands (Mellon et al., 1995), but was not
expressed during fetal development or in the adult rat adrenal. In the present
experiment, the CYP11B1 primers, amplified a 312 bp fragment corresponding to
position 528-840 of CYP11B1 (Oaks and Raff, 1995), also amplified CYP11B3
transcripts. However, the RT-PCR products of CYP11B1 were digested into 92 bp and
220 bp fragments using Smal enzyme (CCCGGG site). In contrast, CYP11B3
transcripts are protected against the enzyme digestion. To examine the expression
levels of CYP11B3 in rat adrenals, different developmental stages of rats were tested.
In agreement with other studies (Mellon et al., 1995; Zhou et al, 1995), the CYP11B3
transcripts were found in 7-day- and 28-day-old rat adrenals, but not in fetal,
4-month-old and pregnant rat adrenals. The relative amount ofCYP11B3 mRNA was
higher in 28-day-old than in 7-day-old rat adrenal. Mellon et al., (1995) suggested that
CYP11B3 gene expression in the newborn rat adrenal was turned on between the 6th
and 8th day of life.
When the CYP11B3 enzyme was expressed in MA-10 or COS-7 cells, the enzyme
converted deoxycorticosterone to corticosterone and 18-hydroxydeoxycorticosterone,
but not aldosterone (Mellon et al., 1995; Zhou et al., 1995). Furthermore, the zonal
distribution of CYP11B3 was also restricted to the ZF and ZR. These results
demonstrate that the function of CYP11B3 enzyme is more similar to CYP11B1. In
addition, the regulation of CYP11B3 gene in the adrenal gland by ACTH is
sex-dependent. When rats were treated with ACTH, the accumulation of CYP11B3
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mRNA decreased only in adrenals from male rats and not from female rats (Mellon et
al., 1995). In the present experiments, no obvious effect of the prenatal DEX
treatment on the amount of the CYP11B3 transcripts was observed in the male
offspring.
It is worthy of note that there is a doublet observed in some adrenal extracts of
28-day-old rats that is recognised by CYP11B1 antibody after stripping off the
original CYP11B2 signal. Whether the extra band observed corresponds to the
CYP11B3 enzyme remains to be determined. Furthermore, the physiological function
of the CYP11B3 enzyme is still unclear and also why the rat adrenal expresses
CYP11B3 gene only for a limited time. Whether the existence of this enzyme plays a
role in steroidogenesis during development needs further investigation.
In the studies reported in Chapter 4, the protein and gene expression of the
CYP11B2 were slightly increased and CYP11B1 were decreased in adrenals of the
fetal rats prenatally treated with DEX throughout gestation. In the present
experiments, the expression of the adrenal steroidogenic enzymes was investigated at
three separate postnatal stages (7-day, 28-day and 4-month-old) in rat offspring
treated with DEX in utero. Although there were no significant changes of the protein
and gene expression of the CYP11B2 and CYP11B1 in adrenals of rat offspring, all
the differences became more obvious in the 4-month-old offspring. For instance, the
protein levels of CYP11B2 and CYP11B1 were slightly reduced in DEX-treated rats
at 7-day and 28-day-old offspring whereas CYP11B2 had nearly 2-fold and CYP1 IB 1
had 20% increases in the 4-month-old offspring. The CYP11B2 mRNA was raised by
40% in 4-month-old DEX-treated offspring compared to the age-matched control
offspring. It is also interesting that the differences of the CYP11B1 expression levels
between DEX-treated offspring and saline-treated control offspring appeared to
increase progressively from 7-day-old offspring to 4-month-old offspring although
the differences were not significant. It is also notable for the levels of CYP11B
mRNA among the three various developmental stages. Both CYP11B2 and CYP11B1
gene transcripts were lower in the 4-month-old offspring compared to 7-day- and
28-day-old offspring. However, if the existence of CYP11B3 transcripts was
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considered, the adrenal levels of CYP11B1 transcripts in 4-month-old offspring were
close to those of the 7-day- and 28-day-old offspring.
Taking all these data into account, the lack of significant changes in the protein
and gene expression of the steroidogeneic enzymes in 7-day and 28-day-old offspring
might be due to a hyporesponsive period in rats. The hyporesponsive period is
associated with decreased ACTH secretion that has been attributed to increased
sensitivity of the neonatal pituitary to glucocorticoid feedback or to increased
expression of a corticotropin release-inhibiting factor during the early postnatal stages
(Schapiro, 1962; Sapolsky and Meany, 1986; Walker et al., 1986). In addition, it was
demonstrated that the levels of angiotensin II receptors in the adrenal ZG were
decreased from very high levels at birth to adult levels during the early postnatal
period (Jones et al., 1989). Also, the sensitivity of aldosterone responses to
angiotensin II was reduced in 7-day-old rats (Feuillan and Aguilera, 1996). These
previous studies may indicate that the higher levels of the CYP11B2 and CYP11B1
mRNA are necessary to compensate for different feedback regulation of the RAS and
HPA axis in 7-day- and 28-day-old offspring compared to the adult offspring. The
existence of CYP11B3 gene transcripts at the specific period may also have some
physiological significance. Another explanation of the negligible changes in
steroidogenic enzyme expression is possibly because no further treatment was given
to offspring after delivery. When female adult offspring prenatally treated with DEX
were given chronic and acute All injection, blood pressure and plasma aldosterone
levels were elevated in the DEX-treated group compared to the control group
(communicated by Dr. C.J. Kenyon). Therefore, the changes of steroidogenic enzyme
expression and the programming effect on hypertension in later adult life may be
manifested by All, ACTH or other stress stimulations.
It has been shown that both maternal malnutrition (Ozanne et al., 1996) and DEX
treatment (Benediktsson et al., 1993; Lindsay et al., 1996) result in impaired glucose
intolerance, insulin resistance and hypertension in adult offspring in rats. Recently,
Bertram et al. (2001) demonstrated that protein restriction during pregnancy
programmed a tissue-specific increase in glucocorticoid receptors in the adrenal gland
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and kidney whereas the expression of the 11P-HSD-2 enzyme was decreased in these
two organs during adult life. Treatment of pregnant rats with DEX programmed
decreased expression of GR in the hippocampal nuclei that mediate the central control
of the HPA axis activity (Levitt et al., 1996). On the other hand, Whorwood et al.
(2001) also reported that angiotensin II type I receptor (ATI), expression, but not AT2,
was elevated in adrenal glands and kidneys of neonatal sheep exposed to maternal
malnutrition during early to mid-gestation. These studies suggest that treatment of
pregnant rats with DEX possibly programmes hyperactivity of the HPA axis through
the increased GR expression in key peripheral glucocorticoid target tissues and
diminished GR expression in the brain. In addition, 11 P-HSD-2 enzyme expression in
the adrenal and kidney is a key factor to protect the mineralocorticoid receptor from
access by glucocorticoid. Furthermore, attenuation of the ATI receptors and the RAS
system in the adrenal and kidney by DEX may be a potential mechanism involved in
the programming effects. Although in this study, there were no significant changes of
the adrenal steroidogeneic enzyme expression, the morphological changes of the
adrenal medulla may indicate another possible mechanism underlying the
programming of adult disease by maternal glucocorticoid treatment.
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Fig. 5.1 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) staining in the
adrenal glands of prenatally saline- (S7) or dexamethasone- (D7) treated 7-day-old rat
offspring. Values are mean±S.E. n represents the number of the animals tested. ZG and
ZF denote zona glomerulosa, zona fasciculata. Data were analysed by the Student's t-
test. * denotes statistical differences (P<0.05).
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Immunostaining results for CYP11B2 in the adrenal ZG
of28-day-old offspring
Immunostaining results for CYP11B1 in the adrenal ZF
of 28-day-old offspring
Fig. 5.2 Immunostaining results for CYP11B2 (A) and CYP11B1 (B) staining in the
adrenal glands ofprenatally saline- (S28) or dexamethasone- (D28) treated 28-day-old
rat offspring. Values are mean±S.E. n represents the number of animals tested. ZG and




























Fig. 5.3 Western blotting results for CYP11B2 (A and B) and CYP11B1 (C and D) in
the adrenal glands of prenatally saline- (S7) or dexamethasone- (D7) treated 7-day-old
rat offspring. A and C: 10% SDS-PAGE gel results, B and D: Relative intensity of the
proteins quantified from the gels. Values are mean±S.E. n represents the number of the













Fig. 5.4 Western blotting results of CYP11B2 (A and B) and CYP11B1 (C and D) in
the adrenal glands of prenatally saline- (28) or dexamethasone- (D28) treated 28-day-
old rat offspring. A and C, 10% SDS-PAGE gel results. B and D, Relative intensity of
the proteins quantified from the gels. Values are mean±S.E. n represents the number of




Fig. 5.5 Western blotting results of CYP11B2 (A and B) and CYP11B1 (C and D) in
the adrenal glands of prenatal saline (SM4-X) or dexamethasone (DM4-X) treated 4-
month-old rats. A and C, 10% SDS-PAGE gel results. B and D, Relative intensity of
the proteins quantified from the gels. Values are mean+S.E. n represents the number of














































Fig. 5.6 Gene expression of the CYP11B2 (A) and CYP1 IB 1 (total) (B) using cRT-
PCR in the adrenal glands of 7-day-old rats prenatally treated with saline (S7) or
dexamethasone (D7) throughout the gestation, n represents the number of animals
tested. Data are expressed as mean±S.E. in the saline-treated groups and the data in









Fig. 5.7 The detection of the gene expression of the CYP11B3 in various
developmental stages of adrenal glands of rats prenatally treated with saline- (S) or
dexamethasone- (D) throughout the gestation. A; Adrenal RNA (lOng) amplified by
CYP11B1 specific primers and digested by restriction enzyme {Sma I) from 28 (S28),
7 (S7)-day-old rats and 20-day (E20) embryos. B; Adrenal RNA from with saline or
dexamethasone treated pregnant (SP-X vs DP-X) rats. C; Adrenal RNA from 4-month-
old rats prenatal treated with saline (S4M-X) or dexamethasone (D4M-X) throughout
the gestation. Sma I digests 312 bp product of CYP11B1 gene into 220 bp and 92 bp
fragments. RT-PCR products of CYP11B3 gene are resistant to Sma I digestion. X
represents an individual animal tested.
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Fig. 5.8 The relative percentage of the gene expression of CYP11B3 and CYP11B1
(total) in the adrenal glands of 7-day-old rats prenatally treated with saline- (S7) or
dexamethasone- (D7) throughout the gestation. A; Adrenal RNA (lOng) amplified by
CYP11B1 specific primers and digested by restriction enzyme (Sma I). Sma I digests
312 bp product of CYP11B1 gene into 232 bp and 80 bp fragments. RT-PCR products
of CYP11B3 gene are resistant to Sma I digestion. B; The relative percentage of
CYP11B3 and CYP11B1 (total) gene expression. Values are meantS.E. n represents














mRNA levels of CYP11B3 in the adrenal glands



















mRNA levels ofCYP11B1 (total-B3) in the










Fig. 5.9 Gene expression of the CYP11B3 (A) and CYP11B1 (total-B3) (B) in the
adrenal glands of 7-day-old rat offspring prenatally treated with saline-(S7) or
dexamethasone-(D7) throughout the gestation, n represents the number of animals
tested. Data are expressed as mean±S.E. in the saline-treated groups and the data in






































Fig. 5.10 Gene expression of CYP11B2 (A), and CYP11B1/B3 (B) using cRT-PCR in
the adrenal glands of 28-day-old rats prenatally treated with saline- (S28) or
dexamethasone- (D28) throughout the gestation. Values are mean ±S.E. n represents
the number ofanimals tested. Data were analysed by Student's t-test.
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Fig. 5.11 The relative percentage of the gene expression of CYP11B3 and CYP11B1
(total) in the adrenal glands of 28-day-old rats prenatally treated with saline- (S28) or
dexamethasone- (D28) throughout the gestation. A; Adrenal RNA (lOng) amplified by
CYP11B1 specific primers and digested by restriction enzyme (Sma I). Sma I digests
312 bp product of CYP11B1 gene into 232 bp and 80 bp fragments. RT-PCR products
of CYP11B3 gene are resistant to Sma I digestion. B; The relative percentage of
CYP11B3 and CYP11B1 (total) gene expression. Values are meaniS.E. n represents
the number of animals tested.
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Fig. 5.12 Gene expression of the CYP11B3 (A) and CYP11B1 (total-B3) (B) in the
adrenal glands of 28-day-old rats prenatally treated with saline (S28) or
dexamethasone (D28) throughout the gestation. Values are mean±S.E. n represents the
number ofanimals tested. Data were analysed by the Student's t-test.
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Fig. 5.13 Gene expression of the CYP11B2 (A) and CYP11B1 (B) using cRT-PCR in
the adrenal glands of 4-month-old rat offspring prenatally treated with saline (SM4) or
dexamethasone (DM4) throughout the gestation. Values are mean±S.E. n represents
the number ofanimals tested. Data were analysed by the Student's t-test.
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Fig. 5.14 Serial staining with various antibodies in the adrenal glands of prenatally
saline- (A-D) or dexamethasone- (E-H) treated 7-day-old rats. A and E: CYP11B2,
arrows showed positive staining for CYP11B2, B and F: CYP11B1, C and G:
Chromogranin A, arrows showed two different staining intensities for chromaffin cells,
D and H: 3 P-Hydroxysteroid dehydrogenase, arrows showed cortical cells in medulla.
ZG, ZF and M denote zona glomerulosa, zona fasciculata and medulla, respectively.
Magnification: 50X.
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Fig. 5.15 Serial staining of various antibodies in the adrenal glands of prenatally
saline- (A-D) or dexamethasone- (E-H) treated 28-day-old rat offspring. A and E;
CYP11B2, arrows showed positive staining for CYP11B2, B and F; CYP11B1, arrows
showed cortical cells in medulla, C and G; Chromogranin A, arrows showed two
different staining intensities for chromaffin cells, arrowhead showed chromaffin cells
in cortex, D and H; 3p-Hydroxysteroid dehydrogenase, arrows showed cortical cells in
medulla. ZG, ZF and M denote zona glomerulosa, zona fasciculata and medulla,
respectively. Magnification: 50X.
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Fig. 5.16 Serial staining of various antibodies in the adrenal glands of prenatally
dexamethasone-treated 28-day-old rat offspring. A and E; CYP11B2, B and F;
CYP11B1, C and G; Chromogranin A, D and H; 3p-Hydroxysteroid dehydrogenase.
ZG, ZF and M denote zona glomerulosa, zona fasciculata and medulla, respectively.
Arrows showed the blood vessels, stars showed cortical cells without CYP11B2 and
CYP11B1 staining, arrowheads showed the chromaffin cells protruded into the ZG.
Magnification: 50X.
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Fig. 5.17 Immunostaining for CYP11B1 in the adrenal glands of prenatally saline-
(A) or dexamethasone- (B-F) treated 28-day-old rat offspring. Stars showed
cortical cells without CYP11B2 and CYP11B1 staining. ZG and ZF denote zona
glomerulosa and zona fasciculata, respectively. Magnification: 50X.
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Chapter 6 Characterisation of a Steroidogenic Acute
Regulatory (StAR) protein antibody in the rat
adrenal glands
6.1 Introduction
The conversion of cholesterol to pregnenolone is the initial step of all the steroid
biosynthesis. This reaction is catalysed by the cytochrome P450 cholesterol
side-chain cleavage enzyme complex (CYP11A), which is localised on the inner
mitochondrial membrane. It was hypothesised for many years that a labile, rapidly
synthesised protein was necessary for the transport of cholesterol through the aqueous
intermembrane space in response to acute hormonal stimulation (Jefcoate et al., 1986).
Steroidogenic acute regulatory (StAR) protein (Clark et al., 1994) was first purified,
cloned and sequenced from mouse MA-10 Leydig tumor cells and then expressed in
COS-1 cells to verify functionality. The expression of StAR in these cells resulted in
significant increases in steroid hormone synthesis in the absence of trophic hormone
stimulation. In addition, the protein was synthesised in a timely- and dose-responsive
manner to hormone stimulation, its synthesis was sensitive to cycloheximide
treatment and the protein was found to be localised in the mitochondria. Cherradi et al.
(1997) also demonstrated that StAR protein was localised to a greater extent in the
intermembrane spaces than in the outer membrane or mitochondria matrix. These
features suggested that StAR might be a key protein, which could potentially be
responsible for cholesterol transport. It was further confirmed clinically that StAR
protein mutation in humans was the cause of congenital lipoid adrenal hyperplasia, an
autosomal recessive condition with severe deficiencies in steroid hormones (Lin et al.,
1995).
Extensive in vitro and in vivo studies on the regulation of StAR protein have been
conducted. Changes in StAR protein and mRNA have been linked to physiological
changes in steroid secretion. In sheep, hypophysectomy resulted in decreased StAR
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mRNA levels in the corpus luteum and serum progesterone levels (Juengel et al.,
1995). Under acute stimulation by ACTH, StAR mRNA increased followed, after a
3-5 hour delay, by an increase in the level of StAR. protein in the rat. On the other
hand, when rat adrenals were hypertrophied by chronic ACTH stimulation, the
expression of StAR protein was increased in the ZG and ZFR (Lehoux et al., 1998).
Sodium restriction also affected StAR protein expression in the ZG, but not in the
ZFR. This may imply that StAR protein is involved in the action of sodium restriction
in promoting aldosterone secretion (Lehoux et al., 1999; Peters et al., 1998). Cherradi
et al. (1997) also demonstrated that physiological increases in cytosolic calcium,
produced either with a Ca2+ inonophore or with All were effective in stimulating
specific StAR protein accumulation, especially in the inner mitochondrial membrane.
On the basis of these previous studies, it was of interest to investigate whether
factors regulating mineralocorticoid and glucocorticoid synthesis in adults, might
have influences on adrenal StAR protein expression during development. Though
time constraints did not allow analysis of changes in StAR protein expression with
changes in mineralocorticoid and glucocorticoid levels in the experiments described
in previous chapters, this chapter describes the characterisation of a novel StAR
protein antibody for the specific analysis of StAR protein by immunohistochemistry
and immunoblotting, which could potentially be employed in future physiological
studies in the rat.
6.2 Results
6.2.1 Localisation by immunohistochemistry
6.2.1.1 StAR protein immunohistochemistry in rat adrenal gland
To loosen or break the crosslinkages caused by formalin fixation, various antigen
retrieval techniques are often used for immunohistochemistry. In the rat adrenal gland,
microwave-based antigen retrieval was essential for StAR protein antibody
immunohistochemical optimisation. The optimal concentration of StAR protein
primary antibody was found to be 1:100 in PBS buffer when various dilution ranges
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were tried from 1:50 to 1:1000. The HRP-conjugated secondary antibody
concentration was found to be optimal at 1:200. When the primary antibody was
omitted from the immunostaining protocol, no staining was observed (Fig. 6.1A). The
brown positive staining for StAR protein was noted in the three zones of the adrenal
cortex and was differentially distributed. The most intense staining was found in the
ZG and the ZF (Fig. 6.IB). The ZR only presented a weak staining. Unexpectedly
there was even more intense in the central area of the rat adrenal (Fig. 6.1C and D).
6.2.1.2 Rat adrenal serial sections staining by various antibodies
To identify the cell types of the central area of the adrenal gland which showed
StAR protein positive staining (Fig. 6.2A), serial sections of adrenal glands were
stained with antibodies, which recognise specific cells of the adrenal cortex or
medulla.
3(3-HSD was localised in all three zones of the adrenal cortex (Fig.6.2B). The
most intense staining area was between the ZG and the ZF in rat adrenal tissues. Most
of the area of the medulla showed no staining, except where some cortical cells were
clustered within the medulla (Fig.6.2B).
A chromogranin A antibody was used as a marker for medullary cells. The
staining for chromogranin A appeared mainly in the adrenal medulla. Some
chromaffin cells presented directly under the adrenal capsule or in the cortex
(Fig.6.2C), where there was no staining for 3P-HSD in the consecutive sections
(Fig.6.2B).
To compare the staining pattern of the peptide StAR protein antibody with another
StAR protein antibody that was raised against the full length recombinant mouse
StAR protein (mouse StAR protein antibody, generously provided by Dr. Buck Hales),
the consecutive sections, incubated with the mouse StAR protein antibody, showed
positive staining only in the adrenal cortex, especially in ZG and the outer ZF
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(Fig.6.2D).
6.2.1.3 Comparisons of two separate StAR protein antibodies in mouse
adrenal sections
The staining patterns of the two StAR protein antibodies in mouse adrenal
sections are shown in Fig.6.3. Both of the negative control sections showed the
absence of positive staining for peptide StAR protein and mouse StAR protein
antibodies (Fig. 6.3 A and D). Immunostaining for both the antibodies was found
intensely and homogeneously in all cortical zones (Fig. 6.3 B and E). However, the
peptide StAR protein antibody also showed positive staining in the adrenal medulla
(Fig 6.3 B and C) whereas the mouse StAR protein antibody did not exhibit any
immunoreactivity in the medulla (Fig 6.3 E and F). In addition, both the antibodies
showed weak staining for the StAR protein in the area between the cortex and the
medulla (Fig 6.3 C and F).
6.2.1.4 StAR protein immunohistochemistry in the rat testis
The negative control section showed the absence of StAR protein staining (Fig.
6.4A) in the rat testis. StAR protein localised in most of the seminiferous tubules (Fig.
6.4B) and interstitial connective tissues (Fig. 6.4C) of the rat testis. Some Leydig cells
displayed the positive staining (Fig. 6.4D). However, spermatocytes, Sertoli cells and
spermatids also showed intense staining.
6.2.2 Immunoblotting
Subcellular samples of the adrenal cortex and total medulla homogenate were
analysed by immunoblotting in the rat (Fig. 6.5 A and B). Immunoblotting
experiments showed intense bands for StAR protein (30 kDa) in the mitochondria of
rat ZG and ZF/R. A weak 30 kDa band was also detected in the microsomes in the rat
ZF/R. No StAR protein was found in the rat medulla (Fig. 6.5A). A 42 kDa protein,
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corresponding to 3J3-HSD, was detected in both the mitochondrial and microsomal
subcellular fractions of the ZG and the ZF/R. (Fig. 6.5B).
Immunoblot analyses of total protein homogenate from various rat tissues
indicated that StAR protein was present only in the adrenal and ovary. There was no
specific signal detected in brain, heart, liver, kidney and testis (Fig. 6.5C).
6.2.3 Expression of StAR mRNA transcripts
RT-PCR with specific StAR primers amplified a 494 bp fragment of the StAR
mRNA (Fig 6.6). To define the profiles of StAR mRNA expression in rats during
development, adrenal total RNA was extracted from pregnant rats and at various
stages of development in offspring of rats treated with saline throughout gestation.
StAR transcripts were expressed in all adrenal samples (Fig 6.6) although at different
levels. Adrenals from 28-day-old rats had the highest expression levels of StAR
mRNA among all the samples. The abundance of StAR mRNA in adrenals of 20 day
embryos was similar to that observed in 7-day-old rat adrenals. In contrast, relatively
lower levels of the StAR mRNA were observed in the 4-month-old and pregnant rat
adrenals.
6.3 Discussion
The localisation of StAR protein has been confined to the adrenal cortex,
testicular and ovarian tissues of adult mice (Clark et ah, 1995), and humans (Pollack
et ah, 1997). The distribution of StAR protein and mRNA in the rat adrenal gland has
also been established (Peters et ah, 1998; Lehoux et ah, 1999). In these studies, the
StAR gene and protein were expressed in the three zones of the adrenal cortex with
high intensity in the ZF. A few cells also appeared positive for StAR protein in the
adrenal medulla (Lehoux et ah, 1999). Peters et al. (1998) detected single cells with
StAR protein gene expression in the adrenal medulla, whereas CYP11B2 mRNA was
always negative in this area using in situ hybridization techniques. In the present
study, the staining for StAR protein was shown, in agreement with others, mainly in
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the adrenal ZG and ZF with less intensity in the ZR. However, the adrenal medulla
also exhibited intense immunoreactivity for the peptide StAR antibody. Moreover,
these immunopositive areas were further confirmed to be medullary cells rather than
cortical cells, except for a few clusters of cortical cells contained within the medulla.
The mouse adrenal cortex has a region called the X-zone that resides between the
ZF/R and the medulla. The expression of the X-zone in mice varies with strains,
genetic condition, age and reproductive status (Deacon et al, 1986; Parker and
Schimmer, 2001). To compare the staining patterns in rat adrenal tissues, mouse
adrenal sections were stained by both peptide StAR protein antisera and mouse StAR
protein antisera in the present studies. Similar results were also shown in mouse
adrenal sections, whereas localisation using mouse StAR protein antibody was
demonstrated mainly in the mouse adrenal cortex. Whether the X-zone is responsible
for the steroid synthesis and expressing StAR protein needs further investigation.
Adrenocortical cells have been found in the medulla in contact with chromaffin
cells forming islets or retaining some contact with the rest of the cortex (Bomstein et
al., 1991; Berka et al., 1996). Because of the close arrangement of cortical and
medullary cells, it has been considered that functionally relevant intra-adrenal
paracrine interactions between these two different endocrine tissues occur
(Gallo-Payet et al., 1987; Bomstein et al., 1991; Bomstein and Ehrhart-Bornstein,
1992; Bomstein et al., 1994).
The specificity of the peptide StAR protein antibody was examined by
immunoblotting. Consistent with other studies, a 30 kDa band, corresponding to StAR
protein, was detected mainly in the mitochondria of the rat ZG, ZF and the total
protein homogenate of the adrenal and ovaiy. Immunoreactive protein was not found
in the rat medulla by immunoblotting, but this may relate to the limited amount of
pure rat medullary tissue available. However, one should also consider that
immunohistochemical findings do not always correlate with immunoblotting results
for some antibodies. This may be due to the fact that the antigenic determinants
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presented to the antibodies are different when comparing fixed tissue sections with
tissue homogenates in which the proteins have become denatured. A similar
conclusion may be relevant to the results seen in the rat testis which showed no
indication of the existence of StAR protein by immunoblotting. Clark et al. (1995)
suggested that the restricted StAR protein in the Leydig cells that compose only 5-8%
of the testicular cell content resulted in a low detection level by immunoblotting
(Clark et al., 1995). However, the immunostaining results indicated that not only the
Leydig cells, but also spermatocytes and Sertoli cells showed StAR protein positive
staining in rat testis. Pollack et al. (1997) reported the presence of StAR protein in
human Sertoli cells, renal tubules and fetal oocytes, which do not express CYP11A
and are not able to convert cholesterol into pregnenolone. Gregory et al. (1998) also
detected StAR protein in mitochondria of cultured rat Sertoli cells incubated with
follicle-stimulating hormone. These authors suggested that StAR protein might have
roles in metabolic process in addition to facilitating pregnenolone synthesis (Pollack
et al., 1997; Gregory et al., 1998). At this preliminary stage one can not rule out the
possibilities that the studies reported by other groups and by myself in this chapter are
detecting a protein which is not StAR protein, but a closely related protein with
common antigenic determinants.
It has been demonstrated that StAR protein is differentially regulated at different
developmental stages in the rat adrenal. StAR transcripts were also expressed in the
adrenal primordium at days 11 of the embryo (Ell) and in the adrenal cortex in the
adult. During the gonadogenesis, StAR protein expression was restricted to testicular
Leydig cells from E12.5 throughout the embryogenesis and in the adult testis
(Hasegawa et al., 2000). On the other hand, the expression of StAR transcripts was
detected in the corpus luteum of adult ovary (Clark et al., 1995). Recently, Furukawa
et al. (1998) found that StAR transcripts were constitutively expressed in the adult rat
brain using more sensitive molecular biological methods. In StAR protein knockout
mice, the adrenal gland was affected most severely at birth and exhibited progressive
increases in lipid deposits with aging, especially marked changes in the ZG and the
ZF (Hasegawa et al., 2000).
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In this preliminary study, the expression ofStAR mRNA was relatively high in the
adrenals of the 20 days of embryos and in early postnatal rats (7-day- and 28-day-old
rats) compared to the expression levels in the adult and pregnant rat adrenals. It is
known that basal plasma corticosterone levels are very low during postnatal
stress-hyporesponsive period in rats (Schapiro, 1962). In contrast, maternal and fetal
corticosterone levels are high during late pregnancy in rats (Dupouy et ah, 1975). It is
not clear why the expression of StAR mRNA was not correlated to the changes in
plasma corticosterone levels during these developmental stages. Accordingly, StAR
protein may have some other as yet unidentified functions in adrenal gland, especially
in the adrenal medulla. Alternatively, there may have other protein in the adrenal
medulla, which exhibits similar epitope to the structure or function to StAR protein.
Notably, however, no immunoreactive species other than the 30 kDa one, was
demonstrated either in total rat adrenal or testis homogenates. Clearly, future studies
are required to increase our knowledge in this area in order to determine the
significance of the findings already reported in the literature by other workers and the
current findings described in this chapter.
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Fig. 6.1 Immunohistochemical localisation of StAR protein in the rat adrenal gland. A,
negative control section shows the absence of StAR protein positive staining (48x
magnification). B, localisation of StAR protein shows brown positive staining in the
adrenal cortex and medulla (48x magnification). C, high power image of the ZG and
ZF (120x magnification). D, high power image of the ZR and medulla (300x
magnification). ZG, ZF, ZR and M denote the zona glomerulosa, zona fasciculata,
zona reticularis and medulla, respectively.
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Fig. 6.2 Consecutive sections of the rat adrenal gland were incubated with
different antibodies. A, section incubated with the StAR peptide antibody shows
positive staining in the adrenal cortex and medulla (48x magnification). B,
localisation of 3P-HSD shows positive staining in adrenal cortex (Arrowheads
show cortical cells within the medulla. Arrows show chromaffin cells under the
adrenal capsule and in the cortex.) (30x magnification). C, localisation of
chromogranin A shows positive staining in adrenal medulla. Some medullary
cells present in cortex and under adrenal capsule (arrows). (30x magnification).
D, section incubated with the mouse StAR protein antibody shows positive
staining in adrenal cortex only (3Ox magnification).
Medulla
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Fig. 6.3 Immunohistochemical localisation of StAR protein in the mouse adrenal gland.
A-C, sections were incubated with or without peptide StAR protein antisera. D-F,
sections were incubated with or without mouse StAR antisera. A and D, negative
control sections show the absence of StAR protein positive staining (50x
magnification). B and E, localisation of StAR protein shows positive staining in the
adrenal cortex and the medulla (50x magnification). C and F, high power images of the
ZG, ZF, ZR and medulla (lOOx magnification). ZG and ZF denote the zona
glomerulosa and zona fasciculata, respectively.
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Fig 6.4 Immunohistochemical localisation of StAR peptide antibody in the rat testis. A,
negative control section shows the absence of StAR protein positive staining (30x
magnification). B, localisation of StAR protein shows positive staining in seminiferous
tubules (ST) (30x magnification). C and D, high power images of the seminiferous
tubules and inetstitial connective tissues of the rat testis (300x magnification). Positive
staining is showing in spermatocytes (ST), Sertoli cells (Ser), and Leydig cells (L).
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Fig 6.5 Immunoblotting of peptide StAR protein (A and C) and 30-HSD (B)
antibodies. A, detection of StAR protein in mitochondria (MT) and microsomes (MS)
from the ZG, ZF/R and medulla of rat adrenal glands. B, detection of 3P-HSD in
mitochondria and microsomes from the ZG and ZF/R of rat adrenal glands. C,
immunoblotting of peptide StAR protein. Total protein homogenates were extracted








































































Fig. 6.6 StAR cDNA optimisation with various amounts of plasmids and mRNA
expression of StAR using RT-PCR in rat adrenal glands obtained from pregnant
rats and at various developmental stages in rat offspring treated with saline
throughout pregnancy (see Chapter 4 and 5). Analyses were performed on 10 ng
of total RNA templates.
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Chapter 7 General discussion
7.1 Summary of results
Functional zonation of the rat adrenal cortex may be defined by the expression
of the mitochondrial enzymes CYP11B2 and CYP11B1 that regulate the secretion of
the steroids aldosterone in the ZG and corticosterone in the ZF, respectively.
Maternal manipulation of (i) the RAS system by changing dietary sodium, and (ii)
the HPA axis by chronic administration of dexamethasone may affect the distribution
and expression of CYP11B2 and CYP11B1 in the adrenal cortex of fetuses and
offspring. On the other hand, synthesis of these steroids is also dependent on StAR
protein that facilitates the transport of cholesterol into the mitochondria. In order to
provide a tool for the study of StAR protein expression in rat adrenal paradigms, an
antibody against a bovine StAR peptide sequence was characterised. The results of
this thesis are summarised below:
1. Low-salt-diet caused significant increases of ZG width in non-pregnant and
pregnant rats whereas high-salt-diet markedly reduced ZG width in both
non-pregnant and pregnant rats compared with tissues of rats fed a normal-salt-diet.
Cell hypertrophy was seen in the ZG of the adrenals from both the non-pregnant and
pregnant low-salt-treated rats. Adult and fetal adrenal CYP11B2 and CYP11B1
expression results are summarised in Table 7.1. These results suggest that dietary
sodium restriction may activate the RAS to induce the expression of CYP11B2 in
fetal adrenals but that responses of protein and mRNA are muted compared with
changes in maternal adrenal expression.
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Table 7.1 Summary of salt diet experiments
Methods [Aldo] CYP11B2 [B] CYP11B1
High- Low- High- Low- High- Low- High- Low-
salt salt salt salt salt salt salt salt
NP IHC ttt t NS NS
IHC ttt t NS NS
Preg WB t tttt NS NS
cRT-PCR tttt tttt NS NS
IHC t tttt NS NS
E20 WB NS NS NS NS




IHC: Immunohistochemistry; WB: Western blotting; cRT-PCR: competitive
RT-PCR; RIA: radioimmunoassay; [Aldo]: plasma aldosterone; [B]: Plasma
corticosterone; NP: Non-pregnant rats; Preg: Pregnant rats. E20: 20-day rat embryos,
t or t: P<0.5 ; tt or tt: P<0.1; ttt or ttt: P<0.05; tttt or iiii: P<0.01
compared to control salt diet group by Tukey's test.




2. Chronic daily injections of DEX throughout gestation significantly reduced the
protein and mRNA expression of the CYP11B1 and caused modest increases in
CYP11B2 mRNA and protein in adrenals of DEX-treated pregnant rats. Intrauterine
DEX-treated rats exhibited fetal growth retardation with differential effects on heart,
kidney and adrenal weights. Some of these effects persisted after birth when
DEX-treatment had been stopped. Postnatal body weights continued to be lower at
age 7-day, 28-day and 4-month-old whereas heart weight was proportionately greater
after DEX-treatment in utero, particularly at days 7 and 28. Protein and mRNA levels
of CYP11B2, CYP11B1 and CYP11B3 in the adrenals of offspring are summarised
in Table 7.2. These results suggest that DEX readily crosses the placenta and
down-regulates fetal HPA axis activity. Furthermore, maternal DEX-treatment may
programme the physiological state of the adult offspring via changes in the activity
of the HPA axis or possibly the RAS system.
3. Immunohistochemical studies in adult rat adrenal glands, using a peptide StAR
antibody, showed the distribution of StAR protein in the ZG and ZF with less intense
staining in the ZR. In addition, intense immunoreactivity was seen in the adrenal
medulla. The specificity of the peptide StAR antibody was examined by
immunoblotting. A 30 kDa band, corresponding to StAR, was detected mainly in the
total protein homogenate of the adrenal and ovary and the mitochondria of the ZG
and ZF. These results suggest that StAR protein may have some other as yet
unidentified functions in the adrenal gland, especially in the medulla. Alternatively,
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Table 7. 2 Summary of dexamethasone experiments
Methods CYP11B2 CYP11B1 CYP11B3
IHC NS tttt 7
Preg WB ttt ttt 7
cRT-PCR t ttt ND
IHC t tt 7
E20 WB NS NS 7
cRT-PCR t tttt ND
IHC ttt NS 7
7-Day WB t t 7
cRT-PCR t NS NS
IHC t NS 7
28-Day WB NS NS 7
cRT-PCR NS tt tt
IHC - - 7
4-Month WB tt t 7
cRT-PCR NS t ND
IHC: Immunohistochemistry; WB: Western blotting; cRT-PCR: competitive
RT-PCR; Preg: Pregnant rats. E20: 20-day rat embryos. 7-Day: 7-day-old rat
offspring; 28-Day: 28-day-old rat offspring; 4-Month: 4-Month-old rat offspring,
t or 4: P<0.5; tf or 44: P<0.1; ttt or ttt: P<0.05; tttt or 44U: P<0.01
compared to control group by the Student's t test.





the adrenal medulla may contain a protein closely related to StAR, sharing common
antigenicity.
7.2 Possible mechanisms of fetal adrenal CYP11B enzyme regulations
by maternal mineralocorticoid or glucocorticoid manipulations
It has been widely reported that maternal environments may programme fetal
and postnatal physiological and metabolic processes when a stimulus or insult is
encountered during a critical period of development. These stimuli include maternal
dietary interventions, stress or exposure of the fetus to glucocorticoid hormones. Rats
exposed to a low sodium diet in utero and on into adult life show growth retardation
and higher blood pressure than rats fed a control diet (unpublished data). The
preliminary data suggest that the intrauterine programming effect caused by the
sodium-restricted diet during pregnancy is similar to other studies in rats exposed to
glucocorticoids and low protein diets in utero. A number of studies have
demonstrated that the intrauterine programming has led to disproportionate growth
retardation of peripheral organs, high blood pressure or other metabolic diseases in
adult life (Benediktsson et al., 1993; Lindsay et al., 1996; Langley-Evans, 1997;
Langley-Evans et al., 1998; Seckl et al., 1998; Langley-Evans et al., 1999)(Fig. 7.1).
The mechanisms responsible for the programming effect remain incompletely
defined. One of the mechanisms may be related to the regulation of the HPA axis
through the MR or GR receptors in the brain, which is a major target for
glucocorticoids and has a role in the control of adrenal corticosterone secretion
through the HPA axis. However, it has been established that maternal
mineralocorticoids and glucocorticoids can cross the placenta and reach the fetal
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adrenal thereby affecting the fetal steroidogenesis. In addition, at the period around
birth the fetal adrenal is exceptionally active both in terms of cell proliferation and
differentiation (Josimovich et al., 1954; Roos, 1967). Therefore, it is reasonable to
hypothesis that the adrenal gland plays a crucial role in the intrauterine programming,
especially in relation to the enzymes responsible for the biosynthesis of
mineralocorticoids and glucocorticoids which are involved in blood pressure
regulation. In this thesis, it has been clearly demonstrated that the supply of a low
sodium diet and DEX treatment throughout pregnancy cause a significant increase of
CYP11B2 and a decrease of CYP11B1, respectively in pregnant rats. In both animal
models, the attenuation of the expression of CYP11B2 and CYP11B1 in fetal (E20)
adrenals is similar to those in maternal adrenals though the effects are less obvious in
fetal adrenals than in the maternal ones. Furthermore, in the DEX-treatment
experiments, adrenal CYP11B2 shows a slightly increased response to intrauterine
DEX-treatment compared to that of CYP11B1 in the offspring. It is known that
glucocorticoid excess in the fetus suppresses the development of fetal adrenal
function because of the feedback inhibition of ACTH secretion by maternal
glucocorticoid. However, experiments in rats and sheep have shown that fetal
expression of genes for renin, angiotensinogen and All receptors are all regulated by
glucocorticoid treatment (Reul et al., 1989; Everett et al., 1991; Sato et al., 1994;
Segar et al., 1995; Whorwood et al., 2001). Therefore, it is likely that programming
of blood pressure or cardiovascular disease by maternal mineralocorticoid and
glucocorticoid manipulations might be mediated by sensitisation of the RAS system.
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Fig. 7. 1 Possible roles and mechanisms of adrenal steroidogenic enzymes in
prenatal programming of cardiovascular disease. Broad lines indicate the main
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On the other hand, lifelong exposure of rats to low sodium diet causes a higher
blood pressure in adult life that is associated with the increased vascular
responsiveness to noradrenaline and vasopressin (unpublished data communicated by
Dr. C.J. Kenyon). Glucocorticoids affect the maturation of fetal organs, including the
growth and innervation of the fetal heart. Infused glucocorticoids raise blood
pressure and increase reactivity to noradrenaline in fetal sheep (reviewed by Clark,
1998). The administration ofDEX also results in transient ventricular hypertrophy in
premature neonates. In this thesis, the morphological changes of the adrenal medulla
were also noticed. Whether the prenatal changes would persist into later life is still
unknown. However, these changes in the medulla may indicate another possible
mechanism underlying the programming of adult disease by maternal
mineralocorticoid and glucocorticoid treatments.
7.3 Possible roles of CYP11B3 in the adrenal development
The physiological function of the CYP11B3 enzyme and why the rat adrenal
expresses CYP11B3 gene only for a limited time interval presently are unclear. In
this thesis, the expression levels of CYP11B3 mRNA were measurable in newborn
rat adrenals, but not in fetal, adult and pregnant rat adrenals, which were in
agreement with other studies (Mellon et al., 1995; Zhou et al, 1995). It has also been
demonstrated that the function of CYP11B3 enzyme is more similar to CYP11B1
(Mellon et al., 1995; Zhou et ah, 1995). Also, Mellon et ah (1995) reported that the
CYP11B3 gene was negatively regulated by ACTH in the male adrenal gland
(Mellon et ah, 1995). It is known that basal and stress-stimulated plasma
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corticosterone levels are very low during the hyporesponsive period. This is
associated with a decreased ACTH secretion (Schapiro, 1962; Sapolsky and Meany,
1986; Walker et ah, 1986). Speculation about the function of CYP11B3 is whether
the expression of the CYP11B3 has been made on related to the hyporesponsiveness
during the neonatal period.
7.4 Possible roles of StAR protein in adrenal development
The regulation of StAR protein expression has been established somewhat
extensively in vitro and in vivo. Changes in StAR protein and mRNA have been
linked to physiological changes in steroid secretion. In humans, StAR protein
mutation causes congenital lipoid adrenal hyperplasia with severe deficiencies
steroid hormones (Lin et al., 1995). Recently, StAR protein was found to be involved
in both the action of sodium restriction and ACTH stimulation in promoting
aldosterone and corticosterone formation in adult rat adrenals (Lehoux et al., 1998;
Lehoux et al., 1999; Peters et al., 1998). It would be of interest to investigate whether
maternal mineralocorticoid and glucocorticoid manipulations affect the change of
StAR protein or mRNA expression during various developmental stages and whether
these changes are concomitant with those of CYP11B2 and CYP11B1 in fetal or
postnatal rat adrenals.
7.5 Conclusion and future plans
The concept of fetal programming proposed by Barker and colleagues is now
widely accepted. The mechanisms linking maternal environments and later raised
blood pressure or other metabolic diseases could include programming of the HPA
axis or the RAS system. The hypothesis arising from this thesis is that over-exposure
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of the fetus to maternal glucocorticoids and to particular levels of sodium during
pregnancy leads to the alteration of steroidogenic enzyme expression, especially
CYP11B2 and CYP11B1 in fetal and postnatal rat adrenals. However, whether such
changes would persist into later life needs further investigations on several aspects.
According to the current results, some of the experiments can be expanded. This
thesis also promotes some future works on examining the RAS system in kidneys
and adrenal glands, especially renin expression levels in these two animal models.
Plasma aldosterone and corticosterone levels and blood pressure need to be
monitored in offspring. Langley-Evans et al. (1999) indicated that fetal exposure to a
maternal low protein diet impairs nephrogenesis and promotes hypertension in the
adult rat offspring (Langley-Evans et al., 1999). Therefore, it is of interest to know
whether the renal function is impaired in these two animal models, especially the salt
diet experiments. Another interesting observation in this thesis is the relationship
between medulla development and the intrauterine treatment with glucocorticoids.
Investigation of the catecholamine secretion would be of great interest in addition to
PMNT enzyme expression in relation to the histology in the adrenal medulla. Finally,
the StAR protein expression may be another key factor to study in more detail in the
rat paradigms described in this thesis.
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SPECIAL DIET SERVICES Ltd
Formula [1653] - Low Na Rat Diet
Predicted Analysis
Moisture 10.5 % Glycine 1.51 %
C Fat 7 % Aspartic 0.85 %
C Protein 14.9 % Glutamic 1.86 %
C Fibre 11.6 % Proline 0.68 %
Ash 3.03 % Serine 0.67 %
NFE 39.6 % Hydroxypro 0.028 %
DC Fat 6.3 % Calcium 0.66 %
D C Protein 13.4 % Total P 0.53 %
T D Fibre (X) oo % PhyP 0.115 %
Pectin 1.0 % AvP 0.413 %
Hemicellulose 5.3 % Na 0.014 %
Cellulose 1.96 % CI 0.054 %
Lignin 0.57 % K 0.466 %
Starch 37.55 % Mg 0.13 mg/kg
Sugar 7.7 % Fe 55.0 mg/kg
G. Energy 16.1 MJ/Kg Cu 10 mg/kg
D Energy 14.1 MJ/Kg Mn 38.2 mg/kg
M Energy 12.9 MJ/Kg Zn 29. mg/kg
Myristol 0.05 % Co 26.5 mg/kg
Palmitol 0.26 % I 39.4 Pg/kg
Oleic 1.7 % F 12.5 mg/kg
Linoleic 2.7 % Se 59 Pg/kg
Linolenic 0.09 % Retinol 1320 Pg/kg
Arachidonic 0.013 % Vit A 4356 mg/kg
Laurie 0.024 % a Tocoph 11 mg/kg
Myristic 0.025 % Vit E 62.1 mg/kg
Palmitic 0.059 % VitBl 6.55 mg/kg
Stearic 0.114 % Vit B2 5.45 mg/kg
Arginine 0.95 % Vit B6 6 mg/kg
Lysine 0.74 % Vit B12 1.1 Pg/kg
Methionine 0.3 % Vit C 2.75 mg/kg
Cystine 0.23 % Vit K 2.57 mg/kg
Tryptophan 0.15 % Folic 0.17 mg/kg
Histidine 0.36 % Nico 30.6 mg/kg
Threonine 0.56 % Panto 12.0 mg/kg
Isoleucine 0.66 % Choline 651 mg/kg
Leucine 1.33 % Inositol 1.65 Pg/kg
Phenylalanine 0.74 % Biotin 55 Pg/kg
Valine 0.72 % Carotene 2.65 mg/kg
Tyrosine 0.59 % Xanthine 8.25 mg/kg
Actual Analysis
0.03% Sodium 0.29% Chloride 0.6% Potassium
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